hgbrian/pdbbind_pp.tsv

Created September 7, 2024 00:02

Star (0) You must be signed in to star a gist
Fork (0) You must be signed in to fork a gist

Learn more about clone URLs
Clone this repository at <script src="https://gist.github.com/hgbrian/413dbb33bd98d75cc5ee6054a9561c54.js"></script>
Save hgbrian/413dbb33bd98d75cc5ee6054a9561c54 to your computer and use it in GitHub Desktop.

Download ZIP

PDB Bind protein-protein binding data parsed into tsv

Raw

pdbbind_pp.tsv

	pdb_id	resolution	year	kind	value	unit	mer	desc	num_chains
	1fc2	2.8	1981	Kd	7.647817481888637	nM	224	Human Fc fragment, Kd=22.5+/-4.6nM, SpAb-1 and Fc gamma-1, pKd=7.65	3
	3sgb	1.8	1983	Kd	10.747146969020108	pM	56	TURKEY OVOMUCOID INHIBITOR (OMTKY3), 1.79 x 10-11M	2
	2tgp	1.9	1983	Kd	5.619788758288394	uM	58	TRYPSIN INHIBITOR, 2.4 x 10-6M	2
	2ptc	1.9	1983	Kd	13.221848749616356	fM	58	Kd=6x10-14M is for trypsin and the pancreatic trypsin inhibitor	2
	2sni	2.1	1988	Kd	11.698970004336019	pM	83	CHYMOTRYPSIN INHIBITOR 2, Kd=2 x 10-12M	2
	1atn	2.8	1992	Kd	9.346787486224656	nM	260	bovine pancreatic deoxyribonuclease I, Dnase I; Kd=0.45nM	3
	1gla	2.6	1993	Kd	6.7447274948966935	uM	168	Glucose specific phosphocarrier, 1.8 x 10-7M	2
	1acb	2.0	1993	Kd	9.698970004336019	nM	70	leech (Hirudo medicinalis) protein proteinase inhibitor eglin c, 2 x 10-10M	2
	2pcc	2.3	1993	Kd	5.795880017344075	uM	108	yeast iso-1-cytochrome c, Kd=1.6uM, not found in reference	4
	2pcb	2.8	1993	Kd	5.0	uM	104	cytochrome c, Ka=10^5M-1, Kd=10-5M	3
	2sic	1.8	1993	Kd	10.147520006363143	pM	107	Streptomyces Subtilisin Inhibitor, Kd=7.12 x 10-11M	2
	2cpk	2.7	1993	Ki	8.638272163982407	nM	20	a 20-amino acid substrate analog inhibitor, Ki=2.3nM	2
	2iff	2.65	1994	Kd	8.0	nM	212	Kd(HyHEL-5/Lysozyme-R68K)=1 E-8 M, Kd(HyHEL-5/Lysozyme-WT)=2.5 E-11M	3
	1brs	2.0	1994	Kd	13.886056647693163	fM	89	barstar(C40, 82A), barnase-barstar complex, calculated Kd=1.3 E-14 M	6
	2btf	2.55	1994	Kd	5.638272163982407	uM	375	beta-actin, Kd=2.3+/-0.9uM for wildtype Profilin	2
	1vfb	1.8	1994	Kd	8.518557371497694	nM	129	hen egg white lysozyme, Kb=3.3x10^8M-1, get Kd=3.03x10-9M	3
	1hrt	2.8	1994	Kd	11.522878745280337	pM	65	noncovalent equimolar complex of hirudin with bovine thrombin, Kd=3pM	3
	1ppe	2.0	1994	Kd	11.522878745280337	pM	29	CMTI-squash inhibitor, Association constant 3.3x10^11 M-1, Kd=3pM	2
	2mta	2.4	1994	Kd	5.346787486224656	uM	105	Kd=4.5x10-6M for methylamine dehydrogenase and amicyanin; structure is ternary complex with C-type cytochrome C551I	4
	1nca	2.5	1994	Kd	8.080921907623926	nM	214	antigen-binding fragment (Fab) of monoclonal antibody NC41, fluorescence quenching Ka=12x10^7M-1, get Kd=8.3x10-9M	4
	1smf	2.1	1994	Ki	6.920818753952375	uM	22	incomplete ligand structure	2
	1ihs	2.0	1994	Ki	9.522878745280337	nM	21	hirutonin-2 with human a-thrombin, led to Ki=0.3nM	3
	1nsn	2.8	1995	Kd	10.0	nM	149	staphylococcal nuclease (SNase), Ka=1x10^10M-1, Kd=10 x 10-11M	3
	1bql	2.6	1995	Kd	7.0	uM	212	ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME, Kd=1 E-7 M	3
	1nma	3.0	1995	Kd	7.853871964321762	nM	109	N9 NEURAMINIDASE COMPLEXE WITH ANTIBODIE NC10 Fab, Kd=1.4 E-8 M	4
	1mlc	2.5	1995	Kd	7.040958607678906	nM	129	HEN EGG WHITE LYSOZYME, Kd=9.1 x 10-8M	6
	1rlb	3.1	1996	Kd	6.096910013008056	uM	174	all-trans retinoic acid-RBP, Kd=0.8uM	6
	1mah	3.2	1996	Kd	10.602059991327963	pM	61	Fasciculin 2, 2.5 x 10-11M	2
	1mtn	2.8	1996	Kd	8.022276394711152	nM	58	BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION, Kd=9.5 E-9 M	8
	1tbr	2.6	1996	Ki	12.698970004336019	pM	103	INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, monoclinic crystals, ki=2 E-13 M	6
	1tbq	3.1	1996	Ki	12.698970004336019	pM	103	INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, orthorhombic crystals, ki=2 E-13 M	6
	1dit	2.3	1996	Ki	12.0	pM	20	A DIVALENT PEPTIDE INHIBITOR CVS995, Ki=1pM	3
	1efn	2.5	1997	Kd	6.42021640338319	uM	152	HIV-1 NEF PROTEIN IN COMPLEX WITH Fyn(R96I) SH3 domain, Kd=0.38uM	4
	1akj	2.65	1997	Kd	3.899629454882437	uM	120	T-cell CD8 coreceptor, 1.26 x 10-4M	5
	1ak4	2.36	1997	Kd	4.769551078621726	uM	145	AMINO-TERMINAL Domain of HIV-1 capsid(1-151), Kd=1.7 X 10-5M, unpublished data	4
	1gua	2.0	1997	Kd	7.3979400086720375	nM	81	protein rap1a and protein C-RAF1; Kd for Rap double mutants/RafRBD	2
	1ycs	2.2	1997	Kd	7.522878745280337	nM	239	P53 core domain and 53BP2 COMPLEX, Kd~30nM	2
	1taw	1.8	1997	Ki	10.698970004336019	nM	58	BOVINE TRYPSIN COMPLEXED TO APPI, Ki<0.02nM	2
	1bth	2.3	1997	Ki	8.0	nM	58	human thrombin mutant E192Q complex with BPTI, Ki=1 E-8 M	6
	1hia	2.4	1997	Ki	7.886056647693163	nM	48	hirustasin-kallikrein complex, Ki of porcine kallikrein and hirustatin is 13nM	6
	1cbw	2.6	1997	Ki	7.795880017344075	nM	58	protein-protein	8
	1toc	3.1	1997	Ki	12.0	pM	120	ornithodorin-thrombin complex, ki=1 E-12 M	12
	1dhk	1.85	1997	Ki	10.455931955649724	pM	223	ALPHA-AMYLASE inhibitor, Ki=3.5 E-11 M	4
	1dfj	2.5	1997	Ki	13.229147988357855	fM	457	Crystal is from Cattle/pig Rnase inhibitor, Ki=59fM yeast, 67fM porcine	2
	1fle	1.9	1997	Ki	8.221848749616356	nM	57	ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE, Ki=6nM. Ki(elafin7-57/PPE)=10nM	2
	1ca0	2.1	1997	Ki	8.148741651280925	nM	54	protein-protein	8
	1b27	2.1	1998	Kd	14.0	pM	90	WT, Kd=0.01pM, ligand mutation:C40A, C82A, it is referred to as peudo wild-type	6
	1wej	1.8	1998	Kd	7.221848749616356	uM	214	FAB E8 COMPLEXED WITH HORSE CYTOCHROME C, Kd=0.6 E-7 M	3
	1a22	2.6	1998	Kd	9.468521082957745	nM	191	G120R mutant human growth hormone (hGH) and receptor, Kd=0.34+/-0.07nM	2
	1a3b	1.8	1998	Kd	9.522878745280337	nM	21	incomplete ligand structure	3
	1b2u	2.1	1998	Kd	7.0	nM	90	bnK27A-bsD35A, Kd=1 E5 pM. D35 in reference is D35 in structure	6
	1xdt	2.65	1998	Kd	8.0	nM	79	DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR, Kd=E-8~E-9M	2
	1b3s	2.39	1998	Kd	9.931814138253838	pM	90	bnH102A-bsY29F, Kd=117 pM. Y30 in reference is Y29 in structure	6
	1jrh	2.8	1998	Kd	7.847711655616943	nM	213	INTERFERON-GAMMA RECEPTOR ALPHA CHAIN(WT) and ANTIBODY A6 complex, Kd=14.2nM	3
	1axi	2.1	1998	Kd	7.853871964321762	nM	191	GROWTH HORMONE(W104A) and RECEPTOR(mutant) complex, Kd=14nM	2
	1avz	3.0	1998	Kd	4.801342913045577	uM	57	Fyn kinase SH3 domain, Kd=1.58 x 10-5M	3
	1a2k	2.5	1998	Kd	6.823908740944319	nM	127	Nuclear Transport Factor 2, microtiter plates: 240+/-90nM, microcalorimetry: 150+/-30nM, fluorescence: 75+/-40nM(yeast)	5
	1b2s	1.82	1998	Kd	9.804100347590767	pM	90	bnK27A-bsT42A, Kd=157pM. T42 in reference should be T43	6
	1wq1	2.5	1998	Kd	4.769551078621726	uM	334	Ras GAP, 1.7 x 10-5M	2
	2vir	3.25	1998	Kd	9.0	nM	210	Neutralizing Antibody Immunoglobulin (Igg1, Lambda), Kd=1nM	3
	2jel	2.5	1998	Kd	8.55284196865778	nM	217	JEL42 FAB/HPR COMPLEX, Kd=2.8nM	3
	1avg	2.6	1998	Kd	11.522878745280337	pM	142	Triabin and bovine alpha-thrombin complex, Kd=3pM	3
	2vis	3.25	1998	Kd	5.3979400086720375	uM	210	T131I BHA and Fab Kd=4uM, Wildtype HA Top and Fab Kd=5nM (code 2VIR)	3
	1avx	1.9	1998	Kd	13.221848749616356	fM	177	Soybean trypsin inhibitor (Kunitz), 6.00 x 10-14M	2
	1buh	2.6	1998	Kd	7.113509274827518	nM	79	CELL CYCLE-REGULATORY PROTEIN CKSHS1, HUMAN CDK2-CksHs1 complex, Kd=7.7 E-8 M	2
	1a4y	2.0	1998	Ki	15.0	fM	123	RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX, Ki<1fM	4
	1kig	3.0	1998	Ki	9.744727494896694	nM	60	recombinant tick anticoagulant peptide (rTAP) complexed to bovine factor Xa, Ki=0.18nM	3
	1an1	2.03	1998	Ki	9.045757490560675	nM	46	LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX, Ki=0.9nM	2
	1ldt	1.9	1998	Ki	8.744727494896694	nM	46	LEECH-DERIVED TRYPTASE INHIBITOR, Ki(bovine pancretic trypsin/rLDTI)=1.8nM	2
	1fmo	2.2	1998	Ki	8.638272163982407	nM	20	protein-protein	2
	1ahw	3.0	1998	Ki	8.468521082957745	nM	214	HUMAN TISSUE FACTOR WITH AN INHIBITORY FAB (5G9), ki=3.4+/-0.3nM	6
	1azz	2.3	1998	Ki	9.292429823902063	pM	142	FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN, Ki=510+/-60pM	4
	1bvn	2.5	1998	Ki	11.045757490560675	pM	74	PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH TENDAMISTAT, Ki=9 E-12 M	2
	1b6c	2.6	1999	Kd	6.552841968657781	uM	342	2.8 x 10-7M	8
	1ibr	2.3	1999	Kd	9.522878745280337	nM	462	Importin beta-1 subunit, 3.0 x 10-10M	4
	1flt	1.7	1999	Kd	8.867740310468955	nM	95	VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR, Kd=113x12pM	4
	1uug	2.4	1999	Kd	5.886056647693163	uM	84	URACIL-DNA GLYCOSYLASE and Uracil-DNA glycosylase inhibitor, Kd=1.3uM	4
	1lfd	2.1	1999	Kd	5.721246399047171	uM	87	Ras-Interacting Domain Of Ralgds, Kd=1.9x10-6M	4
	1kac	2.6	1999	Kd	7.8297382846050425	nM	124	Adenovirus receptor, 1.48 x 10-8M	2
	1sbb	2.4	1999	Kd	3.853871964321762	uM	239	T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH wt SUPERANTIGEN SEB, Kd=140uM	4
	1bvk	2.7	1999	Kd	7.853871964321762	nM	129	hen egg lysozyme, 1.4 x 10-8M	6
	1eer	1.9	1999	Kd	9.0	nM	166	ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 1 Kd=1nM	3
	1ay7	1.7	1999	Kd	6.0	uM	89	RIBONUCLEASE SA COMPLEX WITH BARSTAR, Kd=1 E-6 M	2
	1cn4	2.8	1999	Kd	6.0	uM	166	ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 2 Kd=1uM	3
	1qa9	3.2	1999	Kd	6.0	uM	95	hCD2-hCD58 complex, Kd=1uM, protein mutation:hCD2(K61E, F63L, T67A), hCD58(F1S, V9K, V21Q, V58K, T85S, L93G)	4
	1bj1	2.4	1999	Kd	8.468521082957745	nM	214	VEGF IN COMPLEX WITH A NEUTRALIZING ANTIBODY, Kd=3.4+/-0.9nM, IC50=4.7+/-1.1nM	6
	1grn	2.1	1999	Kd	6.411168274405792	nM	203	CDC42 GAP, Kd=3.88 x 10-7M	2
	1qfu	2.8	1999	Kd	8.522878745280337	nM	217	X31 BHA-HC45 Fab complex, IgG Kd=3+/-1nM	6
	1vrk	1.9	1999	Kd	8.167491087293763	nM	21	E84K-CALMODULIN and RS20 PEPTIDE COMPLEX, 6.8+/-5.2nM	2
	1qse	2.8	1999	Kd	5.142667503568732	uM	100	TCR-pMHC complex;	5
	4thn	2.5	1999	Ki	10.045757490560675	nM	26	incomplete ligand structure	3
	1ava	1.9	1999	Ki	9.657577319177793	nM	181	AMY2/BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR COMPLEX, ki=2.2 E-10 M, PH8	4
	1qur	2.0	1999	Ki	12.537602002101044	pM	22	protein-protein	3
	1fak	2.1	1999	Ki	9.397940008672037	nM	58	protein-protein	4
	1cmx	2.25	1999	Ki	5.769551078621726	uM	76	yeast UCH yuh1 complex with ubiquitin aldehyde, ki=1.7+/-0.38uM	4
	1fg9	2.9	2000	Kd	10.0	nM	134	IFN-gamma Receptor alpha chain binds IFN-gamma, Kd=1 E-10M	5
	1cz8	2.4	2000	Kd	9.958607314841775	nM	213	VEGF(109):Y0317 Fab complex, Kd=0.11+/-0.02nM. protein residue:4-107	6
	1g9i	2.2	2000	Kd	6.920818753952375	uM	22	BOWMAN-BIRK TYPE TRYPSIN INHIBITOR, SPC1 with bovine beta-trypsin, Ki=1.2 X 10-7M	2
	1d6r	2.3	2000	Kd	9.886056647693163	nM	58	bovine TRYPSIN COMPLEXED WITH soybean Bowman-Birk inhibitor, Ki=0.13nM	2
	1fsk	2.9	2000	Kd	9.619788758288394	nM	159	major allergen from birch pollen Bet v 1-A, 2.4 x 10-10M	12
	1ffx	3.95	2000	Kd	6.698970004336019	uM	91	PROTEIN (STATHMIN-LIKE DOMAIN OF RB3); Kd for tubulin/stathmin	5
	1dee	2.7	2000	Kd	6.3979400086720375	uM	214	domain D of SpA complex with the Fab fragment of IgM antibody, Kd=0.4-5.0uM	8
	1e4k	3.2	2000	Kd	5.769551078621726	uM	176	Immobilized HUMAN IGG1 FC FRAGMENT and FC-GAMMA RECEPTOR III COMPLEX	5
	1qfw	3.5	2000	Kd	8.0	nM	114	ternary complex of hCG and Fv2, Anti alpha Kd=1E-8M, Anti beta Kd=1E-10M	6
	1qty	2.7	2000	Kd	11.0	pM	102	VEGF and Flt-1D2 complex, Kd=10pM	8
	1du3	2.2	2000	Kd	7.798602875679548	nM	168	wild type TNF-RELATED APOPTOSIS INDUCING LIGAND-sDR5 complex, Kd=1.59+/-0.23 E-8M	12
	1e96	2.4	2000	Kd	5.568636235841013	uM	203	NEUTROPHIL CYTOSOL FACTOR 2 (NCF-2) TPR DOMAIN	2
	1dqj	2.0	2000	Kd	8.55284196865778	nM	129	hen egg white lysozyme	3
	1emv	1.7	2000	Kd	13.619788758288394	fM	86	cognate immunity protein Im9, Kd=2.4+/-0.4x10-14M	2
	1de4	2.8	2000	Kd	7.619788758288394	nM	640	Transferrin receptor ectodomain, 2.4 x 10-8M	9
	1e6j	3.0	2000	Kd	7.5376020021010435	nM	210	HIV-capsid protein 24, 2.9 x 10-8M	3
	1djs	2.4	2000	Kd	7.3872161432802645	nM	135	1:1 FGF1:FGFR2 complex, compatible with FGF2:FGFR1 complex, Kd=41nM	2
	1dzb	2.0	2000	Kd	6.2839966563652006	nM	253	Fv 1F9 in complex with turkey egg-white lysozyme (TEL), Kd=5.2 E-7 M	4
	1f3v	2.0	2000	Kd	5.107905397309519	uM	171	native TRADD-N/TRAF2 Complex, Kd=7.8+/-3.6uM	2
	1g6v	3.5	2000	Kd	7.142667503568732	nM	126	CAB-CA05 binds to bovine carbonic anhydrase, Kd=72nM	2
	1eo8	2.8	2000	Kd	8.050609993355087	nM	210	X31 HA with the Fab fragment of antibody BH151 Complex, Kd=8.9+/-2nM	6
	1efx	3.0	2000	Kd	5.022276394711152	uM	200	protein-protein; Kd for kir2dl2/hla-cw3	5
	1clv	2.0	2000	Kd	9.0	nM	32	complex between TMA andalpha-amylase inhibitor (AAI); Kd should be nanomolar range	2
	1ezu	2.4	2000	Ki	10.096910013008056	nM	142	Ecotin Y69F, D70P BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.08nM	4
	1ezs	2.3	2000	Ki	9.744727494896694	nM	142	Ecotin 67-70A, M84R BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.18nM	4
	1dp5	2.2	2000	Ki	9.045757490560675	nM	68	PROTEINASE A COMPLEXED WITH IA3 MUTANT INHIBITOR(K31M, K32M), Ki=0.9+/-0.3nM	3
	1c9t	3.3	2000	Ki	9.0	nM	59	BDELLASTASIN WITH BOVINE TRYPSIN, Ki=1.0nM nanomolar range	12
	1c9p	2.8	2000	Ki	9.0	nM	59	BDELLASTASIN WITH PORCINE TRYPSIN, Ki=1.0nM nanomolar range	2
	1icf	2.0	2000	Ki	11.769551078621726	pM	65	P41 II FRAGMENT binds to CATHEPSIN L, Ki=1.7pM	6
	1dpj	1.8	2000	Ki	8.522878745280337	nM	33	IA3 residues 2-34, ki=3+/-0.6nM	3
	1fy8	1.7	2000	Ki	5.045757490560675	uM	58	BPTI complexes of rat Delta I16V17 trypsinogen, Ki=9uM	2
	1hqr	3.2	2001	Kd	7.0	uM	208	MHC class II binds bacterial SAGs on beta chain, Kd=1 E-7M	4
	1i4e	3.0	2001	Kd	6.920818753952375	uM	299	EARLY P35 KDA PROTEIN, Kd=1.16+/-0.01 X 10-7M, with caspase-3	2
	1hez	2.7	2001	Kd	6.838631997765025	uM	214	PpL domain C(D55A-Y64W mutant) Complexed with Human IgM Fab 2A2, Kd=0.145uM	5
	1f34	2.45	2001	Kd	10.0	nM	149	pepsin inhibitor-3 (PI-3) from Ascaris suum, KI=0.10x10-9M	2
	1i8l	3.0	2001	Kd	6.698970004336019	uM	208	HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX, Kd=0.2-0.4uM	4
	1hxy	2.6	2001	Kd	9.301029995663981	nM	182	SEH IN COMPLEX WITH HLA-DR1, Kd=0.5nM, Bmax, 1/2=0.5nM	4
	1e6e	2.3	2001	Kd	6.0655015487564325	uM	128	Adrenoxin, 0.86 x 10-6M	4
	1ffw	2.7	2001	Kd	5.920818753952375	uM	134	kinase cheA(124-257)	4
	1iqd	2.0	2001	Kd	10.853871964321762	pM	211	human monoclonal BO2C11 Fab, 1.4 x 10-11M	3
	1gcq	1.68	2001	Kd	4.774690718274138	uM	70	VAV PROTO-ONCOGENE, Kd=16.8+/-0.5uM, protein-protein complex	3
	1e3u	1.66	2001	Kd	6.0	uM	246	MAD phasing OXA10, dimeric, KD~1uM	4
	1i2m	1.76	2001	Kd	11.602059991327963	pM	402	chromosome condensation (RCC1), Kinetics constant K2=4x10^11 M-1, Kd=2.5pM	4
	1he8	3.0	2001	Kd	5.6020599913279625	uM	965	phosphoinositide 3-kinase gamma, 2.5 x 10-6M	2
	1hcf	2.7	2001	Kd	9.585026652029182	pM	130	TrkB-d5:neurotrophin-4/5 complex, with BDNF Kd=790nM	4
	1fe8	2.03	2001	Kd	5.698970004336019	uM	210	Multimeric vWF binds RU5(collagen inhibitor), collagen Kd=1-7nM. recombinant A3 binds RU5, Kd=2uM	12
	1ewy	2.38	2001	Kd	5.447331783887807	uM	98	Ferredoxin	3
	1ib1	2.7	2001	Kd	3.4559319556497243	uM	245	14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX(2:1), Kd=350+/-24uM	8
	1j7v	2.9	2001	Kd	10.455931955649724	pM	160	HUMAN IL-10/IL-10R1 COMPLEX, Kd=35-200pM	2
	1i4d	2.5	2001	Kd	5.522878745280337	uM	192	protein RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1	3
	1i5k	2.7	2001	Kd	7.376750709602099	nM	30	Kd=42+/-5nM, mK2pg complex with VEK-30	4
	1jiw	1.74	2001	Kd	11.397940008672037	pM	106	APR-alkaline protease inhibitor complex, Kd=4pM	2
	1fqj	2.02	2001	Kd	7.173925197299173	nM	325	ligand is complex of GAMMA SUBUNIT OF PHOSPHODIESTERASE and GT/I1 CHIMERA ALPHA SUBUNIT, Kd=6.7 x 10-8M	5
	1j7d	1.85	2001	Kd	5.698970004336019	uM	145	UBIQUITIN-CONJUGATING ENZYME E2-17 KDA and hMms2 (Uev1), Kd~2uM	2
	1g0v	2.0	2001	Ki	10.0	nM	31	PROTEASE A INHIBITOR 3, K24M MUTANT OF IA3, ki=1.3+/-0.4nM (pH=3.1); ki<0.1nM (pH=4.7)	3
	1jtg	1.73	2001	Ki	9.958607314841775	nM	165	inhibition of TEM-1 by beta-lactamase inhibitor protein, Ki=0.11nM	4
	1gl1	2.1	2001	Ki	9.886056647693163	nM	36	BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, Ki=0.13nM	6
	1gl0	3.0	2001	Ki	9.096910013008056	nM	35	BOVINE ALPHA-CHYMOTRYPSIN AND PMP(R29L), Ki=0.8nM; Ki(PMP, K30M)=2nM	2
	1i3o	2.7	2001	Ki	9.013228265733755	nM	121	Inhibition of XIAP BIR2 on Caspase-3, Ki=9.7+/-5.0 E-10M	6
	1eja	2.7	2001	Ki	9.0	nM	59	PORCINE beta TRYPSIN COMPLEXED WITH BDELLASTASIN, Ki=1.0nM	2
	1id5	2.5	2001	Ki	8.823908740944319	nM	142	bovine thrombin in complex with ecotin M84R mutant, Ki=1.5nM	3
	1f7z	1.55	2001	Ki	4.906578314837765	uM	65	BPTI complexes of rat K15A trypsinogen, Ki=12.4uM	2
	3tgk	1.7	2001	Ki	4.920818753952375	uM	65	ligand is BPTI, ITC Ki=12uM, enzyme inhibition Ki=29uM	2
	1jtd	2.3	2001	Ki	10.5654310959658	pM	273	inhibition of TEM-1 by beta-lactamase inhibitor protein II, Ki=0.0272nM	2
	1f5r	1.65	2001	Ki	4.187086643357144	uM	65	BPTI complexes of rat Delta I16V17/Q156K trypsinogen, Ki=65uM	2
	1gpw	2.4	2002	Kd	7.721246399047171	uM	201	AMIDOTRANSFERASE HISH, Kd=0.019+/-0.009uM	6
	1jmo	2.2	2002	Kd	6.939302159646388	uM	480	wild type recombinant Heparin Cofactor II with thrombin, Kd=kd/ka=1.5x10-3/1.3x104=1.15x10-7M	4
	1jps	1.85	2002	Kd	10.0	nM	214	tissue factor in complex with humanized Fab D3h44, Kd=0.1nM	3
	1lm8	1.85	2002	Kd	6.657577319177793	uM	20	intact HIF-1a-pVHL-ElonginB-ElonginC Complex, Kd=0.22+/-0.04uM	4
	1lzw	2.5	2002	Kd	6.481486060122113	uM	146	wild type ClpS with N-Ternimal domain of ClpA, Kd=3.3 X 10-7M; structure is H66A mutant ClpS and ClpA;Kd=1uM is for E79A, K84A double mutant ClpS	2
	1l2w	2.0	2002	Kd	9.522878745280337	nM	123	SycE-YopE complex, Kd=0.3nM	12
	1i51	2.45	2002	Kd	6.200659450546418	uM	117	structure is CASPASE-7 with XIAP; binding data is for caspase-7 and GST-linker peptide (residues 124-157); Kd=0.63+/-0.04uM	6
	1go4	2.05	2002	Kd	5.982966660701219	uM	100	MAD1 (MITOTIC ARREST DEFICIENT)-LIKE 1, mad1-mad2 complex	8
	1jwh	3.1	2002	Kd	7.8996294548824375	nM	215	ligand is Human Protein Kinase CK2 Holoenzyme beta chain, 1.26 x 10-8M	4
	1l4z	2.8	2002	Kd	6.706416486503883	nM	248	SKa delta-Plasminogen uPg(R561A, S741A) complex(Form II) in presence of CADMIUM IONS, Kd=196.6+/-2.4nM	2
	1l4d	2.3	2002	Kd	6.706416486503883	nM	249	SKa delta- PLASMINOGEN u Pg(S741A) complex(Form I), Kd=196.6+/-2.4nM	2
	1kxp	2.1	2002	Kd	9.0	nM	458	HUMAN VITAMIN D-BINDING PROTEIN with actin	2
	1mxe	1.7	2002	Kd	12.0	pM	148	complex between Calcium-saturated calmodulin (CaM) and CaMKIp	4
	1k5d	2.7	2002	Kd	6.0	uM	386	Kd between Ran-GppNHp-RanBP1 and RanGAP in buffer containing 0M NaCl	12
	1k93	2.95	2002	Kd	7.698970004336019	nM	144	anthrax edema factor (EF) in complex with calmodulin(CaM), Kd=20nM	6
	1ktk	3.0	2002	Kd	4.698970004336019	uM	247	SpeC(C13A, C191A) with T cell receptor beta chain, Kd=2 E-5M	6
	1i8k	1.8	2002	Kd	7.657577319177793	nM	107	DSFV MR1 binds to EGFRVIII PEPTIDE ANTIGEN(Liquid Nitrogen Temp), Kd=22nM	3
	1kxt	2.0	2002	Kd	6.628932137728263	nM	127	PPA/IMMUNOGLOBULIN VHH FRAGMENT AMB7 complexs, Kd=235nM	6
	1ijk	2.6	2002	Kd	7.638272163982407	nM	125	vWF A1 domain-botrocetin Complex, Kd=23nM	3
	1kgy	2.7	2002	Kd	7.6020599913279625	nM	138	EphB receptor 2-ephrinB2 complex, Kd=25nM	8
	1kxv	1.6	2002	Kd	7.6020599913279625	nM	121	PPA/CAMELID VHH DOMAIN CAB10, AMD10 complexs	4
	1lj2	2.38	2002	Kd	4.568636235841013	uM	28	PABP.NSP3-C with eukaryotic protein synthesis initiation factor, eIF4G	4
	1ktz	2.15	2002	Kd	6.5376020021010435	nM	112	ligand is TGF-beta3, 2.9 x 10-7M	2
	1lw6	1.5	2002	Kd	11.698970004336019	pM	64	subtilisin BPN-Chymotrypsin Inhibitor 2(E45A) complex, Kd=2 E-12M	2
	1kxq	1.6	2002	Kd	8.455931955649724	nM	120	porcine pancreatic alpha-amylase PPA, with AMD9 VHH	8
	1lqb	2.0	2002	Kd	7.508638306165727	nM	34	Binding of VCB to HIF-1a peptides, Kd=3.1 E-8M	4
	1h59	2.1	2002	Kd	7.431798275933005	nM	70	COMPLEX OF IGFBP-5 WITH IGF-I, Kd=37nM	2
	1gng	2.6	2002	Kd	7.4089353929735005	nM	26	protein-protein	4
	1kkl	2.8	2002	Kd	7.346787486224656	nM	100	B.subtilis phosphocarrier protein HPr	6
	1eaw	2.93	2002	Kd	10.303643611266669	pM	58	BPTI	4
	1lqs	2.7	2002	Kd	8.397940008672037	nM	157	INTERLEUKIN-10-LIKE PROTEIN cmvIL-10 bound to sIL-10R1, Kd=4nM	4
	1gxd	3.1	2002	Kd	8.2839966563652	nM	194	tissue inhibitor of metalloproteinase 2, high affinity site Kd=5.2nM, low affinity site Kd=0.19uM	4
	1m10	3.1	2002	Kd	8.236572006437063	nM	208	complex of Glycoprotein Ib- alpha (M239V)and vWF A1 Domain(R543Q), Kd=5.8nM	2
	1l0x	2.8	2002	Kd	5.221848749616356	uM	221	Exotoxin type A SpeA without zinc, Kd~6 X 10-6M	4
	1m1e	2.1	2002	Kd	9.0	nM	81	ICAT protein, approximately interaction Kd~1nM	2
	1l0y	2.5	2002	Kd	5.221848749616356	uM	221	Exotoxin type A SpeA with zinc, Kd~6 X 10-6M	4
	1ob1	2.9	2003	Kd	9.698970004336019	nM	215	mAb G17.12 binds to PfMSP1-19, Kd=2 E-10 M	6
	1ogy	3.2	2003	Kd	9.301029995663981	nM	130	di-heme cytochrome C NapB molecule cytochrome subunit, estimated Kd=0.1-1.5nM	16
	1op9	1.86	2003	Kd	9.154901959985743	nM	121	human lysozyme Complex with HL6 camel VHH fragment, Kd=0.7nM	2
	1p27	2.0	2003	Kd	9.154901959985743	nM	106	Human Y14/Magoh complex, Kd=0.7+/-0.1nM	4
	1p9m	3.65	2003	Kd	9.096910013008056	nM	299	for Interleukin-6 Receptor alpha with gp130 D2-D3, Kd=40nM	3
	1lx5	3.3	2003	Kd	8.920818753952375	nM	139	Immobilized Receptor, bone morphogenetic protein 7 BMP7/ActRII Complex, Kd=1.2nM	3
	1p3q	1.7	2003	Kd	5.920818753952375	uM	76	ubiquitin, Kd=1.2uM	4
	1n64	2.34	2003	Kd	8.886056647693163	nM	218	Hepatitis C virus protein P13-40 bound to mAb 19D9D6, Kd=1.3+/-0.1nM	3
	1j2j	1.6	2003	Kd	5.853871964321762	uM	45	ADP-ribosylation factor binding protein GGA1	2
	1mzw	2.0	2003	Kd	5.7055337738384075	uM	31	U4/U6-60K peptide bind to CypH, Kd=1.97uM	2
	1oqe	2.5	2003	Kd	6.962573502059376	nM	144	tumour necrosis factor (TNF) ligand sTALL-1 and eBAFF-R(1-62), Kd=109nM	18
	1nys	3.05	2003	Kd	8.0	nM	116	Activin A, space group p41 form, Kd<10nM	4
	1nyu	3.1	2003	Kd	8.0	nM	116	Activin A, space group p41212 form, Kd<10nM	4
	1mi5	2.5	2003	Kd	5.0	uM	201	LC13 TcR in complex with HLAB8-EBV peptide complex	5
	1uad	2.1	2003	Kd	6.863279432843593	nM	99	Exocyst complex component Sec5	4
	1pjm	2.5	2003	Kd	6.7447274948966935	nM	20	Kd=180nM, for mouse Importin-alpha alone, with RB, human retinoblastoma protein	2
	1mhh	2.1	2003	Kd	9.0	nM	220	a protein L mutant complexed to an Fab fragment, Kd=1nM	6
	1m5n	2.9	2003	Kd	8.67778070526608	nM	28	importin beta (1-485):PTHrP-ncNLS(67-94)	2
	1pjn	2.5	2003	Kd	7.657577319177793	nM	21	Kd=22nM, for mouse Importin-alpha alone with X. laevis phosphoprotein N1N2	2
	1h1v	3.0	2003	Kd	7.638272163982407	nM	331	GELSOLIN G4-G6 RESIDUES 412-742, Kd=2.3 x 10-8M	2
	1r0r	1.1	2003	Kd	10.531652669587842	pM	51	Protein Inhibitor OMTKY3, Ka=3.4x10^10 M-1, Kd=2.94x10-11M	2
	1uex	2.85	2003	Kd	8.698970004336019	nM	125	von Willebrand Factor A1 domain complex with bitiscetin, Kd=2nM	3
	1lp1	2.3	2003	Kd	5.698970004336019	uM	58	protein Z and the antiprotein A affibody ZSPA-1, Kd=2-6uM	2
	1p4l	2.9	2003	Kd	5.522878745280337	uM	122	peptide-selective receptor Ly49C	4
	1mq8	3.3	2003	Kd	5.522878745280337	uM	291	alphaL I Domain(L161C, F299C) Binding to ICAM-1, Kd=3.0+/-0.44uM	8
	1p22	2.95	2003	Kd	6.318758762624412	nM	26	beta-TrCP1-Skp1 and beta-catenin complex, Kd=480+/-40nM	3
	1oey	2.0	2003	Kd	8.397940008672037	nM	83	HETERODIMER OF P40PHOX AND P67PHOX PB1 DOMAINS, Kd=4nM	8
	1o95	3.7	2003	Kd	5.301029995663981	uM	264	TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group p21	6
	1pvh	2.5	2003	Kd	7.096910013008056	nM	169	human leukemia inhibitory factor (LIF)/gp130-CHR Complex, Kd=80+/-6.2nM	4
	1p1z	3.26	2003	Kd	4.096910013008056	uM	120	LY49-C antigen; Kd for H-2Kb-OVAwt Ly49C	4
	1nez	2.1	2003	Kd	5.0	uM	274	TL, a non-classical MHC class I molecule/CD8 alpha alpha Complex, Kd~10uM	4
	1oc0	2.28	2003	Kd	9.0	nM	51	Somatomedin B Domain Of Vitronectin	2
	1nvu	2.2	2003	Kd	5.443697499232713	uM	481	Son of sevenless protein homolog 1, residues 566-1046	3
	1nf3	2.1	2003	Kd	7.301029995663981	nM	128	GTPase-binding domain of the cell polarity protein, Par6	4
	1oph	2.3	2003	Kd	8.301029995663981	nM	394	ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN, Kd=5nM. Ligand mutations:F51L, T59A, T68A, A70G, C232S, M358R, M274I, S381A, K387R	2
	1o94	2.0	2003	Kd	5.301029995663981	uM	264	TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group C2	6
	1nw9	2.4	2003	Ki	7.886056647693163	uM	98	XIAP-BIR3, Ki=0.013uM	2
	1pxv	1.8	2003	Ki	9.508638306165727	nM	111	cysteine protease Inhibitor, Staphostatins, Ki=3.1x10-10M	4
	1p0s	2.8	2003	Ki	10.958607314841775	pM	142	Blood Coagulation Factor Xa Complex with Ecotin M84R, Ki=11pM	3
	1nb5	2.4	2003	Ki	10.161150909262744	pM	220	stefin A and stefin B complex with cathepsin H, Ki=0.027nM and Ki=0.069nM, author confuse two data himself	16
	1mcv	1.8	2003	Ki	7.008773924307505	nM	28	hybrid squash inhibitor HEI-TOE I and porcine pancreatic elastase complex, Ki=9.8 X 10-8M	2
	1oyv	2.5	2003	Ki	8.045757490560675	nM	123	tomato inhibitor-II complex with subtilisin Carlsberg, Ki=9nM	3
	1ry7	3.2	2004	Kd	6.638272163982407	uM	155	3 Ig form of FGFR3c in complex with full length FGF1, Kd=2.3 E-7 M	2
	1u0s	1.9	2004	Kd	6.638272163982407	uM	118	CheA P1-P2 domain and CheY for T. maritima, Temp.28 Kd=0.23+/-0.02uM, Temp.70 Kd=1.0+/-0.2uM	2
	1xqh	1.75	2004	Kd	6.698970004336019	uM	20	incomplete ligand structure	4
	1xd3	1.45	2004	Kd	6.522878745280337	uM	75	UBC protein, Kd=3 x 10-7M	4
	1t6b	2.5	2004	Kd	9.397940008672037	nM	189	Anthrax toxin receptor 2, 4.0 x 10-10M	2
	1nl0	2.2	2004	Kd	8.795880017344075	nM	213	human factor IX Gla domain complex with inhibitory antibody 10C12, Kd=1.6nM. one of the smallest interface between protein-anti body complexes	3
	1tzh	2.6	2004	Kd	8.744727494896694	nM	213	Fab YADS1 Complexed with h-VEGF, Kd=1.8+/-0.3nM	6
	1us7	2.3	2004	Kd	5.7447274948966935	uM	265	COMPLEX OF yeast N-HSP90 AND C-P50	2
	1tzi	2.8	2004	Kd	8.0	nM	214	Fab YADS2 Complexed with h-VEGF, Kd=10+/-2nM	3
	1sv0	2.07	2004	Kd	7.954677021213342	nM	82	Yan-SAM A86R/Mae-SAM Complex, Kd=11.1+/-0.1nM	4
	1vet	1.9	2004	Kd	7.892790030352131	nM	125	Late endosomal/lysosomal Mp1 interacting protein, code 1veu is the same protein at 2.15A	2
	1veu	2.15	2004	Kd	7.892790030352131	nM	126	p14/MP1 complex, resolution=1.9 or 2.15 angstrom? Kd=12.8nM	2
	1tdq	2.6	2004	Kd	7.920818753952375	nM	283	CLD:rat tenascin-R(TN3-5), Kd=12nM	2
	1syq	2.42	2004	Kd	7.8326826652518236	nM	25	Kd for vinculin binding site 1 (VBS1)=14.7nM, VBS2=32.8nM, VBS3=3.1nM	2
	1w72	2.15	2004	Kd	7.853871964321762	nM	210	HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3	10
	1tzn	4.3	2004	Kd	9.769551078621726	pM	181	CMG2 VWA domain protein, Kd=170pM	28
	1sg1	2.4	2004	Kd	6.730487055782084	nM	120	2:1 Nerve Growth Factor/p75 complex, Kd=186nM	3
	1t44	2.0	2004	Kd	6.0	uM	370	actin with chimera of gelsolin domain 1 and c-terminal	2
	1th1	2.5	2004	Kd	8.67778070526608	nM	179	Beta-catenin(full length) complex with a phosphorylated APC-2, 3 , Kd=2.1nM	4
	1sy6	2.1	2004	Kd	5.563837352959244	uM	213	CD3 epsilon gamma Heterodimer in Complex with OKT3 Fab, Kd=27.3+/-4.74 E-7 M	3
	1xt9	2.2	2004	Kd	6.698970004336019	nM	76	Den1 in complex with Nedd8, Kd=200nM	2
	1vyt	2.6	2004	Kd	7.698970004336019	nM	25	alpha interaction domain 1, AID with beta subunit, Kd=20nM	4
	1w1w	2.9	2004	Kd	3.5850266520291822	uM	121	protein-protein; Kd of two Smc1hd/Scc-C monomers	8
	1u7v	2.7	2004	Kd	6.528708288941061	nM	236	Smad2/Smad4 heterotrimeric complex, Kd=296+/-165.8nM	3
	1usu	2.15	2004	Kd	5.481486060122113	uM	170	COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form1, Kd=3.3+/-0.8uM	2
	1usv	2.7	2004	Kd	5.481486060122113	uM	170	COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form2, Kd=3.3+/-0.8uM	8
	1sq0	2.6	2004	Kd	7.522878745280337	nM	214	wt Von Willebrand Factor A1 domain and Glycoprotein Ib alpha, Kd=30nM	2
	1p6a	2.9	2004	Kd	7.455931955649724	nM	185	Ad12 knob mutants S489Y-CAR D1, Kd=35+/-4.4nM	2
	1rkc	2.7	2004	Kd	7.4089353929735005	nM	26	Vh domain in complex with talin vinculin-binding site3 VBS3, Kd=39nM	2
	1t01	2.06	2004	Kd	7.4089353929735005	nM	24	still vh, talin 482-636, with talin (vinculin binding site 1)VBS1, IC50=3nM	2
	1p4b	2.35	2004	Kd	10.397940008672037	pM	135	sc Fv Fragment Complexed With The peptide GCN4(7P-14P), Kd=40pM	3
	1oyh	2.62	2004	Kd	7.376750709602099	nM	432	Antithrombin-III beta glycoform, ionic strength=2, Kd=4.2+/-0.1 X 10-8M	5
	1rvj	2.75	2004	Kd	5.3979400086720375	uM	260	RH(H177) revertant RC in the trigonal form, Kd=4+/-1uM	3
	1rke	2.35	2004	Kd	7.301029995663981	nM	185	vinculin head (1-258) complex with vinculin tail (879-1066), Kd=50-80nM	2
	1u7f	2.6	2004	Kd	7.236572006437063	nM	239	Smad3/Smad4 heterotrimeric complex, Kd=58+/-2.9nM	3
	1vg0	2.2	2004	Kd	8.301029995663981	nM	207	protein-protein; Kd for Rab7/REP-1	2
	1ty4	2.2	2004	Kd	8.193820026016112	nM	170	EGL-1 with cell-killing caspase CED-9, Kd=6.4nM	4
	1s4y	2.3	2004	Kd	8.16304326294045	nM	98	two ActRIIb-ECD, Kd=6.87nM	4
	1p69	3.1	2004	Kd	7.119186407719209	nM	185	Ad12 knob mutants P417S-CAR D1, Kd=76+/-4.1nM	2
	1shy	3.22	2004	Kd	7.045757490560675	nM	234	HGF beta complex with Met ECD, Kd=90nM	2
	1p2c	2.0	2004	Kd	10.008773924307505	pM	129	Lysozyme C, Ka=1.02x10^10 M-1, Kd=0.98x10-10M	6
	1s1q	2.0	2004	Kd	3.3010299956639813	uM	76	TSG101 UEV-Ubiquitin complex, Kd~500uM	4
	1nm5	2.4	2004	Kd	7.221848749616356	nM	203	(dI.Q132N)2(dIII)1 asymmetric complex, Kd~60nM	3
	1tm7	1.59	2004	Ki	11.481486060122112	nM	64	protein-protein	2
	1tm1	1.7	2004	Ki	11.522878745280337	nM	64	protein-protein	2
	1tm5	1.45	2004	Ki	10.769551078621726	nM	64	protein-protein	2
	1tm3	1.57	2004	Ki	10.721246399047171	nM	64	protein-protein	2
	1tm4	1.7	2004	Ki	9.886056647693163	nM	64	protein-protein	2
	1to1	1.68	2004	Ki	9.337242168318426	nM	64	protein-protein	2
	1tt5	2.6	2004	Ki	4.657577319177793	uM	26	Ubc12 N-terminus Ubc12N26, Ki=22+/-5uM	6
	1uuz	1.8	2004	Ki	7.6020599913279625	nM	137	Ki app=25nM	4
	1te1	2.5	2004	Ki	8.468521082957745	nM	190	family 11 xylanase (GH11) in complex with inhibitor (XIP-I), Ki=3.4nM	2
	1ta3	1.7	2004	Ki	8.045757490560675	nM	303	xylanase (GH10) in complex with inhibitor (XIP), Ki=9nM	2
	2ass	3.0	2005	Kd	8.221848749616356	uM	69	protein-protein	3
	1vyh	3.4	2005	Kd	7.096910013008056	uM	410		20
	1z7x	1.95	2005	Kd	15.537602002101044	fM	461	Ribonuclease inhibitor-RNase 1 complex, Kd=2.9x10-16M	4
	1zhi	2.7	2005	Kd	6.698970004336019	uM	138	Regulatory protein SIR1, 2 x 10-7M	2
	1r6q	2.35	2005	Kd	6.481486060122113	uM	106	ligand is ATP-dependent Clp protease adaptor protein clpS, Kd=3.3 x 10-7M	4
	1zm4	2.9	2005	Kd	6.008773924307505	uM	207	exotoxin A	6
	1y8n	2.6	2005	Kd	5.931814138253839	uM	97	protein-protein	2
	2c1m	2.2	2005	Kd	8.958607314841775	nM	46	NUP50(1-109):IMPORTIN-ALPHA(70-529) COMPLEX, Kd=1.1+/-0.2nM. Structure is not intact.	2
	1ze3	1.84	2005	Kd	5.920818753952375	uM	125	Complex of FimD N-terminal domain with FIMC and the Pilin Domain of FIMH, Kd=1.2uM	3
	1uwx	2.2	2005	Kd	5.795880017344075	uM	225	P1.2 SEROSUBTYPE ANTIGEN IN COMPLEX WITH FAB FRAGMENT, Kd=1.6+/-0.5uM	8
	1ydi	1.8	2005	Kd	8.749579997691106	nM	24	ligand is Alpha-actinin 4, Kd=1.78nM	2
	2b4j	2.02	2005	Kd	7.962573502059376	nM	98	IN-binding domain of lens epithelium-derived growth factor (LEDGF), 1.09 x 10-8M	4
	2b0z	2.7	2005	Kd	4.0	uM	108	F82I cytochrome c and cytochrome c peroxidase, Kd=100uM	2
	1v18	2.1	2005	Kd	8.0	nM	47	BETA-CATENIN(full length) COMPLEXED WITH PHOSPHORYLATED APC R3, Kd=10+/-1.3nM	2
	1z92	2.8	2005	Kd	8.0	nM	219	Interleukin-2 Complexed with Its Alpha Receptor, low Kd=10nM	2
	2ajf	2.9	2005	Kd	8.0	nM	180	SARS-CoV RBD and human ACE2 complex, Kd=1 E-8 M	6
	2b5i	2.3	2005	Kd	11.0	pM	133	Interleukin-2 alpha beta gamma chain, quaternary complex, Kd=10pM. Protein mutation:alpha, N68Q; beta, N3, 17, 45Q; gamma, N53Q	6
	2b10	2.8	2005	Kd	5.0	uM	108	F82S cytochrome c and cytochrome c peroxidase, Kd=10uM	4
	1x1y	1.9	2005	Kd	4.896196279044043	uM	90	barnase(Q2A)-barstar(D35A), Kd=1.27 E-7 M, ligand mutation:D35A, C40A, C82A	6
	2aep	2.1	2005	Kd	7.920818753952375	nM	214	Memphis/98 NA-Mem5 fab complex, frozen crystals(-166 centigrade ), Kd=12nM	4
	2aeq	3.0	2005	Kd	7.920818753952375	nM	214	Memphis/98 NA-Mem5 fab complex, room temperature(20 centigrade ), Kd=12nM	3
	1x1u	2.3	2005	Kd	7.87942606879415	nM	89	barnase(wt)-barstar(pwt), Kd=1.32 E-10 M, ligand mutation:C40A, C82A	6
	2bnr	1.9	2005	Kd	4.876148359032914	uM	100	TCR-pMHC complex;	5
	1wdw	3.0	2005	Kd	7.844663962534938	nM	385	Tryptophan synthase beta chain, K=0.7x10^8M-1, Kd=1.43x10-8M, temperature is 35 degree	12
	1t63	2.07	2005	Kd	4.823908740944319	uM	20	incomplete ligand structure	2
	1x75	2.8	2005	Kd	7.756961951313706	nM	101	GyrA14 protects against Cytotoxic protein ccdB, Kd=17.5nM	4
	1y6m	2.8	2005	Kd	6.761953896871205	nM	145	Epstein-Barr virus IL-10 and sIL-10R1 complex, Kd=173nM	2
	1yd8	2.8	2005	Kd	3.7423214251308154	uM	98	ligand is GAT domain of GGA3, Kd=181+/-39uM	4
	1y6k	2.52	2005	Kd	9.0	nM	214	ligand is Interleukin-10 receptor alpha chain, ITC Kd=1nM, solution affinity Kd=8nM	2
	1yru	2.5	2005	Kd	9.0	nM	74	wild type CyaA-ACD and C-CaM complex with exogenous CaCl2, Kd=1nM	2
	2bp7	2.9	2005	Kd	9.0	nM	339	the peripheral subunit binding domain (PSBD) E2, Kd less than 10-9M	8
	2c1t	2.6	2005	Kd	8.698970004336019	nM	51	KAP60P:NUCLEOPORIN NUP2 COMPLEX, Kd=2.0+/-0.2nM	4
	1yy9	2.6	2005	Kd	8.638272163982407	nM	213	sEGFR binds to immobilized FabC225, Kd=2.3+/-0.5nM	7
	2byk	2.4	2005	Kd	5.638272163982407	uM	140	CHRAC14 and CHRAC16 HETERODIMER, crystal form I, Kd=2.3uM	4
	2bym	2.8	2005	Kd	5.638272163982407	uM	140	CHRAC14 and CHRAC16 HETERODIMER, crystal form II, Kd=2.3uM	4
	2be6	2.0	2005	Kd	8.580044251510243	nM	150	ligand is Ca2+/CaM C lobe, for C lobe Kd=2.63+/-0.07nM, for N lobe Kd=57.6+/-35.5nM	6
	1ri8	1.85	2005	Kd	8.537602002101044	nM	134	camelid ANTIBODY HEAVY CHAIN D2-L19 and HEWL, Kd=2.9nM	2
	2b12	3.02	2005	Kd	4.698970004336019	uM	108	F82Y cytochrome c and cytochrome c peroxidase, Kd=20uM	2
	2bqz	1.5	2005	Kd	4.698970004336019	uM	29	incomplete ligand structure	4
	1wr6	2.6	2005	Kd	3.6363880201078556	uM	76	GGA3 GAT domain in complex with ubiquitin, Kd=231+/-13uM	8
	2aw2	2.8	2005	Kd	7.6020599913279625	nM	108	ligand is Tumor necrosis factor receptor superfamily member 14	6
	1t0p	1.66	2005	Kd	4.6020599913279625	uM	175	binding domains of ICAM-3 and alpha L I domain, untreated Kd=25.0+/-2.80uM (ICAM-3 uncleaved, from 293T cell)	2
	1x1w	2.1	2005	Kd	7.578396073130169	nM	90	barnase(wt)-barstar(E80A), Kd=2.64 E-10 M, ligand mutation:E80A, C40A, C82A	6
	1y6n	2.7	2005	Kd	7.568636235841013	nM	145	Epstein-Barr virus IL-10 A87I/sIL-10R1 complex, Kd=27nM	2
	1z5s	3.01	2005	Kd	5.517126416391246	uM	83	SUMO-RanGAP1-Ubc9 and Nup358/RanBP2, Kd=3.04+/-0.47uM	4
	1t5z	2.3	2005	Kd	4.481486060122113	uM	20	incomplete ligand structure	2
	1za3	3.35	2005	Kd	7.468521082957745	nM	134	YSd1:human death receptor Extra-cellular domain(hDR5-ECD) complex, Kd=34nM	6
	1xwd	2.92	2005	Kd	3.4111682744057927	uM	111	FSH-FSHRHB complex, monomer-dimer equilibrium Kd=388+/-120uM	8
	1xj7	2.7	2005	Kd	4.4089353929735005	uM	20	incomplete ligand structure	2
	1shz	2.85	2005	Kd	5.522878745280337	uM	233	ligand is Rho guanine nucleotide exchange factor 1	4
	1wrd	1.75	2005	Kd	3.388276691992658	uM	76	Tom1 GAT domain in complex with ubiquitin, Kd=409+/-13uM	2
	1zc3	2.0	2005	Kd	7.376750709602099	nM	113	ligand is exocyst complex protein Exo84	4
	1zc4	2.5	2005	Kd	7.376750709602099	nM	120	ligand is exocyst complex protein Exo84; same as 1zc3	4
	1yyl	2.75	2005	Kd	8.397940008672037	nM	214	CD4M33/core YU2 gp120/Fab 17b, Kd=4+/-1nM	8
	1x1x	2.3	2005	Kd	7.275724130399211	nM	89	barnase(wt)-barstar(E76A), Kd=5.30 E-10 M, ligand mutation:E76A, C40A, C82A	6
	1pk1	1.8	2005	Kd	7.267606240177032	nM	89	Hetero SAM domain structure of Ph and Scm, Kd=54+/-2nM	4
	1xg2	1.9	2005	Kd	8.301029995663981	nM	153	pectin methylesterase complex with PME inhibitor protein, Kd=5nM(PH5.5)	2
	2b11	2.3	2005	Kd	5.301029995663981	uM	108	F82W cytochrome c and cytochrome c peroxidase, Kd=5uM	4
	2b2w	2.4	2005	Kd	5.301029995663981	uM	20	human CHD1 with Histone H3 Tail (trimethyllysine 4), Kd=5uM	4
	2bnq	1.7	2005	Kd	5.301029995663981	uM	100	TCR-pMHC complex	5
	1xqs	2.9	2005	Kd	5.187086643357144	uM	191	ligand is Hsp70 ATPase domain, 5mM AMP ADP ATP, Kd=6.5uM	4
	1ul1	2.9	2005	Kd	7.221848749616356	nM	261	human FEN1-Proliferating cell nuclear antigen (PCNA) complex, Kd=60nM	6
	2a78	1.81	2005	Kd	7.221848749616356	nM	223	ligand is Mono-ADP-ribosyltransferase C3	2
	2a9k	1.73	2005	Kd	7.221848749616356	nM	223	RalA-GDP-C3bot complex, Kd=60+/-20nM	2
	2c5d	3.3	2005	Kd	8.221848749616356	nM	422	human Gas6-LG/Axl-IG complex, Kd=6+/-2nM	6
	1zmy	3.0	2005	Kd	8.119186407719209	nM	142	cAbBCII-10 VHH with CDR loops of cAbLys3 complex with HEWL, Kd=7.6nM	3
	1z0k	1.92	2005	Kd	5.113509274827519	uM	69	RAB4 binding domain of Rabenosyn, SPR Kd=7.7+/-1.9uM	4
	1rjc	1.4	2005	Kd	10.113509274827518	pM	137	camelid heavy chain antibody cAb-Lys2 and HEWL, Kd=77pM	2
	1wve	1.85	2005	Kd	8.154901959985743	nM	80	flavoprotein and cytochrome c subunit of 4-cresol dehydrogenase [hydroxylating], strong interaction Kd=7nM	4
	2ast	2.3	2005	Kd	5.154901959985743	uM	24	incomplete ligand structure	4
	1wqj	1.6	2005	Kd	6.062983892535185	nM	70	binary complex of NBP-4 and IGF-I, Kd=865+/-78nM	2
	1yym	2.2	2005	Kd	5.023191662661934	uM	214	F23/core YU2 gp120/Fab 17b, Kd=9480+/-440nM	8
	2ak4	2.5	2005	Kd	5.00436480540245	uM	276	SB27 TCR in complex with HLA-B*3508-LPEP, Kd=9.9uM	20
	1y3c	1.69	2005	Ki	10.602059991327963	nM	64	protein-protein	2
	1y3b	1.8	2005	Ki	9.508638306165727	nM	64	protein-protein	2
	1y1k	1.56	2005	Ki	9.522878745280337	nM	64	protein-protein	2
	1y34	1.55	2005	Ki	9.2839966563652	nM	64	protein-protein	2
	1y3d	1.8	2005	Ki	9.2518119729938	nM	64	protein-protein	2
	1y4a	1.6	2005	Ki	8.920818753952375	nM	64	ligand is chymotrypsin inhibitor 2	2
	1y4d	2.0	2005	Ki	8.920818753952375	nM	63	protein-protein	2
	1zli	2.09	2005	Ki	8.886056647693163	nM	75	Tick carboxypeptidase inhibitor, Ki=1.3+/-0.2nM	2
	1y33	1.8	2005	Ki	8.769551078621726	nM	64	protein-protein	2
	1y48	1.84	2005	Ki	8.769551078621726	nM	64	protein-protein	2
	1wpx	2.7	2005	Ki	8.744727494896694	nM	220	carboxypeptidase Y complexed with cognate proteinase, Ki=1.80nM	2
	1zr0	1.8	2005	Ki	7.886056647693163	nM	63	Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin, Ki=13nM	4
	2bo9	1.6	2005	Ki	8.522878745280337	nM	222	HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN, ki=3+/-0.3nM	4
	2cmr	2.0	2006	Kd	10.301029995663981	nM	208	HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX, Kd=0.05nM	3
	2gww	2.72	2006	Kd	9.958607314841775	nM	30	Vh1 IpaA-VBS complex, Kd=0.11nM	2
	2nyy	2.61	2006	Kd	9.903089986991944	nM	218	BoNT A complexed with monoclonal antibody CR1, Kd=0.125nM	3
	2a6i	2.5	2006	Kd	6.920818753952375	uM	214	germline antibody 36-65 complex with dodecapeptide KLASIPTHTSPL, Kd=0.12uM	3
	2nz9	3.79	2006	Kd	9.866461091629782	nM	218	BoNT A complexed with monoclonal antibody AR2, Kd=0.136nM	6
	2a6d	2.9	2006	Kd	6.823908740944319	uM	214	germline antibody 36-65 complex with dodecapeptide RLLIADPPSPRE, Kd=0.15uM	5
	1zvy	1.63	2006	Kd	10.0	nM	136	VHH D3-L11 in complex with hen egg white lysozyme, Kd>0.1nM	2
	2cjs	1.78	2006	Kd	7.0	uM	62	Munc13-1 3-150(K32E) and Rim2a 82-142 complex, apparent Kd=0.10uM	3
	2a6k	3.0	2006	Kd	6.6777807052660805	uM	214	germline antibody 36-65 complex with dodecapeptide SLGDNLTNHNLR, Kd=0.21uM	5
	2d1k	2.5	2006	Kd	6.638272163982407	uM	32	Dnase I is necessary to prevent actin polymerization during crystallization	4
	2f6a	3.29	2006	Kd	6.698970004336019	uM	30	CNA31-344 and collagen peptide complex, Kd=0.2+/-0.02uM	10
	2dx5	3.35	2006	Kd	3.4814860601221125	mM	76	ligand is Ubiquitin, Kd=0.33+/-0.02mM	2
	2gl7	2.6	2006	Kd	6.338187314462739	uM	550	Kd( beta -catenin(Y142E)-BCL9)=0.459+/-0.053uM	6
	2b7c	1.8	2006	Kd	6.3979400086720375	uM	94	elongation factor-1 beta K1205A mutant in complex with eEF1A, Kd=0.4+/-0.1uM	2
	2hfg	2.61	2006	Kd	9.221848749616356	nM	214	hBR3 bound to CB3s-Fab, Kd=0.6nM	3
	2f5z	2.18	2006	Kd	9.10790539730952	nM	64	E3-Binding Domain/E3 Complex, Kd=7.8 E-10 M	15
	2fu5	2.0	2006	Kd	9.154901959985743	nM	183	MSS4 and Rab8 GTPase complex, Kd=0.7nM	4
	1yk0	2.4	2006	Kd	9.017728766960431	nM	21	atrial natriuretic peptide (ANP), NPR-C and ANP complex, Kd=0.96nM	4
	2f9z	2.4	2006	Kd	6.045757490560675	uM	205	Complex between chemotaxis deamidase CheD and chemotaxis phosphatase CheC, Kd=0.9-1.4uM	4
	2b42	2.5	2006	Kd	8.97061622231479	nM	381	Xylanase inhibitor, 1.07 x 10-9M	2
	2j1k	2.3	2006	Kd	8.958607314841775	nM	128	CAV-2 FIBRE HEAD IN COMPLEX WITH Coxsackievirus and adenovirus receptor, CAR D1, Kd=1.1nM	24
	2g2u	1.6	2006	Kd	5.903089986991944	uM	165	SHV-1 Beta-lactamase/inhibitor protein (BLIP) complex, Kd=1252+/-52nM	2
	2i32	2.7	2006	Kd	5.886056647693163	uM	182	the ASF1a N-terminal core domain (1-157) with Human HIRA, Kd=1.3uM	4
	2fjg	2.8	2006	Kd	8.823908740944319	nM	214	G6 Fab, in complex with human VEGF, Kd=1.5nM	6
	2d10	2.5	2006	Kd	8.769551078621726	nM	28	NHERF-1 Peptides with Radixin FERM Domain, Kd=1.69+/-0.4nM	8
	2b2x	2.2	2006	Kd	8.721246399047171	nM	213	VLA1 RdeltaH I-domain complex with H:T50V, K64E, L:S28Q, N52Y mutant Antibody AQC2 Fab; Kd=1.9nM	6
	2iy0	2.77	2006	Kd	7.97061622231479	nM	156	SENP1 (C603A)) and SUMO1 RANGAP complex, Kd=10.7+/-3.12nM	3
	2f31	2.1	2006	Kd	6.991399828238082	nM	20	ligand is FH2+DAD protein segment; DID-DAD complex, GST-DAD Kd=240nM, FH2+DAD Kd=102nM	2
	2hth	2.7	2006	Kd	3.978810700930062	uM	76	ubiquitin complex with human EAP45/ESCRT-II GLUE domain, Kd=105uM	2
	2c0l	2.3	2006	Kd	6.962573502059376	nM	122	TPR DOMAIN OF HUMAN PEX5P IN COMPLEX WITH HUMAN MSCP2, Kd=109+/-34nM	2
	1zv5	2.0	2006	Kd	8.0	nM	130	antibody D2-L29 complex with hen egg white lysozyme, Kd=10nM	2
	2erj	3.0	2006	Kd	11.0	pM	133	Interleukin-2(C125A) and IL2 receptor alpha beta gamma chain, Kd=10pM	16
	2aq2	1.8	2006	Kd	7.958607314841775	nM	112	TCR V beta A52V/S54N/K66E and SEC3-1D3 complex, Kd=1.1 E-8 M	2
	2fjh	3.1	2006	Kd	7.920818753952375	nM	214	B20-4 Fab, in complex with human VEGF, Kd=12nM	6
	2fdb	2.28	2006	Kd	6.809668301829708	nM	164	Fibroblast growth factor 8b complex with FGF Receptor (FGFR)2c, Kd=1.55 E-7 M	4
	2ftm	1.65	2006	Kd	10.795880017344075	pM	58	trypsin complexed with Y35G BPTI at 100K, Kd=1.6 E-11M	2
	1yrt	2.1	2006	Kd	9.0	nM	74	wild type CyaA-ACD and C-CaM complex without exogenous CaCl2, Kd=1nM	2
	2i5y	2.2	2006	Kd	8.568636235841012	nM	214	ternary complexes of CD4M47 with HIV-1 gp120 and the 17b antibody, Kd=2.71+/-0.65nM	8
	2g45	1.99	2006	Kd	5.549750891680639	uM	76	znf ubp domain in complex with ubiquitin, Kd=2.82+/-0.09uM	4
	2hd5	1.85	2006	Kd	5.552841968657781	uM	76	USP2 in complex with ubiquitin, ki=2.8+/-0.14uM	2
	2dd8	2.3	2006	Kd	7.698970004336019	nM	213	SARS-CoV Complex with Fab m396, Kd=20nM	3
	2j12	1.5	2006	Kd	7.698970004336019	nM	194	AD37 FIBRE HEAD IN COMPLEX WITH CAR D1, Kd=20nM	2
	2hwn	1.6	2006	Kd	8.698970004336019	nM	22	RII alpha D/D domain and helical motif from d-AKAP2, typically Kd=2nM in 1-5nM	6
	2dsr	2.1	2006	Kd	6.498940737782249	nM	82	ternary complex of N- and C-terminal domain fragments of IGFBP4 and IGF1, Kd=317+/-19nM	3
	2dsp	2.5	2006	Kd	5.522878745280337	uM	92	binary complex of the N-terminal domains of IGFBP4 and IGF1, Kd=3020+/-410nM	2
	2bdn	2.53	2006	Kd	11.337242168318426	pM	214	human MCP-1 bound to a blocking antibody, 11K2, Kd=4.6pM	3
	2aze	2.55	2006	Kd	5.309803919971486	uM	106	ligand is Transcription factor E2F1CM-DP1CM heterodimer, Kd=4.9+/-3uM	3
	2hle	2.05	2006	Kd	7.3979400086720375	nM	138	EphB4 in complex with the extracellular domain of ephrinB2, Kd=40+/-20nM	2
	2h4m	3.05	2006	Kd	7.376750709602099	nM	865	Kap beta2-Transportin-M9NLS, ITC Kd=42+/-2nM, fluorescence titration Kd=2nM	4
	2arp	2.0	2006	Kd	6.366531544420414	nM	152	Activin A in complex with Fs12 fragment of follistatin, Kd=430nM	2
	1yk1	2.9	2006	Kd	7.34008379993015	nM	21	brain natriuretic peptide (BNP), NPR-C and BNP complex, Kd=45.7nM	4
	2fju	2.2	2006	Kd	5.275724130399211	uM	799	Activated Rac1 bound to its effector phospholipase C beta 2	2
	2aq1	2.1	2006	Kd	8.259637310505756	nM	112	TCR V beta H72Q-r and SEC3-1A4 complex, Kd=5.5 E-9 M	8
	2dsq	2.8	2006	Kd	6.2644011003018205	nM	92	hybrid ternary complex using the C-terminal domain fragment of IGFBP1 instead of IGFBP4, Kd=544+/-45nM	6
	2g2w	1.8	2006	Kd	6.235077015350112	nM	165	SHV D104K Beta-lactamase/inhibitor protein (BLIP) complex, Kd=582+/-42nM	2
	2es4	1.85	2006	Kd	8.301029995663981	nM	319	Lif-cognate lipase LipA complex, Kd=5nM	4
	2h9g	2.32	2006	Kd	8.301029995663981	nM	130	Fab-BDF1:hDR5 complex, Kd=5+/-1nM	6
	2i60	2.4	2006	Kd	8.204815410317575	nM	214	ternary complexes of [Phe23]M47 with HIV-1 gp120 and the 17b antibody, Kd=6.24+/-0.1nM	8
	2c7m	2.4	2006	Kd	5.1938200260161125	uM	76	RUZ-MIU:ubiquitin complex, crystal form I Kd=6.4uM	2
	2c7n	2.1	2006	Kd	5.1938200260161125	uM	76	RUZ-MIU:ubiquitin complex, crystal form II Kd=6.4uM	12
	2hsq	3.97	2006	Kd	8.17979854051436	nM	23	Vh1 IpaA-VBS2 complex, Kd=6.61nM	2
	2ftl	1.62	2006	Kd	13.221848749616356	fM	58	trypsin complexed with wt BPTI at 100K, Kd=6 E-14M	2
	2f4m	1.85	2006	Kd	7.187086643357144	nM	61	Mouse PNGase core and HR23B-XPCB domain Complex, Kd=65nM	2
	2aq3	2.3	2006	Kd	5.119186407719209	uM	112	TCR V beta-SEC3 complex, Kd=7.6 E-6 M	8
	1zvh	1.5	2006	Kd	7.154901959985743	nM	134	VHH domain D2-L24 in complex with hen egg white lysozyme, Kd=70nM	2
	2iy1	2.46	2006	Kd	6.104025267640935	nM	83	SENP1 (MUTANT) with FULL LENGTH SUMO1, Kd=787+/-90.4nM	4
	2bwe	3.1	2006	Kd	4.096910013008056	uM	77	The yeast protein Dsk2 UBA-UBL domain complex, Kd=80+/-15uM	21
	2gh0	1.92	2006	Kd	7.045757490560675	nM	101	artemin, ARTN-GFR alpha3 complex, Kd=90nM	5
	2hrk	2.05	2006	Kd	8.045757490560675	nM	122	Kd for Arc1p and full-length GluRS; structure is GluRS-N(1-207) and Arc1p-N(1-222)	2
	2g9h	2.0	2006	Kd	7.0	uM	218	Staphylococcal Enterotoxin I Complex with a Human MHC class II Molecule(+peptide from HA), Zn2+ dependent, Kd~1E-7M	4
	2j7p	1.97	2006	Kd	8.0	nM	283	GMPPNP-mediated assembly of the T. aquaticus Ffh NG:FtsY NGd20 heterodimer	4
	2j0t	2.54	2006	Ki	9.397940008672037	nM	126	INHIBITORY DOMAIN OF TIMP-1 and MMP-1cd complex, Ki=0.4nM	6
	2abz	2.16	2006	Ki	8.55284196865778	nM	67	C19A/C43A LCI (Metallocarboxypeptidase inhibitor) in complex with bovine carboxypeptidase A, Ki=2.8+/-0.3nM	6
	2o3b	2.3	2006	Ki	11.494850021680094	pM	136	NucA and intra-cellular inhibitor NuiA complex, Ki=3.2+/-1.9 E-12 M	2
	1yvb	2.7	2006	Ki	8.187086643357144	nM	111	Cystatin, Ki=6.5 x 10-9M	2
	2j8x	2.3	2006	Ki	8.096910013008056	nM	84	wt EBV UNG(delta24) and URACIL-DNA GLYCOSYLASE INHIBITOR complex, Ki=8nM	4
	2p5e	1.89	2007	Kd	10.318758762624412	nM	100	human T-cell receptors bound to peptide MHC complex	5
	2omy	1.7	2007	Kd	6.698970004336019	uM	105	InlA S192N and N-terminal domain of human E-cadherin, hEC1 complex, InlA Kd=0.2+/-0.05uM	2
	2uzi	2.0	2007	Kd	9.455931955649724	nM	166	ligand is GTPASE HRAS(G12V) mutant; Kd=6.2nM(for ANTI-RAS FV VH#6 with HRAS)	3
	2qxv	1.82	2007	Kd	6.42021640338319	uM	30	Enhancer of zeste homolog 2 recognition by EED, Kd=0.38uM	2
	2oin	2.5	2007	Kd	6.292429823902063	uM	21	NS4A co-factor peptide, enzymatic IC50=0.51+/-0.23uM, Replicon IC50=3.6+/-0.3uM	4
	2j4w	2.5	2007	Kd	9.221848749616356	nM	213	PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=0.6nM	3
	2omu	1.8	2007	Kd	9.221848749616356	nM	462	Internalin-A G194S+S Y369S-HEC1 COMPLEX, Kd=0.6+/-0.2nM	2
	2r0k	3.51	2007	Kd	9.221848749616356	nM	214	inhibitor antibody Fab58:HGFA complex, Kd=0.6+/-0.1nM	3
	2j6e	3.0	2007	Kd	6.221848749616356	uM	232	RF61 Fab-IgG1 Fc complex, Kd=6 X 10-7M	8
	2oje	3.0	2007	Kd	6.221848749616356	uM	214	MAM/HLA-DR1/HA complex, Kd=0.6uM	8
	2o98	2.7	2007	Kd	9.070581074285707	nM	242	ligand is T14-3cDeltaC, 1 uM FC in presence, CT52 YDI, Kd=0.85nM, YTV Kd=41nM	4
	2gox	2.2	2007	Kd	9.096910013008056	nM	297	ligand is Complement C3-inhibitory domain, Kd(Efb-C/C3dg)=0.8+/-0.1nM	4
	2i9b	2.8	2007	Kd	9.017728766960431	nM	145	ligand is Urokinase plasminogen activator	12
	2ifg	3.4	2007	Kd	9.045757490560675	nM	120	Beta-nerve growth factor and receptor complex, Kd(TrkA-NGF)=0.9+/-0.3nM	16
	2nyz	2.6	2007	Kd	9.045757490560675	nM	93	ligand is C-Chemokine XCL1, NaCl 0.2M, Kd=0.9+/-0.2nM	4
	2pkg	3.3	2007	Kd	5.97469413473523	uM	88	binding between phosphatase 2A and the small t core domain, Kd=1.06+/-0.09uM, Kd(full-length ST/A subunit of PP2A)=2.14+/-0.08uM	4
	2i25	1.8	2007	Kd	9.0	nM	129	PBLA8 variable domain in complex with lysozyme, Kd=1.0nM	4
	2qej	3.2	2007	Kd	8.958607314841775	nM	201	Staphylococcus aureus protein (SSL7) in complex with Fc of human IgA1, Kd=0.0011 E-6 M	6
	2omv	1.9	2007	Kd	8.920818753952375	nM	105	InlA S192N Y369S and N-terminal domain of human E-cadherin, hEC1 complex, InlAm Kd=1.2+/-0.3nM	2
	2ot3	2.1	2007	Kd	5.7447274948966935	uM	170	rabex-5 VPS9 domain in complex with nucleotide free RAB21, Kd=1.8uM	2
	2pms	2.91	2007	Kd	7.987162775294828	nM	125	human lactoferrin N-lobe and PSPA complex, Kd=10.3+/-3.2nM	4
	2omt	2.0	2007	Kd	7.0	nM	462	Internalin-A G194S+S-HEC1 COMPLEX, Kd=100+/-30nM	2
	2q7n	4.0	2007	Kd	11.0	pM	180	human Leukemia inhibitory factor binds to mLIFR, Kd=10-46pM, Kd(mLIF:mLIFR)1-4nM, Kd(hLIF:hLIFR)=300-900pM	19
	2qc1	1.94	2007	Kd	11.0	pM	74	alpha-bungarotoxin, Endo-H not treated Kd=1.02 X10-11M, treated Kd=7.3 X10-9M	3
	2nup	2.8	2007	Kd	5.0	uM	196	human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal I	3
	2nut	2.3	2007	Kd	5.0	uM	196	human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal II	3
	2omw	1.85	2007	Kd	5.0	uM	105	InlA S192N Y369S and N-terminal domain of murine E-cadherin, mEC1 complex, InlAm Kd=10+/-2uM	2
	2qiy	1.69	2007	Kd	6.924453038607469	nM	48	BRE5 with Ubiquitin carboxyl-terminal hydrolase 3, UBP3, Kd=119nM	4
	2omx	1.7	2007	Kd	6.920818753952375	nM	462	Internalin-A S192N G194S+S and HEC1 COMPLEX, Kd=120+/-40nM	2
	2noj	2.7	2007	Kd	7.886056647693163	nM	297	Ehp / C3d complex, Kd=13nM	8
	2rf9	3.5	2007	Kd	4.886056647693163	uM	65	complex between the EGFR kinase domain and a Mig6 peptide, Kd=13+/-1.3uM	4
	2r0l	2.2	2007	Kd	7.835647144215563	nM	214	inhibitor antibody Fab75:HGFA complex, Kd=14.6+/-1.5nM	5
	2q0o	2.0	2007	Kd	7.826813731587726	nM	107	ligand is Probable transcriptional repressor traM (chain C, D)	4
	2h64	1.92	2007	Kd	6.853871964321762	nM	129	ligand is BMPR-IA/ActR-IIB, Kd(BMP-2(L100K/N102D)/BMPR-IA)=22uM, Kd(BMP-2(L100K/N102D)/ActR-IIB)=140nM	3
	2r9p	1.4	2007	Kd	4.853871964321762	uM	58	Mesotrypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=1.4 X10-5M	8
	2jcc	2.5	2007	Kd	4.812479279163537	uM	100	TCR-pMHC complex; W167A mutant protein; Kd(equilibrium)=15.4uM, Kd(kinetic)=14.8uM	10
	2oor	2.32	2007	Kd	7.809668301829708	nM	174	transhydrogenase (dI.NAD+)2(dIII.H2NADPH)1 asymmetric complex mean value=15.5nM	3
	2ij0	2.25	2007	Kd	9.744727494896694	pM	118	TSST-1 with penultimate affinity-matured variant of hVbeta 2.1, D10, Kd=180pM	4
	2p4a	1.9	2007	Kd	9.744727494896694	pM	121	a camelid affinity matured single-domain vhh antibody fragment, affinity mature Kd=180+/-18pM	4
	2jgz	2.9	2007	Kd	3.0	mM	260	PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B, Kd>1mM	2
	2p5t	3.2	2007	Kd	9.0	nM	253	ligand is fragment of PezA helix-turn-helix motif complex with PezT, Kd<1nM	9
	2v2w	1.6	2007	Kd	5.657577319177793	uM	100	TCR-pMHC complex	6
	2p1l	2.5	2007	Kd	5.638272163982407	uM	31	Bcl-XL:wild type Beclin 1 complex, Kd=2.3uM	8
	2oza	2.7	2007	Kd	8.602059991327963	nM	356	p38alpha MAPK and MAPK-activated protein kinase 2 (MK2), Kd=2.5nM, recent data Kd=0.5nM	2
	2h62	1.85	2007	Kd	5.568636235841013	uM	129	ligand is BMPR-IA/ActR-IIB, Kd(BMP-2/ActR-IIB)=2.7uM, Kd(BMP-2/BMPR-IA)=24uM	4
	2i3t	2.8	2007	Kd	5.568636235841013	uM	54	Bub3 complex with Mad3 (BubR1) GLEBS motif, Kd=2.7uM	8
	2ot8	3.1	2007	Kd	7.698970004336019	nM	30	human Kapb2 bound to the bPY-NLS of human hnRNP M2, 6-8, Kd=20nM	4
	2ra3	1.46	2007	Kd	10.698970004336019	pM	58	Cationic trypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=2.0 X10-11M	4
	2v8s	2.22	2007	Kd	4.657577319177793	uM	147	Vti1b / human clathrin adaptor epsinR (EPNR) complex, Kd=22+/-3uM, n=6 (ITC)	2
	2p49	1.38	2007	Kd	7.638272163982407	nM	123	ligand is camelid single-domain vhh antibody fragment, Kd=23+/-3nM	2
	2hqs	1.5	2007	Kd	7.568636235841013	nM	118	TolB and Peptidoglycan-associated lipoprotein (Pal) complex, Kd=27nM(PH7.5)	8
	2j8s	2.54	2007	Kd	7.552841968657781	nM	169	DARPIN inhibitor 1108_19, protein-protein complex	5
	2v6x	1.98	2007	Kd	4.552841968657781	uM	54	yeast Vps2 and Vps4 MIT-domain, Kd=28uM	2
	2yvj	1.9	2007	Kd	3.5316526695878427	uM	109	ligand is Biphenyl dioxygenase ferredoxin subunit, aerobic condition; Kd=14.6uM at reducing condition	3
	2hqw	1.9	2007	Kd	8.698970004336019	nM	24	ligand is NR1C1 (peptide spanning 875-898), titrations Kd=2.0+/-0.1nM	2
	2iou	3.16	2007	Kd	5.459670525209126	uM	535	Mtd-P1 and Pertactin Extracellular Domain, Kd=3.47+/-0.13uM	8
	2i3s	1.9	2007	Kd	5.443697499232713	uM	36	Bub3 complex with Bub1 GLEBS motif, Kd=3.6uM	6
	2iyb	2.35	2007	Kd	5.443697499232713	uM	114	Lim3 and EVH1 domain of MENA, Kd=3.6+/-0.4uM	8
	2jix	3.2	2007	Kd	7.522878745280337	nM	225	ligand is Erythropoietin receptor EPOR, unpublished Biacore Kd=30nM	9
	2psm	2.19	2007	Kd	10.522878745280337	pM	78	ligand is Interleukin-15 receptor alpha chain; Kd=30-100pM	4
	2j8u	2.88	2007	Kd	4.497572880015567	uM	100	TCR-pMHC complex; K66A mutant protein; Kd(equilibrium)=31.8uM, Kd(kinetic)=34.0uM	10
	2iwg	2.35	2007	Kd	7.431798275933005	nM	181	COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC	6
	2z3q	1.85	2007	Kd	10.42021640338319	pM	119	IL-15/IL-15Ra complex, native 1 Kd=38pM	4
	2z3r	2.0	2007	Kd	10.42021640338319	pM	119	Interleukin-15/IL-15Ra complex, native 2 Kd=38pM	16
	2pop	3.1	2007	Kd	5.376750709602099	uM	95	TAB1D and BIR1 complex, Kd=4.2+/-0.2uM	4
	2z8w	2.45	2007	Kd	8.327902142064282	nM	116	New antigen receptor variable domain, IgNAR-AMA1 complex, 2Z8W (AMA1/14I1-M15), Kd=4.7+/-2.0nM	4
	2uwe	2.4	2007	Kd	5.327902142064283	uM	100	TCR-pMHC complex; T163A mutant protein; Kd(equilibrium)=4.7uM, Kd(kinetic)=4.6uM	10
	2z8v	2.35	2007	Kd	8.318758762624412	nM	116	New antigen receptor variable domain, 2Z8V (AMA1/14I-1), Kd=4.8+/-2.2nM	4
	2omz	1.6	2007	Kd	6.3979400086720375	nM	466	Internalin-A Y369A-HEC1 COMPLEX, Kd=400+/-100nM	2
	2ihs	2.2	2007	Kd	7.3979400086720375	nM	20	20-mer from ATP-dependent RNA helicase vasa, Kd about 40nM	4
	2ptt	1.63	2007	Kd	5.3979400086720375	uM	110	NK cell receptor 2B4 (CD244) bound to its ligand CD48	2
	2j59	2.1	2007	Kd	7.259637310505756	nM	168	ligand is RHO-GTPASE ACTIVATING PROTEIN 10, in presence of GTP	12
	2oob	1.9	2007	Kd	4.2441251443275085	uM	76	ligand is ubiquitin, Kd=57+/-3uM	2
	2r56	2.8	2007	Kd	5.301029995663981	uM	162	beta-lactoglobulin (BLG, Bos d 5)	6
	2v3b	2.45	2007	Kd	5.301029995663981	uM	55	RUBREDOXIN-RUBREDOXIN REDUCTASE complex(in presence of Fe3+), kd=5+/-2uM	2
	2qho	1.85	2007	Kd	4.221848749616356	uM	76	ligand is ubiquitin, Kd=60+/-15uM	8
	2onl	4.0	2007	Kd	8.221848749616356	nM	406	full length p38a-MAPKAP kinase 2 Heterodimer group P41, Kd=6nM	4
	2ibf	3.2	2007	Kd	8.10790539730952	nM	25	IpaA-VBS2, two binding sites Kd=7.8nM and 510nM	3
	2qr0	3.5	2007	Kd	8.10790539730952	nM	213	VEGF COMPLEXED TO FAB-D1, Kd=7.8nM	24
	2j5l	2.9	2007	Kd	7.113509274827518	nM	213	PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=77nM	3
	2v9t	1.7	2007	Kd	8.086186147616283	nM	220	Slit2 D2-Robo1 Ig complex, Kd=8.2nM	2
	2pye	2.3	2007	Kd	7.088309841246139	nM	100	human T-cell receptors bound to peptide/MHC complex	5
	2uyz	1.4	2007	Kd	7.086186147616283	nM	79	NON-COVALENT COMPLEX BETWEEN UBC9 AND SUMO1, Kd=82+/-23nM(PH8.0).previous Kd=250+/-70nM(PH7.5)	2
	2i26	2.5	2007	Kd	8.0268721464003	nM	129	ancestral variable domain in complex with lysozyme, Kd=9.4nM	6
	3biw	3.5	2007	Kd	7.013228265733755	nM	574	Neuroligin-1, 3BIW, NL1/Nrx1b	11
	2v1d	3.1	2007	Ki	7.301029995663981	uM	21	LSD1-CoREST in complex with pLys4Met H3 peptide, Ki=0.05+/-0.02uM	3
	2o8v	3.0	2007	Ki	5.958607314841775	uM	128	PAPS reductase in a covalent complex with thioredoxin C35A, Ki=1.1uM	2
	2uxn	2.72	2007	Ki	6.920818753952375	nM	235	N-methylpropargyl-K4 H3 1-21 compound CoREST inhibited LSD1	3
	2g81	1.55	2007	Ki	7.866461091629782	nM	83	Bowman-Birk inhibitor (BTCI), Ki=1.36+/-0.16 X 10-8M	2
	2nz1	2.5	2007	Ki	7.7447274948966935	nM	76	ligand is CC-Chemokine CCL2/MCP-1, competition with Heparin, Ki=18+/-7nM	6
	2ijo	2.3	2007	Ki	7.619788758288394	nM	58	NS2B-NS3(WT) protease complex with pancreatic trypsin inhibitor, Ki=24nM	3
	2pw8	1.84	2007	Ki	13.602059991327963	fM	65	sulfo-hirudin complexed to thrombin, Ki=25fM	3
	2nqd	1.75	2007	Ki	10.4089353929735	pM	109	cysteine protease inhibitor, chagasin complex with human cathepsin L, Ki=39pM	3
	2p3f	3.1	2007	Ki	10.366531544420413	pM	78	FACTOR XA-NAP5 COMPLEX, Ki=43pM	3
	2uuy	1.15	2007	Ki	8.2518119729938	nM	52	Tick Tryptase Inhibitor, Ki=5.6+/-2.0nM	2
	2za4	1.58	2008	Kd	9.853871964321762	nM	90	Barnase (K98A) and barstar (D39A, C40A, C82A) Complex, Kd=1.4 X 10-10M	4
	2vdb	2.52	2008	Kd	9.823908740944319	nM	55	ligand is PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN, Ka=6.7x10^9M-1, get Kd=1.5x10-10M	2
	3dxc	2.1	2008	Kd	6.657577319177793	uM	35	APP intracellular domain / Fe65-PTB2 complexes, Kd=0.22+/-0.02uM	4
	2vfx	1.95	2008	Kd	6.6020599913279625	uM	206	SYMMETRIC MAD2 DIMER equilibrium dissociation constant	12
	3dvu	2.5	2008	Kd	6.698970004336019	uM	26	M11-Beclin 1 BH3 domain complex, Kd=0.2+/-0.1uM	4
	3dxe	2.0	2008	Kd	6.481486060122113	uM	35	APP intracellular domain (T668A mutant) / Fe65-PTB2 complexes, Kd=0.33+/-0.01uM	4
	3dxd	2.2	2008	Kd	6.468521082957745	uM	35	APP intracellular domain (T668E mutant) / Fe65-PTB2 complexes, Kd=0.34+/-0.02uM	4
	2vlp	2.0	2008	Kd	12.265200170411154	pM	86	R54A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.543+/-0.066pM	2
	2pjy	3.0	2008	Kd	6.301029995663981	uM	108	ternary complex, Transforming growth factor beta-3 with TGF-beta receptor type-1 and type-2	3
	3ddc	1.8	2008	Kd	6.113509274827519	uM	163	ligand is NORE1A K302D	2
	2vof	1.8	2008	Kd	9.154901959985743	nM	26	ligand is Puma BH3-domain, Kd=0.7nM	4
	2vlo	1.8	2008	Kd	12.049635145623878	pM	93	K97A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.892+/-0.11pM	3
	2z34	2.4	2008	Kd	6.050609993355088	uM	29	ligand is Hip1 B domain peptide, hir1; Kd=0.89+/-0.01uM	4
	3c4m	1.95	2008	Kd	6.008773924307505	uM	21		6
	3f5c	3.0	2008	Kd	6.045757490560675	uM	268	Dax-1 bound to liver receptor homolog 1 (LRH-1), Kd=0.9+/-0.1uM	3
	3dbr	3.05	2008	Kd	5.991399828238082	uM	88	APPBP1-UBA3Arg190Gln complex with NEDD8 Ala72Arg mutant, Kd=1020+/-10nM	12
	3b2u	2.58	2008	Kd	9.0	nM	213	ligand is Fab fragment of IMC-11F8, Kd=1.0+/-0.1nM	42
	2v51	2.35	2008	Kd	6.0	uM	32	Kd=1.0+/-0.3uM, G-actin bound to RPEL1-MAL peptide	4
	2qja	2.6	2008	Kd	8.958607314841775	nM	116	ligand is Bone morphogenetic protein 2, BMP2, Kd=1.1nM	4
	2voi	2.1	2008	Kd	8.958607314841775	nM	34	ligand is Bid BH3-domain, Kd=1.1nM	2
	2v4z	2.8	2008	Kd	5.903089986991944	uM	142	ligand is REGULATOR OF G-PROTEIN SIGNALING 2, RGS2(C106S, N184D, E191K) triple mutant	2
	2jjt	2.3	2008	Kd	5.920818753952375	uM	126	CD47 complex with HUMAN SIGNAL Human signal regulatory protein (SIRP) alpha, space group p21 21 21	4
	2jjs	1.85	2008	Kd	5.920818753952375	uM	126	CD47 complex with Human signal regulatory protein (SIRP) alpha, space group p21	4
	2jki	3.3	2008	Kd	5.785156151952302	uM	90	COMPLEX OF HSP90 N-TERMINAL AND SGT1 CS DOMAIN, Kd=1.64uM	6
	3dbh	2.85	2008	Kd	5.779891911959945	uM	88	APPBP1-UBA3Arg190Ala complex with NEDD8 Ala72Arg mutant, Kd=1660+/-10nM	12
	2vln	1.6	2008	Kd	11.774690718274137	pM	86	N75A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=1.68+/-0.3pM	2
	2v52	1.45	2008	Kd	5.721246399047171	uM	32	Kd=1.9+/-0.1uM, G-actin bound to RPEL2-MAL peptide	2
	3c8k	2.9	2008	Kd	3.9913998282380825	uM	274	Natural killer cell receptor Ly-49C recognize H-2 class I histocompatibility antigen	4
	2vwe	3.4	2008	Kd	9.944239535312265	pM	167	Fab fragment of antibody (Fab-2H10) with VEGF-B	6
	2p45	1.1	2008	Kd	6.935542010773082	nM	123	cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-1(clone 22) form, Kd=116+/-33nM	2
	2p46	2.5	2008	Kd	6.935542010773082	nM	123	cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-2(clone 22) form, Kd=116+/-33nM	4
	2p48	2.3	2008	Kd	6.935542010773082	nM	123	cAb-RN05 VHH complexes with RNase A, SE5b-tetra(clone 22) form, Kd=116+/-33nM	2
	2p47	2.5	2008	Kd	6.935542010773082	nM	123	cAb-RN05 VHH complexes with RNase A, SE5b-tri(clone 22) form, Kd=116+/-33nM	2
	3e3q	2.95	2008	Kd	6.935542010773082	nM	110	m13 high-affinity mutant of the 2C TCR in complex with Ld/QL9	32
	3ch5	2.1	2008	Kd	3.9208187539523753	uM	52	ligand is mutant Nup153-ZnF2, Kd=120uM; Kd=60uM for wt ZnF2	2
	3eg5	2.7	2008	Kd	5.90204892900585	nM	178	Kd=1253+/-86nM, complex between Cdc42-Gpp(NH)p and the mDiaN-TSH mutant	4
	3eab	2.5	2008	Kd	4.920818753952375	uM	89	C-terminal tail of CHMP1B with the MIT domain of spastin, Kd=12uM	12
	2q5d	3.2	2008	Kd	7.806875401645538	nM	40	importin beta and Snurportin-1 sIBB-(25-65) complexes, crystal form II, Kd=15.6+/-6.8nM	4
	2p8q	2.35	2008	Kd	7.806875401645538	nM	40	importin beta sIBB-(25-65) complexes, crystal form I, Kd=15.6+/-6.8nM	2
	2z58	1.88	2008	Kd	7.795880017344075	nM	318	ligand is S324A-subtilisin, Kd=16+/-0.8nM	2
	2w2m	2.4	2008	Kd	6.707743928643524	nM	107	WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR, nuetral PH Kd=196nM	3
	3d5r	2.1	2008	Kd	7.721246399047171	nM	297	3D5R(N138A/Complement C3d), ITC Kd=19+/-4nM, SPR Kd=19.8+/-6.0nM	4
	2voh	1.9	2008	Kd	9.0	nM	26	ligand is Bak BH3-domain, Bak Kd=1-20nM, not listed. but Bad Kd=1700nM	2
	3dgc	2.5	2008	Kd	9.0	nM	141	Interleukin-22/Interleukin-22 receptor subunit alpha-1 DDQ mutant	5
	3d5o	2.8	2008	Kd	6.0	uM	177	human SAP complex with the extracellular domain of Fc gama RIIa, Kd=1-3uM	6
	3eba	1.85	2008	Kd	8.627087997029893	nM	127	CAbHul6 FGLW mutant (humanized) in complex with human lysozyme	2
	3e2u	2.6	2008	Kd	5.638272163982407	uM	97	ligand is CAP-Gly domain of human dynactin-1 (p150-GLUED), Kd=2.3+/-0.4uM	8
	2qj9	2.44	2008	Kd	8.619788758288394	nM	116	ligand is Bone morphogenetic protein 2, BMP2, Kd=2.4nM	4
	3eoy	3.4	2008	Kd	8.55284196865778	nM	104	Reovirus sigma1 with Junctional Adhesion Molecule-A, in ref27 Kd=2.8nM	12
	2oqj	2.8	2008	Kd	3.6989700043360187	uM	21	Biacore Kd=200uM	12
	2p44	1.8	2008	Kd	7.698970004336019	nM	123	cAb-RN05 VHH complexes with RNase A, SE5a-Mono-1(clone 7) form, Kd=20+/-11nM	2
	3bpo	3.0	2008	Kd	7.698970004336019	nM	205	IL13-IL4R-IL13Ra ternary complex, Kd of IL13-IL13Ra for Interleukin-4 receptor alpha chain is 20nM	4
	3bn3	2.1	2008	Kd	4.698970004336019	uM	180	ICAM-5 in complex with F265S, F292G double mutant Integrin alpha-L, I domain, Kd around 20uM	3
	2vog	1.9	2008	Kd	6.6777807052660805	nM	27	ligand is Bmf BH3-domain, Kd=210nM	2
	2vlq	1.6	2008	Kd	10.642065152999546	pM	86	F86A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=22.8+/-3.7pM	2
	3bk3	2.7	2008	Kd	7.657577319177793	nM	114	CV-2 VWC1 and BMP-2, Kd=22nM	4
	2p43	1.65	2008	Kd	7.638272163982407	nM	123	cAb-RN05 VHH complexes with RNase A, native SE3-Mono-1 form	2
	2p42	1.8	2008	Kd	7.638272163982407	nM	123	cAb-RN05 VHH complexes with RNase A, native SE3-Mono-2 form	4
	3b9f	1.6	2008	Kd	4.619788758288394	uM	395	ligand is protein C inhibitor(PCI); Kd=24+/-8uM(positivepH 7.0)	5
	3eo1	3.1	2008	Kd	9.602059991327963	pM	112	Fab Fragment of GC-1008 Complex with Transforming Growth Factor-Beta 3, Kd=250pM, IC50=7+/-2nM	12
	3be1	2.9	2008	Kd	7.585026652029182	nM	624	Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2	3
	3bgf	3.0	2008	Kd	7.585026652029182	nM	212	SARS coronavirus spike receptor binding domain in complex with F26G19 Fab	6
	3d5s	2.3	2008	Kd	7.585026652029182	nM	297	3D5S (R131A/Complement C3d), ITC Kd=26+/-6nM, SPR Kd=62.1+/-32.4nM	4
	3b2v	3.3	2008	Kd	8.481486060122112	nM	213	ligand is Fab fragment of IMC-11F8, Kd=3.3+/-0.5nM	6
	3bdy	2.6	2008	Kd	6.522878745280337	nM	102	Dual specific bH1 Fab in complex with VEGF	3
	3blh	2.48	2008	Kd	6.522878745280337	nM	260	CDK9/CycT1, Kd=300nM, unpublished data	2
	3ech	1.8	2008	Kd	6.522878745280337	nM	25	Kd=300+/-70nM	3
	3bky	2.61	2008	Kd	7.522878745280337	nM	25	Fab fragment of the antibody C2H7 complex with CD20 epitope peptide, Kd=3 X 10-8M	3
	3d7u	4.11	2008	Kd	4.522878745280337	uM	277	ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~30uM	4
	3cx8	2.0	2008	Kd	6.468521082957745	nM	203	RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GTP gamma S	2
	2vsm	1.8	2008	Kd	7.455931955649724	nM	140	NIPAH VIRUS ATTACHMENT GLYCOPROTEIN WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2	2
	2efh	2.1	2008	Kd	7.443697499232712	nM	181	ARA7-GDP / VPS9a-D185N mutant complex, Kd=3.6x10-8M with Mg2+	4
	2rgn	3.5	2008	Kd	7.443697499232712	nM	354	ligand is p63 (149-502), Kd=36+/-3nM, Ki=29+/-4nM	6
	3c66	2.6	2008	Kd	5.522878745280337	uM	26	ligand is Fip1 residues 80-105 (Fippbd)	4
	3d2u	2.21	2008	Kd	8.397940008672037	nM	281	UL18 protein	8
	3bp8	2.85	2008	Kd	8.3829996588791	nM	406	Putative NAGC-like transcriptional regulator, Mlc/EIIB complex, Kd=4.14+/-1.22nM	4
	3dvm	2.6	2008	Kd	8.364516253185087	nM	22	Ca2+/CaM-CaV2.1 IQ domain complex, N-lobe Kd=51+/-20nM, C-lobe Kd=4.32+/-0.39nM	2
	3c4p	1.75	2008	Kd	8.356547323513812	nM	165	SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M) mutant, Kd=4.4+/-0.6nM	2
	3cqx	2.3	2008	Kd	5.346787486224656	uM	88	Hsc70-NBD complex with BAG family molecular chaperone regulator 2, Kd=4.5+/-2uM for Bag2-BNB dimer, not for the Hsc70-NBD-Bag2-BNB complex	4
	3c4o	1.7	2008	Kd	8.337242168318426	nM	165	SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M, S130K, S146M) mutant, Kd=4.6+/-0.2nM	2
	3e2h	3.8	2008	Kd	5.337242168318426	uM	110	m67 high-affinity mutant of the 2C TCR in complex with Ld/QL9	4
	3cx6	2.5	2008	Kd	5.318758762624412	uM	203	RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GDP	2
	2qjb	2.5	2008	Kd	8.309803919971486	nM	116	ligand is Bone morphogenetic protein 2, BMP2, Kd=4.9nM	4
	2vlr	2.3	2008	Kd	5.309803919971486	uM	100	TCR-pMHC complex	10
	3c09	3.2	2008	Kd	7.366531544420414	nM	212	Fab fragment of matuzumab (Fab72000) complex with sEGFR domain 3, Kd=43.0+/-12.9nM	6
	2vyr	2.0	2008	Kd	7.356547323513812	nM	101	VH9 and Humain MDM4 N-terminal domain, Kd=44nM	12
	3ejj	2.4	2008	Kd	6.341988603342887	nM	289	ligand is domains (D1-D3) of FMS; (D1-D3) of FMS Kd=455nM, (D1-D5) of FMS Kd=9.0nM	5
	3bpn	3.02	2008	Kd	6.3124710387853655	nM	314	ternary complex of IL-4Ra/IL-4 complex and Interleukin-13 receptor alpha-1 chain, Kd=487nM	3
	3cqc	2.53	2008	Kd	8.397940008672037	nM	227	ligand is human Nucleoporin Nup133; His-tagged hNup107 658-925, kd=4+/-2nM	2
	3cqg	3.0	2008	Kd	8.397940008672037	nM	227	ligand is human Nucleoporin His-tagged hNup133 (934-1156), kd=4+/-2nM	2
	2ve7	2.88	2008	Kd	5.3979400086720375	uM	250	ligand is Nuf2(1-169)-Spc24(122-197); Kd=4~5uM	4
	2vlj	2.4	2008	Kd	5.2839966563652006	uM	100	TCR-pMHC complex	5
	3beg	2.9	2008	Kd	7.301029995663981	nM	115	ASF/SF2, kd~50nM	2
	3cx7	2.25	2008	Kd	6.2839966563652006	nM	203	RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to ALF and GDP	2
	3bpl	2.93	2008	Kd	6.252588192113577	nM	199	ternary complex of IL-4Ra/IL-4 complex and Cytokine receptor common gamma chain, Kd=559nM	5
	3chw	2.3	2008	Kd	7.2441251443275085	nM	139	Profilin	3
	2efd	3.0	2008	Kd	8.136677139879543	nM	181	GDP Nucleotide-free ARA7 / VPS9a complex, with Mg2+, Kd=7.3nM	4
	3c9a	1.6	2008	Kd	8.113509274827518	nM	52	ligand is Spitz EGF-domain(SpitzEGF: residues 48-99), for full length Argos419, Kd=20nM	4
	2vay	1.94	2008	Kd	8.102372908709558	nM	21	ligand is CAV1.1 IQ PEPTIDE	2
	3d7t	2.9	2008	Kd	4.154901959985743	uM	286	ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~70uM	2
	2v5q	2.3	2008	Kd	7.1487416512809245	nM	167	DESIGN ANKYRIN REPEAT PROTEIN VARIANT 3H10, rough estimated Kd=71nM	4
	3crk	2.3	2008	Kd	5.080921907623926	uM	87	PDHK2 complex with inner lipoyl-bearing domain of dihydrolipoamide transacetylase (L2), Potassium phosphate buffer, Kd=8.3+/-0.3uM	4
	3dbl	2.9	2008	Kd	5.057991946977687	uM	88	APPBP1-UBA3Arg190 (wt) complex with NEDD8 Ala72Gln mutant, Kd=8750+/-70nM	12
	3dvg	2.6	2008	Kd	8.060480747381382	nM	80	Apu3.A8-K63-linked diubiquitin	4
	2qna	2.84	2008	Kd	7.080921907623926	nM	66	ligand is IBB domain of Snurportin-1 (1-65); for full length Imp beta Kd=79nM, for 127-876, Kd=83nM	2
	3bik	2.65	2008	Kd	5.096910013008056	uM	222	murine PD-1 and Programmed cell death 1 ligand 1 (human PD-L1), Kd=8uM	3
	3bs5	2.0	2008	Kd	7.0338582672609675	nM	106	ligand is SAM domain of HYP; SAM domain dimer complex	2
	3dvn	2.7	2008	Kd	7.036212172654444	nM	80	Apu2.16-K63-linked diubiquitin	8
	3bh6	2.6	2008	Kd	7.022276394711152	nM	352	ligand is wild type RP2, Kd=95+/-2nm	2
	3bx1	1.85	2008	Kd	5.886056647693163	uM	181	Alpha-amylase/subtilisin inhibitor, BASI in complex with the B. lentus subtilisin Savinase	4
	3d1m	1.7	2008	Kd	5.886056647693163	uM	102	wt Sonic hedgehog protein complex with third FNIII domain of CDO	4
	3b4v	2.48	2008	Kd	10.522878745280337	pM	116	Activin in complex with FSTL3, Kd~30pM	8
	3fju	1.6	2008	Ki	8.795880017344075	nM	65	metallocarboxypeptidase (MCP) inhibitor, ACI, Ki=1.6+/-0.2nM	2
	2oul	2.2	2008	Ki	8.769551078621726	nM	241	chagasin, in complex with a cysteine protease Falcipain 2, Ki=1.7+/-0.53nM	2
	2ody	2.35	2008	Ki	8.744727494896694	nM	127	bovine a-thrombin boophilin complex, Ki=1.8nM	6
	3bg4	2.5	2008	Ki	7.46432619657425	nM	57	Guamerin, ki=34.33+/-4.76nM	4
	3gjn	2.48	2009	Kd	12.0	pM	86	ColE7-R12-13 complex, Kd<1x10-12M	4
	3a6b	1.8	2009	Kd	6.966576244513051	uM	129	ligand is hen egg white lysozyme; Ka=0.93x10^7M-1, Kd=1.08x10-7M	3
	2vxq	1.9	2009	Kd	9.958607314841775	nM	96	huMab2 and POLLEN ALLERGEN PHL P 2, KD=1.1x10-10M	3
	3da7	2.25	2009	Kd	6.886056647693163	uM	90	Circular Permutant of Barnase and Barstar, 20C Kd=0.13uM, 30C Kd=1.9uM, 37C Kd=60uM	8
	3k2u	2.35	2009	Kd	9.795880017344075	nM	225	HGFA/Fab40 complex, KD=0.16+/-0.01nM	5
	2w9e	2.9	2009	Kd	10.0	nM	113	ICSM-18 with HUMAN PRP FRAGMENT 119-231	3
	3fp6	1.49	2009	Kd	13.0	pM	58	Kd=0.1pM for bovine trypsin with pancreatic trypsin inhibitor; not for rattus norvegicus	2
	2wjv	2.85	2009	Kd	6.698970004336019	uM	97	UPF1(115-914) and UPF2(1105-1198), Kd is for UPF2(1105-1207) and UPF1(115-287)	4
	3huj	2.5	2009	Kd	6.698970004336019	uM	284	human CD1d-alpha-Galactosylceramide with semi-invariant NKT cell receptor	10
	3inb	3.1	2009	Kd	6.698970004336019	uM	126	MV-H-CD46 complex	4
	2wel	1.9	2009	Kd	6.522878745280337	uM	150	Kd=0.3-0.6uM; protein Fragment: KINASE DOMAIN, RESIDUES 11-335 ;	2
	3dxa	3.5	2009	Kd	6.522878745280337	uM	276	DM1 TCR and HLA-B4405 EENL complex, Kd=0.3+/-0.1uM	15
	2w83	1.93	2009	Kd	6.376750709602099	uM	77	JIP4-LZII (fused to GST) and Delta 12-ARF6GTP-Q67L, Kd=0.42+/-0.05uM	5
	3g3a	2.2	2009	Kd	6.366531544420414	uM	129	lamprey variable lymphocyte receptor in complex with a protein antigen	8
	3d3v	2.8	2009	Kd	6.337242168318426	uM	275	A6 TCR binding affinities for modified Tax Y5F-34F peptides presented by HLA-A2, ligand is a complex	5
	3gty	3.4	2009	Kd	9.327902142064282	nM	149	ligand is 30S ribosomal protein S7; overall dissociation constant of K(AABB) is 4.7x10-10M	2
	2zvk	2.7	2009	Kd	6.3979400086720375	uM	21	ligand is DNA polymerase eta fragment	6
	3d39	2.81	2009	Kd	6.1938200260161125	uM	275	A6 TCR binding affinities for modified Tax Y5F4F peptides presented by HLA-A2, ligand is a complex	5
	3idc	2.7	2009	Kd	9.221848749616356	nM	164	RII beta(102-265):C in the presence of AMP-PNP and 2Mn2+ ions	2
	2wp0	2.67	2009	Kd	6.031517051446065	uM	112	the HobA/DnaAI-II structure	4
	3knb	1.4	2009	Kd	6.026872146400302	uM	107	ligand is obscurin-like protein 1, Kd=0.94+/-0.08uM	2
	3gd1	3.5	2009	Kd	6.008773924307505	uM	363	ligand is Clathrin-(1-363), Kd=0.98+/-0.01uM	4
	3h3g	1.94	2009	Kd	6.00436480540245	uM	24	ligand is 24-mer parathyroid hormone-related protein (PTHrP)	3
	3ew3	3.8	2009	Kd	8.920818753952375	nM	203	1:2 complex between prolactin and prolactin receptor, site 1 Kd=1.2nM, site 2+3 Kd=312nM	3
	3hcu	2.6	2009	Kd	5.8297382846050425	uM	155	TRAF6 in complex with Ubc13 in the C2 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123	4
	3hct	2.1	2009	Kd	5.8297382846050425	uM	155	TRAF6 in complex with Ubc13 in the P1 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123(Supplementary data)	2
	3kpr	2.6	2009	Kd	5.823908740944319	uM	276	LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF	10
	2zvo	2.9	2009	Kd	5.795880017344075	uM	87	NEMO CoZi domain incomplex with diubiquitin in C2 space group	4
	2zvn	3.0	2009	Kd	5.795880017344075	uM	87	NEMO CoZi domain incomplex with diubiquitin in P212121 space group	8
	3htu	2.0	2009	Kd	5.7447274948966935	uM	39	human VPS25c-VPS20 alpha1-3 complex; Kd=1.8+/-0.2uM for helix 1-3, structure is helix 1 only	8
	3g6j	3.1	2009	Kd	8.721246399047171	nM	214	C3b in complex with a C3b specific Fab antibody, S77 IgG	8
	2wo2	2.45	2009	Kd	4.966576244513051	uM	153	EphA4-ephrinB2 complex	2
	3k8p	2.6	2009	Kd	8.0	nM	357	Dsl1Clactis-Sec39 complex, ref Kd data not shown	2
	3hi1	2.9	2009	Kd	7.950781977329818	nM	215	YU2 HIV-1 gp120 (core with V3) complex CD4-Binding-Site Antibody F105(supplementary data)	6
	3idb	1.62	2009	Kd	7.94692155651658	nM	161	RII beta(108-268):C in the presence of AMP-PNP and 2Mn2+ ions	2
	3dco	1.0	2009	Kd	4.935542010773082	uM	445	Kd1=11.6uM in the presence of excess ADP(1mM), NOD bound to Bovine Alpha Tubulin	3
	3eiq	3.5	2009	Kd	6.958607314841775	nM	358	Programmed cell death protein 4, mPdcd4 DeltaN-eIF4A complex	3
	3ifq	2.8	2009	Kd	6.935542010773082	nM	107	ligand is pE--cadherin-CBD, Kd=116+/-31nM	4
	2wii	2.7	2009	Kd	4.958607314841775	uM	277	COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4, Kd=11+/-2uM	4
	3hh2	2.15	2009	Kd	7.910094888560602	nM	109	myostatin in complex with Fst288, Kd for Fst317=12.3nM, not Fst288	4
	3h2u	2.75	2009	Kd	4.8996294548824375	uM	188	Human raver1 RRM1, RRM2, and RRM3 domains with human vinculin tail domain Vt	4
	3f1p	1.17	2009	Kd	3.9208187539523753	uM	121	human HIF2alpha-ARNT PAS-B heterodimer	2
	3gni	2.35	2009	Kd	7.920818753952375	nM	389	STRAD alpha binds MO25 alpha, in present of ATP, two sites Kd1=2.5uM, Kd2=12nM	2
	3fku	3.2	2009	Kd	9.886056647693163	pM	280	H5-VN04 and Neutralizing antibody F10 complex, Kd=130+/-28pM in sup.info	30
	3ff8	2.0	2009	Kd	3.886056647693163	uM	100	mKLRG1-hEC1, Kd=1.3x10-4M	4
	3jsv	2.7	2009	Kd	3.882728704344236	uM	76	mouse NEMO CC2-LZ in complex with K63-Ub2	4
	2wqz	3.9	2009	Kd	6.87942606879415	nM	588	ligand is Neuroligin4, X-Linked; 2VH8 (Nrxb1-NL4 complex)	4
	3hpw	1.45	2009	Kd	4.886056647693163	uM	36	CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM	3
	2w19	2.15	2009	Kd	6.853871964321762	nM	90	COMPLEX BETWEEN DAHP SYNTHASE AND CHORISMATE MUTASE, Kd=140+/-30nM	4
	2wfx	3.2	2009	Kd	7.853871964321762	nM	152	ShhN-eHHIP Delta N with Ca2+, Kd=14+/-1.6nM	2
	2wub	2.9	2009	Kd	6.823908740944319	nM	224	HGFA complex with Fab40.DeltaTrp, Kd=150+/-9.1nM	10
	3g6d	3.2	2009	Kd	10.823908740944319	pM	113	anti-IL-13 antibody fab CNTO607/IL-13 complex	3
	3h6g	2.7	2009	Kd	4.823908740944319	uM	395	GluR6 amino terminal domain, monomer dimer equilibrium	2
	2wuc	2.7	2009	Kd	6.79317412396815	nM	224	Kd=161+/-7.6nM, Antibody FAB40.DELTA TRP Binding to HGFA, not ligand	6
	3hg0	2.1	2009	Kd	7.795880017344075	nM	136	Kd=16nM for BppL alone, Kd=22nM for BppU/BppL complex	4
	3di2	2.7	2009	Kd	4.7447274948966935	uM	154	E106A mutant human IL-7 with unglycosylated IL-7R alpha(EC), Kd=18uM; IC50=3.0uM	4
	3g9v	2.76	2009	Kd	12.0	pM	151	receptor IL-22BP bound to interleukin-22	4
	3jrm	2.9	2009	Kd	12.0	pM	228	ligand is V230Y mutated P26 activator	21
	3kv4	2.19	2009	Kd	6.0	uM	24	ligand is 24-mer Histone H3 peptide	2
	2vxs	2.63	2009	Kd	8.67778070526608	nM	216	IL-17A IN COMPLEX WITH ANTIBODY CAT-2200	12
	3gc3	2.2	2009	Kd	5.6777807052660805	uM	363	ligand is Clathrin-(1-363), Kd=2.1+/-0.4uM	2
	3eoa	2.8	2009	Kd	8.657577319177793	nM	181	Efalizumab Fab and LFA-1 alpha L I domain, Form I, Kd=2.2+/-0.5nM	6
	3eob	3.6	2009	Kd	8.657577319177793	nM	181	Efalizumab Fab and LFA-1 alpha L I domain, Form II, Kd=2.2+/-0.5nM	6
	2wo3	2.35	2009	Kd	5.638272163982407	uM	157	EphA4-ephrinA2 complex	3
	3ff7	1.8	2009	Kd	3.6989700043360187	uM	100	hKLRG1-hEC1, Kd=2x10-4M	4
	3gxu	2.5	2009	Kd	6.692503962086787	nM	143	ligand is Ephrin-B2	2
	2wby	2.6	2009	Kd	7.698970004336019	nM	20	insulin, Kd1 = 20nM(insulin-binding site 1); Kd2 =280nM(insulin-binding site 2), IC50=180nM	6
	3doe	2.25	2009	Kd	7.698970004336019	nM	165	ligand is ARL2 binding protein, BART; Crystal Form 1	2
	3g7z	2.35	2009	Kd	10.698970004336019	pM	36	CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM	4
	3fhc	2.8	2009	Kd	7.665546248849069	nM	405	human DBP5(1-405), Kd=21.6+/-1.7nM	2
	2w2x	2.3	2009	Kd	4.6595558851598815	uM	185	RAS-Related C3 Botulinum Toxin Substrate 2	4
	3di3	2.9	2009	Kd	7.6777807052660805	nM	154	E106A mutant human IL-7 with glycosylated IL-7R alpha(S2), Kd=21nM	5
	3h8k	1.8	2009	Kd	7.6777807052660805	nM	28	Ube2g2:G2BR complex, Kd=21+/-4nM	2
	3h2v	2.9	2009	Kd	4.655607726314889	uM	74	ligand is Human raver1 RRM1 domain; Kd=22.1uM; for RRM1-3, Kd=12.6uM	8
	3ho5	3.01	2009	Kd	6.657577319177793	nM	169	ligand is Sonic hedgehog (SHH) ; Kd=220nM, IC50=53nM	3
	3gsn	2.8	2009	Kd	4.557520230935552	uM	274	RA14 TCR and HLA-A*0201 loaded with a NLV peptide(NLVPMVATV); Kd=27.7+/2.3uM, ligand is a complex	5
	3jvf	3.3	2009	Kd	6.534617148551582	nM	133	Interleukin-17 receptor A and Interleukin-17F complex, Kd=292+/-19nM	4
	3he7	2.8	2009	Kd	6.528708288941061	nM	302	mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR	5
	3etb	3.8	2009	Kd	10.537602002101044	pM	252	antibody M18 complex PAD4, KD=2.9x10-11	8
	3gqi	2.5	2009	Kd	7.481486060122112	nM	226	The Secondary Binding Site on the N-SH2 Domain of Phospholipase C-gamma-1	2
	3g3b	2.4	2009	Kd	7.468521082957745	nM	129	lamprey variable lymphocyte receptor mut13 complex with a protein antigen	8
	3g9w	2.17	2009	Kd	4.443697499232712	uM	52	talin2/Integrin beta-1D complex, Kd=36+/-2uM	4
	2w8b	1.86	2009	Kd	7.42021640338319	nM	118	PROCESSED TOLB IN COMPLEX WITH PAL, Kd=38+/-3nM	8
	3jse	2.9	2009	Kd	11.522878745280337	pM	228	ligand is V230F mutated P26 activator	21
	3gj8	1.82	2009	Kd	5.522878745280337	uM	92	human RanGDP-Nup153 ZnF34 complex	4
	3idx	2.5	2009	Kd	8.393618634889394	nM	215	HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C222(supplementary data)	3
	3idy	3.2	2009	Kd	8.393618634889394	nM	215	HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C2221(supplementary data)	6
	2zxx	2.8	2009	Kd	8.356547323513812	nM	79	mouse tGeminin (residues 79-157) and tCdt1 (residues 172-368), Kd=4.4+/-2.2nM	6
	3hi6	2.3	2009	Kd	5.327902142064283	uM	180	Fab fragment of AL-57 in complex with IA	6
	3it8	2.8	2009	Kd	10.366531544420413	pM	161	TNF alpha complexed with a poxvirus MHC-related TNF binding protein	12
	3hae	2.9	2009	Kd	7.337242168318426	nM	212	HLA-A2-NYESO-1-3M4E5, in reference 3gje and 3gjg exchange	20
	3gj5	1.79	2009	Kd	4.327902142064283	uM	34	human RanGDP-Nup153 ZnF4 complex	4
	3f7p	2.75	2009	Kd	4.309803919971486	uM	248	integrin beta4(1126-1370) and plectin(1-293), Kd=49+/-7uM	5
	3gj3	1.79	2009	Kd	4.309803919971486	uM	33	human RanGDP-Nup153 ZnF2 complex	2
	3kps	2.7	2009	Kd	4.309803919971486	uM	276	Kd=49uM, LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY, ligand is a complex	5
	2w81	2.35	2009	Kd	8.397940008672037	nM	123	FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group C2, Kd=4+/-1nM	6
	2w80	2.35	2009	Kd	8.397940008672037	nM	123	FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group P1, Kd=4+/-1nM	8
	3h42	2.3	2009	Kd	11.397940008672037	pM	217	PCSK9 in complex with Fab from LDLR competitive antibody	4
	3gj7	1.93	2009	Kd	5.3979400086720375	uM	98	human RanGDP-Nup153 ZnF12 complex	4
	3kls	3.6	2009	Kd	8.259637310505756	nM	231	ligand is SSL7 protein from Staphylococcus aureus; ITC test	6
	3a67	1.8	2009	Kd	8.250263684430939	nM	129	ligand is hen egg white lysozyme; Ka=17.8x10^7M-1, Kd=5.62x10-9M	3
	2wbj	3.0	2009	Kd	3.2479515521805613	uM	279		9
	3ejh	2.1	2009	Kd	5.301029995663981	uM	23	Fibronectin 8-9FnI Domain Pair complex a Type-I Collagen Peptide, Kd=5+/-1uM	4
	3gb8	2.9	2009	Kd	5.187086643357144	uM	329	CRM1/Snurportin-1 complex, Kd=1.4uM at temp 15, Kd=6.5uM at temp 23	2
	3gj6	2.7	2009	Kd	5.187086643357144	uM	34	human RanGDP-Nup153 ZnF1 complex	2
	3gj4	2.15	2009	Kd	5.180456064458132	uM	33	human RanGDP-Nup153 ZnF3 complex	4
	3gjf	1.9	2009	Kd	7.200659450546418	nM	212	HLA-A2-NYESO-1-3M4F4, T-cell receptor-like antibody	10
	3he6	2.9	2009	Kd	7.1605219526258015	nM	302	mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta8.2 NKT TCR	5
	3a6c	1.8	2009	Kd	8.146301788223825	nM	129	ligand is hen egg white lysozyme; Ka=14x10^7M-1, Kd=7.14x10-9M	3
	2wg3	2.6	2009	Kd	7.133122185662502	nM	164	DHHN-eHHIP Delta N without Ca2+, Kd=73.6+/-12.9nM	4
	2wg4	3.15	2009	Kd	7.131355561605174	nM	155	ShhN-eHHIP Delta N without Ca2+, Kd=73.9+/-12.3nM	2
	2wwx	1.5	2009	Kd	7.102372908709558	nM	217	SIDM/DRRA(GEF/GDF DOMAIN)-RAB1 (GTPASE DOMAIN) COMPLEX	2
	3jtl	3.2	2009	Kd	11.154901959985743	pM	228	ligand is C7PAN mutated P26 activator	21
	3dmm	2.6	2009	Kd	5.086186147616283	uM	275	ligand is murine MHCI molecule H-2Dd	5
	3ffc	2.8	2009	Kd	5.050609993355088	uM	202	CF34 TCR in complex with HLA-B8/FLRGRAYGL, Kd=8.89+/-1.31uM	10
	2wss	3.2	2009	Kd	7.096910013008056	nM	190	F1-ATPase; the OSCP; and a subcomplex between subunits b, d, and F6, Kd=80nM high-affinity site; Kd=6-8uM low-affinity site.	25
	2wx0	2.4	2009	Kd	5.096910013008056	uM	31	TAB2 NZF 663-693 and K63 U2. Kd=8+/-1.7uM	6
	3ia3	3.2	2009	Kd	7.031517051446065	nM	145	ligand is wild-type bishis-Hemoglobin subunit alpha, Kd=93+/-5nM	4
	3bzd	2.3	2009	Kd	4.017728766960432	uM	237	ligand is Enterotoxin type C-3; Kd=9.6x10-8M, SEC3-1A4 and mVBeta8.2; SEC3-wt and mVBeta8.2, Kd=12uM	2
	3gmw	2.1	2009	Kd	10.301029995663981	nM	156	BLIP-I and TEM-1 complex, BLIP and BLIP-I share Ki=0.1-0.6nM, Kd~0.05nM	4
	2vxt	1.49	2009	Kd	9.698970004336019	nM	157	ligand is HUMAN INTERLEUKIN-18 cysteine mutant	3
	3fxd	2.1	2009	Kd	7.698970004336019	nM	73	ligand is Protein IcmR; Kd~20nM, actual Kd may be lower	4
	3fsh	2.76	2009	Kd	8.301029995663981	nM	28	the binding affinity is for Ube2ge bound GST-gp78C.	3
	3h8d	2.2	2009	Kd	7.096910013008056	nM	39	myosin VI CBD in complex with the Dab2 MIR residues 675-713	8
	3f4y	2.0	2009	Ki	9.698970004336019	nM	40	HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 3, Ki<0.2nM	6
	3e1z	1.86	2009	Ki	10.443697499232712	nM	110	chagasin, a protein inhibitor from Trypanosoma cruzi	2
	3h6s	2.22	2009	Ki	10.096910013008056	nM	152	ligand is clitocypin, Ki=0.08+/-0.03nM	8
	3fii	2.17	2009	Ki	8.721246399047171	nM	33	BoNT F-inh2 complex	2
	3fie	2.1	2009	Ki	9.0	nM	38	BoNT F-inh1 complex	4
	3k9m	2.61	2009	Ki	8.698970004336019	nM	98	affinity data is not for human source stefin A and cathepsin B, Ki=2+/-0.42nM	4
	3e2l	1.87	2009	Ki	10.161150909262744	pM	165	KPC-2 Beta-lactamase G175S mutant and BLIP, space group C2, Ki=69+/-6pM	4
	3e2k	2.1	2009	Ki	10.161150909262744	pM	165	KPC-2 Beta-lactamase G175S mutant and BLIP, space group P212121, Ki=69+/-6pM	4
	3g7a	2.8	2009	Ki	8.045757490560675	nM	38	HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 10, Ki=9nM	2
	3f50	2.8	2009	Ki	8.045757490560675	nM	40	Oligomer 10. The binding affinity is for gp41-5. IC50=5+/-2nM.	2
	3ma9	2.05	2010	Kd	8.0	nM	217	gp41 derived protein complexed with fab 8066, Kd<<10nM	3
	3ixt	2.75	2010	Kd	10.455931955649724	nM	26	ligand is Peptide Epitope	6
	3mc0	2.0	2010	Kd	6.903089986991944	uM	239	ITC KD=0.125uM, SPR KD=0.270uM	4
	3fpu	1.76	2010	Kd	9.920818753952375	nM	70	ligand is C-C motif chemokine 3	2
	3iu3	2.9	2010	Kd	9.853871964321762	nM	223	ligand is IL-2Ra (CD25) ectodomain	12
	3laq	3.2	2010	Kd	9.769551078621726	nM	134	ligand is murine Urokinase-type plasminogen activator	4
	2wpt	1.78	2010	Kd	7.0	uM	86	ligand is COLICIN-E2 IMMUNITY PROTEIN	2
	3lk2	2.2	2010	Kd	7.0	uM	52	ligand is CARMIL, capping protein interacting motif, CBR52; Kd=0.1~0.2uM	3
	3nfp	2.86	2010	Kd	9.568636235841012	nM	223	ligand is Interleukin-2 receptor subunit alpha (CD25) ectodomain; SPR Kd=0.27nM	6
	3ogo	2.8	2010	Kd	9.494850021680094	nM	123	ligand is GFP-nanobody; ITC Kd<1nM, in reference SPR Kd=0.32nM	8
	3l9j	2.1	2010	Kd	9.468521082957745	nM	149	trimeric TN-2-B1-C31, Biacore Kd=3.4 x 10-10M	2
	3mca	2.74	2010	Kd	6.4089353929735005	uM	390	ligand is Protein dom34; Kd=0.39+/-0.02uM, in support info	2
	3kuc	1.92	2010	Kd	6.354577730650909	uM	81	ligand is RafRBD(A85K/N71R)	2
	3o6q	2.5	2010	Kd	9.337242168318426	nM	56	ligand is Stage II sporulation protein SB; a Toxin-Antitoxin System, Kd=4.6x10-10M	4
	3lev	2.5	2010	Kd	9.221848749616356	nM	179	epitope scaffold ES2, Kd=0.600+/-0.004 nM	3
	2wp3	1.48	2010	Kd	6.100179497572904	uM	109	ligand is OBSCURIN LIKE 1 IG, Form I, trigonal, Ka=12.6+/-1.5 x10^5M-1	2
	3n85	3.2	2010	Kd	9.102372908709558	nM	217	ligand is ryptophan-rich antibody fragment fab37; Kd=0.79+/-0.33nM	5
	3mxw	1.83	2010	Kd	9.154901959985743	nM	169	ITC in solution, Kd=0.7nM	3
	2wwk	1.7	2010	Kd	5.892790030352131	uM	109	ligand is OBSCURIN LIKE 1 IG F17R MUTANT, Ka=7.8+/-1.3 x10^5M-1	2
	3oky	2.19	2010	Kd	5.886056647693163	uM	565	mouse Sema6A-PlxnA2(1-4); Kd for monomerized Sema	3
	3ma2	2.05	2010	Kd	5.815308569182402	uM	125	ligand is Metalloproteinase inhibitor 1	4
	3lk4	1.99	2010	Kd	8.823908740944319	nM	29	ligand is CARMIL, capping protein interacting motif, CBR115	36
	3lqa	3.4	2010	Kd	5.795880017344075	uM	217	CAP210 plus sCD4 interaction with human anti HIV 21c Fab	4
	3kud	2.15	2010	Kd	5.769551078621726	uM	81	ligand is RafRBD(A85K) mutant	2
	3m0a	2.61	2010	Kd	5.769551078621726	uM	75		4
	3osl	6.0	2010	Kd	8.744727494896694	nM	74		4
	3k75	2.95	2010	Kd	6.958607314841775	nM	252	ligand is DNA polymerase beta catalytic domain; Kd=110+/-10nM	4
	3kz1	2.7	2010	Kd	6.958607314841775	nM	182	Fragment:residues 710-1085; Kd= 110+/-15 nM	4
	2xb6	2.6	2010	Kd	6.939302159646388	nM	179	ligand is NEUREXIN-1-BETA LNS DOMAIN; Kd=115nM, in reference similar Kd=132nM	4
	3pl6	2.55	2010	Kd	4.844663962534939	uM	268	Autoimmune TCR Hy.1B11 in complex with HLA-DQ1 and MBP 85-99, Kd=14.3+/-1.5uM	4
	3k3q	2.6	2010	Kd	9.832682665251824	pM	151	ligand is llama Aa1 VHH domain, Kd=1.47x10-10M, IC50=4.7x10-10M	3
	3h3p	2.7	2010	Kd	7.853871964321762	nM	85	ligand is epitope peptide; Kd=14nM by SPR, ITC data is not successful	6
	3k6g	1.95	2010	Kd	7.782516055786093	nM	42	ligand is Telomeric repeat-binding factor 2 (275-316)	6
	3oak	2.15	2010	Kd	6.772113295386326	nM	31	Spn1 (Iws1)-Spt6 complex	4
	2x1w	2.7	2010	Kd	7.795880017344075	nM	110	ligand is VASCULAR ENDOTHELIAL GROWTH FACTOR C(VEGF-C); Kd=16+/-6.7nM(measured by ITC) , Kd=18.2+/-5.3nM(measured by SPR)	21
	2x1x	3.1	2010	Kd	7.795880017344075	nM	110	ligand is VEGF-C(VASCULAR ENDOTHELIAL GROWTH FACTOR C); Kd=16+/-6.7nM(ITC); Kd=18.2+/-5.3nM(SPR)	6
	3m63	2.4	2010	Kd	6.756961951313706	nM	101		2
	3l5n	7.54	2010	Kd	6.7447274948966935	nM	88	ligand is Staphylococcal Complement Inhibitor (SCIN), SCIN binds directly to activated C3b in near-physiological buffers	3
	3m18	1.95	2010	Kd	9.744727494896694	pM	129	ligand is hen egg lysozyme C; code 3m19 is pure VLRA.R5.1, complex Kd=120pM	2
	2wh6	1.5	2010	Kd	7.7447274948966935	nM	26	ligand is THE BIM BH3 DOMAIN, Kd=18+/-2nM	2
	3mv7	2.0	2010	Kd	5.657577319177793	uM	241	with Beta-2-microglobulin and HPVG peptide, Kd= 2.2+/-0.2uM, WT TK3 TCR with two chain	5
	3o4o	3.3	2010	Kd	5.627087997029894	uM	158	ligand is Interleukin-1 beta; Interleukin-1 beta with IL1-RI, Kd=6.38nM, type II Kd=2.36uM	5
	3onw	2.38	2010	Kd	8.638272163982407	nM	36	G-alpha-i1 mutation: Q147L; Kd=1.9-2.6 nM with GDP	4
	3mjh	2.03	2010	Kd	5.619788758288394	uM	34	34-mer C2H2 Zinc Finger of EEA1	4
	3l95	2.19	2010	Kd	8.602059991327963	nM	244	ligand is human Notch1 Negative Regulatory Region (NRR); Kd=2.5x10-9M	7
	3mhp	1.7	2010	Kd	5.560667306169737	uM	26	FNR:Tic62 peptide, Kd=2.75+/-0.33uM	3
	3a4s	2.7	2010	Kd	5.55129368009492	uM	79	Kd=2.81+/-0.81um	4
	3ohm	2.7	2010	Kd	6.698970004336019	nM	885	ligand: phospholipase C beta 3; AlF4-, Mg2+ containing	2
	3hug	2.35	2010	Kd	7.698970004336019	nM	92	ligand is RNA polymerase sigma factor of SigL; Zn2+ containing; Kd=150nM(Zn2+ free Mycobacterium tuberculosis RslA to sigma SigL)	20
	3nh7	2.7	2010	Kd	7.698970004336019	nM	129	ligand is Bone morphogenetic protein receptor type-1A extracellular domain	12
	3ncc	2.5	2010	Kd	0.6736641390712486	mM	210	KD=3.6 x 10-6M, PH=7.0, Kd=0.212M	2
	3kyi	2.8	2010	Kd	3.6615435063953954	uM	145	ligand is CheY6 from R. sphaeroides; Kd=218+/-8uM	2
	3aaa	2.2	2010	Kd	7.6777807052660805	nM	123	Actin capping protein in complex with V-1 Myotrophin	3
	3o6b	3.1	2010	Kd	6.6439741428068775	nM	76	ligand is Cell division control protein 53, WHB Subdomain; Kd=227+/-37nM	10
	2wd5	2.7	2010	Kd	7.657577319177793	nM	213	SMC hinge heterodimer (Mouse)	2
	3mzw	2.9	2010	Kd	10.657577319177793	pM	58	ligand is ZHER2 affibody molecule	3
	3ouw	2.91	2010	Kd	7.638272163982407	nM	65	ligand is nonphosphorylated Lymphoid enhancer-binding factor 1; Kd=23+/-3nM	2
	3aa6	1.9	2010	Kd	6.585026652029182	nM	23	CP/CD23, Cp-binding motif derived from CD2AP	3
	3l5x	1.9	2010	Kd	9.570247719997592	pM	113	complex between IL-13 and H2L6 FAB, Kd=269+/-24pM	3
	3kxf	3.1	2010	Kd	4.568636235841013	uM	276	ligand is HLA-B*3508 (Q65A, T69A, Q155A); Kd=27uM for AAA mutant	20
	3l89	3.5	2010	Kd	6.546681659952962	nM	126	ligand is domains SCR1 and SCR2 of CD46 (membrane cofactor protein, MCP)	24
	3nvq	2.4	2010	Kd	6.542118103266008	nM	476	ligand is Semaphorin-binding module of PlexinC1	4
	3lhp	2.7	2010	Kd	10.55284196865778	pM	123	ligand is HIV epitope-scaffold 4E10_D0_1ISEA_004_N (T93); SPR, mAb 4E10 fv in solution, Kd=28pM and Epitope-scaffold in solution Kd=7.5pM	6
	3kj2	2.35	2010	Kd	8.698970004336019	nM	22	ligand is Bim BH3 mutant F4aE, Kd<2nM	2
	3kj1	1.95	2010	Kd	8.698970004336019	nM	22	ligand is Bim BH3 mutant I2dA, Kd<2nM	2
	3kj0	1.7	2010	Kd	8.698970004336019	nM	27	ligand is Bim BH3 mutant I2dY, Kd<2nM	2
	2wvw	9.0	2010	Kd	5.698970004336019	uM	155	ligand is RbcL.	24
	3npz	3.35	2010	Kd	5.501689446210399	uM	199	ligand is Natural Hormone (PRL), wild type Kd=3.15+/-0.16uM, unit should be uM	3
	3n06	2.0	2010	Kd	2.5086383061657274	mM	210	KD=2.9+/-2 x 10-8M, PH=7.0, Kd=0.0031M	2
	2xra	2.3	2010	Kd	8.481486060122112	nM	228	ligand is TRANSMEMBRANE PROTEIN GP41 MIMETIC 5-HELIX; SPR Kd=3.3nM	3
	3m9d	4.5	2010	Kd	5.468521082957745	uM	68	Kd range from 3.4uM to 4.2uM, Pup and Mpa 1-234 complex	18
	3oiq	2.4	2010	Kd	5.42021640338319	uM	36	ligand is catalytic subunit of DNA polymerase alpha Pol1	2
	2xgy	1.8	2010	Kd	4.522878745280337	uM	173	ligand is PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A, CYCLOPHILIN A	2
	2xqr	2.58	2010	Kd	7.508638306165727	nM	149	ligand is protein inhibitor (CIF, or cellwall inhibitor of beta-fructosidase) from tobacco; Kd=31+/-10nM at PH4.5	24
	3mv8	2.1	2010	Kd	4.460171441622101	uM	242	TK3 TCR with two chain, mutation at chain B Gln55His; with Beta-2-microglobulin and HPVG peptide, Kd= 34.66+/-1.66uM	5
	2xa0	2.7	2010	Kd	7.452225294612178	nM	31	BCL-2 IN COMPLEX WITH A 31-mer BAX BH3 PEPTIDE, Kd=35.3+/-2.42nM	4
	3oux	2.4	2010	Kd	7.455931955649724	nM	67	ligand is Casein kinase II phosphorylated Lymphoid enhancer-binding factor 1; Kd=35+/-12nM	2
	2wy8	1.7	2010	Kd	6.443697499232712	nM	80	ligand is STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV; ITC Kd=360nM, IC50=10uM	2
	3kw5	2.83	2010	Kd	6.414539270491499	nM	75	ligand is ubiquitin vinylmethylester	2
	3jza	1.8	2010	Kd	11.522878745280337	pM	197	ligand is GEF domain of DrrA/SidM from Legionella pneumophila(DrrA(340-533)), Kd=3pM(without GDP or GTP) , Kd=7uM(with GDP)	2
	2xtj	2.7	2010	Kd	8.356547323513812	nM	131	apparent equilibrium affinity constant KD=4.4+/-1.4nM	6
	2x9a	2.47	2010	Kd	5.356547323513812	uM	65	ligand is C-TERMINAL DOMAIN OF TOLA; Kd=4.4uM for isolated N1, Kd=7.1uM for N1 within G3P	4
	3lb6	3.05	2010	Kd	11.327902142064282	pM	132	ligand is Interleukin-13; Kd=4.7pM(measured by ITC); IL-13R alpha2 has sub-100fM affinity for IL-13 by SPR,	4
	3mzg	2.1	2010	Kd	2.303643611266668	mM	210	KD=3.3+/-2 x 10-8M, PH=7.0, Kd=0.00497M	2
	3ajb	2.5	2010	Kd	7.38933983691012	nM	49	ligand is Peroxisomal biogenesis factor 19 N-terminal peptide; Kd=40.8+/-1.6nM for pex19p N-terminal, full length pex19p is 3.4nM	2
	3lbx	2.8	2010	Kd	6.3979400086720375	nM	185	The overall structure of the alpha 0-1/beta 16-17 complex, Kd=400+/-100nM	2
	3h7b	1.88	2010	Kd	4.3872161432802645	uM	100	TCR-pMHC complex	6
	3lh2	2.65	2010	Kd	10.327902142064282	pM	114	ligand is HIV epitope-scaffold 4E10_1VI7A_S0_002_N (T88); SPR, mAb 4E10 fv in solution, Kd=47pM and Epitope-scaffold in solution Kd=5.6nM	12
	3im4	2.29	2010	Kd	7.318758762624412	nM	45		3
	3kr3	2.2	2010	Kd	10.309803919971486	pM	251		3
	3aa0	1.7	2010	Kd	5.3979400086720375	uM	21	ligand is peptide from Leucine-rich repeat-containing protein 16A(CA21), Kd=4000nM	3
	3n0p	2.1	2010	Kd	2.2924298239020637	mM	210	KD=5.3+/-2 x 10-8M, PH=7.0, Kd=0.0051M	2
	3h9h	2.0	2010	Kd	5.267606240177032	uM	100	TCR-pMHC complex; Kd=5.4+/-0.1uM	6
	3ol2	2.99	2010	Kd	5.259637310505756	uM	528	human Sema4D-PlxnB1(1-2); Kd for monomerized Sema	8
	3mv9	2.7	2010	Kd	5.239577516576788	uM	241	TK3 TCR with two chain, mutation at chain B Gln55Ala; with Beta-2-microglobulin and HPVG peptide, Kd= 5.76+/-0.07uM	5
	2xqb	2.6	2010	Kd	10.2839966563652	pM	114	ligand is human INTERLEUKIN 15	3
	3l5w	2.0	2010	Kd	10.2839966563652	pM	113	complex between IL-13 and C836 FAB, Kd=52+/-10pM	6
	3mj7	2.8	2010	Kd	5.301029995663981	uM	225	ligand is Coxsackie and Adenovirus receptor, CAR	4
	2x2d	1.9	2010	Kd	5.214670164989233	uM	147	Kd=6.1+/-0.9uM; ligand is HIV-1 N-TERM CAPSID DOMAIN	4
	3o9w	2.8	2010	Kd	5.2076083105017466	uM	209	with BbGL-2c ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )	6
	2wy3	1.8	2010	Kd	7.180456064458132	nM	158	ligand is UNCHARACTERIZED PROTEIN UL16; MICBpf Kd=66nM, complete ectodomain Kd=67nM	4
	3lb8	2.6	2010	Kd	4.180456064458132	uM	106	covalent putidaredoxin reductase-putidaredoxin complex, Determined by cyclic voltammetry	4
	3me2	2.8	2010	Kd	10.167491087293763	pM	171	ligand is Tumor necrosis factor ligand superfamily member 1; Kd=6.8x10-11M	2
	3o8x	2.74	2010	Kd	6.161150909262744	nM	209	with GalA-GSL ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )	6
	3lk3	2.68	2010	Kd	8.221848749616356	nM	115	ligand is CD2AP peptide	3
	3ngb	2.68	2010	Kd	8.113509274827518	nM	353	ligand is HIV-1 gp120; non-CD4-bound conformations Kd=7.7nM, CD4-bound Kd=0.617nM, see support info	16
	3k2m	1.75	2010	Kd	8.154901959985743	nM	101	ligand is Monobody HA4, Kd for HA4 and Abl2 SH2 is 18nM	4
	3egg	1.85	2010	Kd	8.060480747381382	nM	170	ligand is PP1 binding and PDZ domains of Spinophilin	4
	3o34	1.9	2010	Kd	5.055517327849832	uM	22	ligand:H3(13-32)K23ac peptide; Kd=8.8+/-0.1uM; imcomplete ligand structure	2
	3kbt	2.75	2010	Kd	8.031984286006358	nM	161	wild type Kd=9.29nM	4
	3gs2	1.7	2010	Kd	8.036212172654444	nM	30	ligand is Chromobox protein homolog 7, Cbox domain	4
	3nvn	2.26	2010	Kd	8.0268721464003	nM	476	ligand is Semaphorin-binding module of PlexinC1	2
	3orv	1.91	2010	Kd	5.026872146400302	uM	373	ligand is Methylamine utilization protein mauG Y294H mutant; Kd=9.4+/-0.1uM for quinone MADH and diferrous Y294H MauG	6
	3ixa	2.1	2010	Kd	5.008773924307505	uM	100	TCR-pMHC complex; Kd=9.8+/-0.1uM	6
	3ixs	1.7	2010	Kd	7.045757490560675	nM	37	ligand is RING1 and YY1-binding protein C-terminal domain	12
	3ncb	2.1	2010	Kd	1.031517051446065	mM	210	KD=1.36 x 10-6M, PH=7.0, Kd=0.093M	2
	3k1r	2.3	2010	Kd	9.0	nM	74	ligand is SAM-PBM of Sans, for only SAM Kd=40uM, for only PBM Kd~1uM	2
	3mac	2.5	2010	Kd	6.698970004336019	nM	217	GP41-derived protein complexed with fab 8062, Kd~200nM	3
	2wus	2.9	2010	Kd	5.301029995663981	uM	112	Kd~5-10uM, temperature is 10 C	4
	3lms	2.5	2010	Ki	8.920818753952375	nM	74	ligand is tick-derived carboxypeptidase inhibitor(TCI), Ki=1.2nM	2
	3l33	2.48	2010	Ki	6.866461091629782	nM	52	Ki=1.36 +/- 0.19 x 10-7M, so Ki is 136nM, not 19nM	8
	2xtt	0.93	2010	Ki	10.698970004336019	pM	36	liand is PROTEASE INHIBITOR SGPI-1; SGPI with bovine trypsin Ki micromolar range, SGPI-1-P02 Ki is pM range, in ref. 20	2
	3kz0	2.35	2010	Ki	6.5638373529592435	nM	23	ligand is Mcl-1 specific peptide MB7; Ki=273+/-37nM	4
	3p8m	2.9	2011	Kd	8.154901959985743	uM	46		4
	3tnf	2.5	2011	Kd	11.0	nM	174	mGppNHp form	2
	3zrz	1.7	2011	Kd	10.522878745280337	nM	20	complex Fn and SfbI-5; Kd=0.030+/-0.001nM	4
	2xqw	2.3	2011	Kd	6.7447274948966935	uM	133		3
	2ybr	2.55	2011	Kd	9.67778070526608	nM	66	crystal space group P212121	9
	3p71	2.7	2011	Kd	6.42021640338319	uM	304	Ka=2.62+/-0.77uM-1; LCMT-1: Mutation: C19M, A21E, D22N, P115S; PP2A: Fragment: CATALYTIC SUBUNIT ALPHA ISOFORM;	2
	3p11	3.7	2011	Kd	9.4089353929735	nM	522	see support information table S1, Kd=0.39+/-0.03nM for DL11f and HER3 ECD domain I-IV	4
	3alz	4.51	2011	Kd	6.2839966563652006	uM	149	Kd=0.52+/-0.21uM	2
	3au4	1.9	2011	Kd	6.275724130399211	uM	63	Kd=0.53+/-0.06uM	2
	3tac	2.2	2011	Kd	6.259637310505756	uM	334	ITC Kd=0.55+/-0.03uM	2
	3ry6	3.8	2011	Kd	3.3010299956639813	mM	167	Kd=0.5+/-0.02mM	6
	3oed	3.16	2011	Kd	6.301029995663981	uM	310	Kd=0.5+/-0.05uM, asymmetric unit	4
	3ona	2.6	2011	Kd	6.167491087293763	uM	80	mean KD value of two measurements	2
	3syn	3.06	2011	Kd	6.221848749616356	uM	23		8
	2y8s	2.55	2011	Kd	9.00480370840282	nM	37	Kd=9.89 x 10-10M	4
	3qbt	2.0	2011	Kd	6.045757490560675	uM	174	Kd=1.1uM (from kinetics), OCRL1 (539-901) was used to determine the kinetics, crystal is OCRL1 (540-678)	8
	3n4i	1.56	2011	Kd	8.958607314841775	nM	165	Kd=1.1+/-0.2nM	2
	3qhy	2.06	2011	Kd	11.958607314841775	pM	271	Stopped-flow Tryptophan Fluorescence Spectrometric Measurements	2
	3rt0	2.11	2011	Kd	5.920818753952375	uM	183	in the absence of ABA	4
	3r1g	2.8	2011	Kd	8.886056647693163	nM	222		3
	3uc0	2.71	2011	Kd	8.886056647693163	nM	236	Indirect ELISAs, PH=7.0, Kd=1.3nM	6
	3noc	2.7	2011	Kd	8.823908740944319	nM	169		5
	3o5t	2.09	2011	Kd	5.823908740944319	uM	112	Kd=1.5+/-0.1uM	2
	3qq8	2.0	2011	Kd	5.823908740944319	uM	85	ITC Kd=1.5+/-0.42uM	2
	3p0y	1.8	2011	Kd	8.71669877129645	nM	214	see support information table S1, Kd=1.92+/-0.32nM for DL11f and EGFR ECD domain I-IV	6
	3p6z	1.7	2011	Kd	5.709965388637482	uM	71	Kd1=1.95+/-0.05uM(SA-FPR-alpha-thrombin); Kd2=2.06+/-0.05uM(CM5-FPR-alpha-thrombin)	6
	3sdc	3.1	2011	Kd	4.971022294791222	uM	302	ligand is Gb3; Kd=10.69+/-0.62uM	5
	3qc8	2.2	2011	Kd	4.950781977329818	uM	84		2
	2xze	1.75	2011	Kd	6.94692155651658	nM	40		4
	3qlu	2.91	2011	Kd	7.958607314841775	nM	395	GluR6 Delta 1/KA2 heterodimer, affinity is for GluR6 Delta 2/KA2	4
	2xbb	2.68	2011	Kd	4.958607314841775	uM	76		4
	3rbb	2.35	2011	Kd	7.910094888560602	nM	61	Kd=12.3+/-2nM	4
	3onl	2.2	2011	Kd	4.920818753952375	uM	97		3
	3qib	2.7	2011	Kd	4.863279432843593	uM	270		5
	3oj2	2.2	2011	Kd	6.886056647693163	nM	231	Kd(FGFR2b WT), X-ray(FGFR2b A172F)	4
	3ojm	2.1	2011	Kd	6.886056647693163	nM	231	Kd(FGFR2b WT), X-ray(FGFR2b P253R)	2
	3qml	2.31	2011	Kd	7.886056647693163	nM	315		4
	2y8t	1.95	2011	Kd	7.847711655616943	nM	37	wild type, Kd=1.42 x 10-8M	4
	2xpx	2.05	2011	Kd	6.823908740944319	nM	26	KD=150+/-69nM	2
	3zs9	2.1	2011	Kd	6.823908740944319	nM	38	Kd=150+/-20nM	4
	3rgv	2.9	2011	Kd	4.823908740944319	uM	236	YAe62 recognized pWM presented by Kb	5
	3t4a	3.4	2011	Kd	4.772113295386326	uM	73		8
	3zwl	2.2	2011	Kd	6.795880017344075	nM	50		4
	3b08	1.7	2011	Kd	4.764471553092451	uM	152	Kd=17.2+/-0.1uM	10
	3qeq	2.59	2011	Kd	3.769551078621726	uM	275	for DMF4-nonamer/HLA-A2 complex, Kd=170+/-11uM	5
	3rea	2.0	2011	Kd	6.747146969020107	nM	61	Kd=179+/-29nM	4
	3q9n	2.0	2011	Kd	7.769551078621726	nM	158	measured by yeast display in 10 mM phosphate + 150 mM NaCl +0.1% BSA	4
	3sja	3.0	2011	Kd	7.769551078621726	nM	65	Kd=17+/-2nM	10
	3vh8	1.8	2011	Kd	4.769551078621726	uM	275	Kd=16.63+/-1.52uM	8
	3sua	4.39	2011	Kd	4.723538195826756	uM	633	Kd=18.9+/-0.8uM	6
	3quy	2.25	2011	Kd	6.728158393463501	nM	285	ligand is BnNH-GSL-1', modify the complex type	5
	3sdy	2.85	2011	Kd	9.0	nM	227		9
	3sip	3.5	2011	Kd	6.0	uM	115	drICE inhibition by BIR1, Three weak interfaces between BIR1 and drICE cooperate to yield a stable hetero-tetramer with a KD of approximately 1~2uM	6
	3tn0	3.2	2011	Kd	5.657577319177793	uM	302	ligand is Alpha-C-GalCer; Kd=2.20+/-0.73uM	5
	3owt	2.0	2011	Kd	5.603800652904264	uM	27	ITC Kd=2.49+/-0.38uM	3
	3sf4	2.6	2011	Kd	8.619788758288394	nM	52		6
	3rdz	2.26	2011	Kd	8.570247719997592	nM	79		4
	3sgk	2.4	2011	Kd	8.537602002101044	nM	204		7
	3uaj	3.23	2011	Kd	8.537602002101044	nM	236	Indirect ELISAs, PH=5.5, Kd=2.9nM	6
	3r4d	3.1	2011	Kd	7.669586226650809	nM	288		6
	3nog	3.34	2011	Kd	7.649751981665837	nM	169		5
	3qbq	2.5	2011	Kd	6.638272163982407	nM	170	extracellular domains of mouse RANK-RANKL complex	4
	3qux	2.91	2011	Kd	6.607303046740334	nM	285	ligand is alpha-C-GalCer, modify the complex type	5
	3r2x	3.1	2011	Kd	7.5376020021010435	nM	93		4
	3qdm	2.8	2011	Kd	4.5376020021010435	uM	275	for DMF4-decamer/HLA-A2 complex, Kd=29+/-4uM	5
	2y9m	2.6	2011	Kd	8.698970004336019	nM	130	Kd=2+/-0.08nM	2
	3rk3	3.5	2011	Kd	5.698970004336019	uM	63	for wt CPX, Kd=16uM, for ScCPX, Kd=2uM	5
	3scm	2.5	2011	Kd	5.518557371497695	uM	302	ligand is iGb3; Kd=3.03+/-0.24uM	5
	3aon	2.0	2011	Kd	8.494850021680094	nM	115	structure is Eh-D and Eh-F; binding data is for Eh-A3B3D and Eh-F	2
	3r9a	2.35	2011	Kd	5.455931955649724	uM	394	KD=3.5uM for protein cargo	4
	2xhe	2.8	2011	Kd	8.4089353929735	nM	279		2
	3t6g	2.5	2011	Kd	7.522878745280337	nM	229	support information figure S5-d, ITC Kd=30nM	4
	3sjd	4.6	2011	Kd	7.508638306165727	nM	46	ADP state, bioassay use Get1-CD	5
	3qiu	2.7	2011	Kd	6.493494967595128	nM	243		5
	3ru8	2.07	2011	Kd	7.474955192963154	nM	230		3
	3oxu	2.1	2011	Kd	4.468521082957745	uM	317	SPR Kd=34+/-1uM	6
	3quz	2.3	2011	Kd	7.402304814074488	nM	285	ligand is NU-alpha-GalCer, modify the complex type	5
	3t2n	2.55	2011	Kd	7.400116927926312	nM	225	KD=39.8nM	6
	3q4f	5.5	2011	Kd	5.3872161432802645	uM	186	Kd=4.1+/-0.2uM(Xrcc4 1-157);Kd=3.9+/-0.2uM(Xrcc4 1-203);	8
	3rug	2.2	2011	Kd	5.356547323513812	uM	302	not a very strict binary complex, ternary complex	10
	3r0l	1.35	2011	Kd	8.346787486224656	nM	39	the more toxic class I isoforms are more stable (Kd=4.5 nM)	4
	3sdd	3.0	2011	Kd	5.315154638355588	uM	302	ligand is beta-LacCer; Kd=4.84+/-0.53uM	5
	3q3g	2.7	2011	Kd	8.303643611266669	nM	190	Fab 107 did not bind to low-affinity rWT, but for human hWT Kd=4.97+/-0.24nM	12
	3qs7	4.3	2011	Kd	7.3979400086720375	nM	423		8
	3qdj	2.3	2011	Kd	4.3979400086720375	uM	275	for DMF5-nonamer/HLA-A2 complex, Kd=40+/-2uM	5
	3r85	1.95	2011	Kd	4.384049948343599	uM	26		8
	3pvm	4.3	2011	Kd	7.376750709602099	nM	1642		4
	2x89	2.16	2011	Kd	7.356547323513812	nM	94		7
	3uai	3.06	2011	Kd	7.346787486224656	nM	400	Gar1 and Nhp2 did not affect the binding affinity within experimental error, Kd=45+/-27nM	4
	3sda	2.8	2011	Kd	5.280668713016273	uM	302	ligand is beta-GalCer; Kd=5.24+/-0.58uM	5
	3q9u	2.3	2011	Kd	8.2839966563652	nM	158	measured by yeast display in 10 mM phosphate + 150 mM NaCl +0.1% BSA	4
	3s5l	2.1	2011	Kd	5.275724130399211	uM	191		8
	3o6f	2.8	2011	Kd	5.259637310505756	uM	245		8
	3qdg	2.69	2011	Kd	5.251811972993799	uM	275	for DMF5-decamer/HLA-A2 complex, Kd=5.6+/-1.5uM	5
	3rkd	1.9	2011	Kd	8.229884705212898	nM	230	Biacore ITC assay	6
	3pbp	2.6	2011	Kd	7.301029995663981	nM	148	yeast heterotrimeric Nup82-Nup159-Nup116 nucleoporin complex, Kd=50+/-30nM in the presence of Nup159T	12
	3s8v	3.1	2011	Kd	7.301029995663981	nM	88	Alpha Technology binding assay	3
	3to4	3.1	2011	Kd	7.301029995663981	nM	253	Kd=50+/-10nM	5
	3zs8	3.0	2011	Kd	7.292429823902063	nM	84	Kd=51+/-3nM	4
	3rpg	2.65	2011	Kd	5.301029995663981	uM	149	Kd=5+/-1uM	3
	3t1q	2.7	2011	Kd	5.301029995663981	uM	136	Kd=5+/-0.8uM	3
	3uyo	1.83	2011	Kd	5.167491087293763	uM	95	Kd=6800+/-200nM	2
	3rzw	2.15	2011	Kd	7.167491087293763	nM	99		4
	2y0b	2.1	2011	Kd	8.221848749616356	nM	136		6
	3rdt	2.7	2011	Kd	5.221848749616356	uM	217		4
	3rgf	2.2	2011	Kd	8.1518108830086	nM	285	Kd=7.05+/-0.85nM	2
	3zyi	2.6	2011	Kd	8.136677139879543	nM	353		2
	3zyj	3.25	2011	Kd	8.102372908709558	nM	426		4
	3sku	4.0	2011	Kd	7.154901959985743	nM	319		13
	3s2k	2.8	2011	Kd	7.14569395819892	nM	97	Kd=71.5+/-12nM	7
	3rzc	2.8	2011	Kd	6.1438755557577	nM	241	Kd=718+/-14nM	7
	3q1s	2.15	2011	Kd	7.136677139879544	nM	151	Kd=73+/-8nM	3
	3pp4	1.6	2011	Kd	5.154901959985743	uM	25		3
	3s4s	2.4	2011	Kd	5.055517327849832	uM	191		8
	2xns	3.41	2011	Kd	6.0915149811213505	nM	40	protein Fragment: RESIDUES 30-354 ; peptide Fragment:RESIDUES 497-517; GDP-containing; ternary complexes;	4
	3skj	2.5	2011	Kd	9.09151498112135	pM	206	assay by ProteOn XPR36 instrument (Bio-Rad, Hercules, CA), Kd=810+/-296pM	6
	3pmh	3.2	2011	Kd	7.0915149811213505	nM	36	Tyr276, 278, 279 to modified Tys; Kd=81+/-20 nM; Fragment: unp residues 17-306; Mutation: C65A;	4
	3qht	2.4	2011	Kd	7.086186147616283	nM	97		4
	3qwo	1.9	2011	Kd	7.060480747381382	nM	57		6
	3mj9	2.95	2011	Kd	8.096910013008056	nM	223		4
	2xzd	2.1	2011	Kd	8.017728766960431	nM	136		6
	3olm	2.5	2011	Kd	4.042871802323187	uM	79	fluorescence anisotropy, Kd=90.6+/-6.4uM	2
	3qsk	1.75	2011	Kd	7.040958607678906	nM	123		2
	3reb	3.45	2011	Kd	7.017728766960431	nM	90	Kd=96+/-15nM	4
	3qiw	3.3	2011	Kd	3.3010299956639813	uM	243		5
	3opz	3.4	2011	Kd	9.142667503568731	nM	222	Kd~7.2x10-10M	9
	2ygg	2.23	2011	Kd	7.698970004336019	nM	150	Kd~20nM(residue637-657);Kd~350nM(residue 657-700)	2
	3t04	2.1	2011	Kd	7.2839966563652006	nM	103		2
	3ay4	2.2	2011	Kd	7.221848749616356	nM	179	SPR Kd=6x10-8M, just a figure, no exact data listed, estimated Kd value	7
	2y6t	2.74	2011	Ki	11.698970004336019	nM	148	data from ref. 23	8
	3u1j	1.8	2011	Ki	7.585026652029182	uM	58	Dengue virus protease covalently bound to aprotinin, a 58-amino-acid polypeptide	3
	2y48	3.0	2011	Ki	3.677780705266081	mM	20	using a monomethyl-Lys4 H3-peptide as substrate, Ki=0.21+/-0.07mM, using a dimethylated substrate, Ki=0.22+/-0.09mM	3
	3b23	2.4	2011	Ki	9.497572880015568	nM	32	Ki=0.318+/-0.02nM;IC50=8.25+/-0.45nM	3
	4a1u	1.54	2011	Ki	6.267606240177032	uM	20	ligand is ALPHA-BETA-FOLDAMER 2C	2
	3qtl	2.6	2011	Ki	8.844663962534938	nM	75		4
	3o40	2.1	2011	Ki	8.853871964321762	nM	40	fluorescence polarization assay	2
	3p95	1.3	2011	Ki	5.823908740944319	uM	58	Ki=1.50+/-0.09uM	2
	3pnr	2.6	2011	Ki	7.924453038607469	nM	187	fluorimetric protease assay, Ki=11.9+/-4.7nM	2
	3zv0	2.8	2011	Ki	3.958607314841775	uM	195	Kd of hTERC-3'sl for SHQ1 is 75uM, and NAP57 competitive inhibition of SHQ1 with hTERC-3'sl is Ki=110uM	4
	4a94	1.7	2011	Ki	11.309803919971486	pM	53	Ki=4.9+/-0.6pM	4
	3p92	1.6	2011	Ki	8.229147988357855	nM	58	Ki=5.9+/-1.7nM	2
	3nps	1.5	2011	Ki	10.152427340857887	pM	226	Apparent KI values calculated from the IC50 value	3
	3o43	2.8	2011	Ki	8.045757490560675	nM	40	fluorescence polarization assay	2
	3v1c	1.13	2012	Kd	7.522878745280337	nM	46	symmetric homodimer in presence of Zinc; Kd<30nM(with zinc); Kd=4uM(with out zinc)	2
	3ukx	2.2	2012	Kd	10.522878745280337	nM	28		2
	3ro2	2.3	2012	Kd	7.337242168318426	uM	28		2
	4di3	3.05	2012	Kd	7.221848749616356	uM	301	2:1 complex of Treponema pallidum TatP(T) (Tp0957) bound to TatT (Tp0956)	5
	3uzq	1.6	2012	Kd	10.086186147616283	nM	253		2
	4drb	2.63	2012	Kd	6.958607314841775	uM	141	Kd1=0.11uM, Kd2=4.42uM	15
	4dke	3.0	2012	Kd	9.920818753952375	nM	230	method:biolayer interferometry.	8
	4dck	2.2	2012	Kd	6.920818753952375	uM	192	binding data is for NaV1.5WT and FGF12B WT	3
	4etq	2.1	2012	Kd	9.744727494896694	nM	221		6
	3v6b	3.21	2012	Kd	6.552841968657781	uM	424	Kd=0.28uM for VEGF-A/VEGFR-2 D23 complex, not Kd=5.99uM for VEGF-A/VEGFR-2 ECD	2
	4g6m	1.81	2012	Kd	9.537602002101044	nM	220		3
	3tsr	2.2	2012	Kd	15.698970004336019	fM	457	Kd=2x10-16M	8
	4eee	2.71	2012	Kd	9.698970004336019	nM	157		4
	4b1v	1.75	2012	Kd	6.494850021680094	uM	32	complex G-actin and RPEL-N; Kd=0.32+/-0.05uM	4
	3thm	2.1	2012	Kd	9.455931955649724	nM	245		4
	4hkx	2.5	2012	Kd	6.443697499232713	uM	231		3
	4etp	2.3	2012	Kd	6.431798275933005	uM	333	Kd=0.37+/-0.07uM for ADP	2
	4am0	3.02	2012	Kd	9.3767507096021	nM	217		12
	4g59	2.44	2012	Kd	6.376750709602099	uM	205		4
	3uzv	2.1	2012	Kd	9.366531544420413	nM	253		2
	3tkl	2.18	2012	Kd	6.366531544420414	uM	267	GTP-bound	2
	4al8	1.66	2012	Kd	9.346787486224656	nM	217		3
	4dgi	2.4	2012	Kd	6.346787486224656	uM	111		3
	4ala	1.84	2012	Kd	9.327902142064282	nM	217		3
	4auo	3.0	2012	Kd	6.3979400086720375	uM	40	full length MMP-1 with collagen	8
	4dbg	2.71	2012	Kd	6.2839966563652006	uM	162	Kd=5.2x10-7M	2
	3uz0	2.82	2012	Kd	6.251811972993799	uM	152	binding constant Ka=1.8x10-6M-1, Kd=0.555uM	4
	4dt1	1.9	2012	Kd	6.251811972993799	uM	245	Kd=0.56+/-0.04uM	2
	3tei	2.4	2012	Kd	6.301029995663981	uM	24	ligand is pepRSK1; incomplete ligand	2
	3u9d	2.5	2012	Kd	6.301029995663981	uM	54	Mg2+ and ATP containing	4
	4ft4	2.7	2012	Kd	6.301029995663981	uM	32	Intermolecular interaction between the BAH domain of ZMET2 and H3(1 C32)K9me2 peptide	4
	4apf	3.1	2012	Kd	6.187086643357144	uM	388		2
	4eef	2.7	2012	Kd	9.221848749616356	nM	74	ligand is F-HB80.4 (G12K, L17l, L21l, A35K, S42K mutants)	12
	3twi	2.55	2012	Kd	6.221848749616356	uM	179	method:biolayer interferometry.	6
	4f3f	2.65	2012	Kd	9.142667503568731	nM	69		3
	3ux9	2.8	2012	Kd	9.126679398184601	nM	256		4
	3vwj	3.09	2012	Kd	6.130768280269024	uM	284	Kd=0.74+/-0.07uM	4
	3vwk	2.94	2012	Kd	6.080921907623926	uM	284	Kd=0.83+/-0.03uM	4
	4aei	2.3	2012	Kd	9.096910013008056	nM	229		9
	4afz	2.25	2012	Kd	9.045757490560675	nM	84		4
	4fqi	1.71	2012	Kd	9.045757490560675	nM	230		5
	4fqj	2.5	2012	Kd	9.045757490560675	nM	234		6
	4dra	2.41	2012	Kd	5.931814138253839	uM	84		8
	4fqv	5.75	2012	Kd	8.958607314841775	nM	224		12
	4ehq	1.9	2012	Kd	5.886056647693163	uM	20	Ca-containing; one CaM molecule binds two Orai1-CMBDs	2
	3u9z	2.09	2012	Kd	5.812479279163537	uM	58	Mg2+ and ADP containing	2
	3tq7	2.3	2012	Kd	5.823908740944319	uM	71		4
	4dm6	1.9	2012	Kd	5.823908740944319	uM	25	The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5 uM.Kd=1.5+/-0.1uM	4
	4dm8	2.3	2012	Kd	5.823908740944319	uM	25	The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5 uM.Kd=1.5+/-0.1uM	4
	4dxa	1.95	2012	Kd	5.7447274948966935	uM	322	Kd(Pulldown Assays)	2
	3ve0	3.35	2012	Kd	5.7121982700697735	uM	220		6
	3qt2	2.55	2012	Kd	8.721246399047171	nM	117		6
	3vys	2.35	2012	Kd	5.721246399047171	uM	338	HypC-HypD-HypE complex (form I); Kd=1.9+/-0.2uM	3
	4fqr	4.1	2012	Kd	7.0	nM	241		48
	4hcn	2.6	2012	Kd	3.9718355805755303	uM	98		2
	3ul4	1.95	2012	Kd	7.943095148663527	nM	65	Ka=8.77E7+/-1.31E7M-1	2
	4gg6	3.2	2012	Kd	4.943095148663527	uM	215	Kd=11.4+/-0.6uM	10
	3zuv	2.72	2012	Kd	6.931814138253839	nM	136		4
	3vfr	1.85	2012	Kd	3.9244530386074694	uM	100	Kd=119.0+/-1.0uM	3
	4fzv	2.0	2012	Kd	7.876148359032914	nM	239	Kd=13.3+/-0.4nM	2
	4auq	2.18	2012	Kd	3.8664610916297826	uM	81		6
	3vyr	2.55	2012	Kd	6.853871964321762	nM	372	HypC-HypD complex; Kd=140+/-20nM	2
	3rtq	2.8	2012	Kd	6.823908740944319	nM	99		6
	3zwh	1.94	2012	Kd	5.812479279163537	nM	45		3
	4drx	2.22	2012	Kd	6.809668301829708	nM	169	Kd=155+/-10nM, Mg-containing	6
	4f9p	3.52	2012	Kd	7.823908740944319	nM	254		4
	3vhx	2.81	2012	Kd	4.823908740944319	uM	120	complex Arf6-MKLP1	8
	3sri	1.6	2012	Kd	6.782516055786093	nM	29		2
	3p9w	2.41	2012	Kd	7.795880017344075	nM	123		8
	3u82	3.16	2012	Kd	7.767003889607846	nM	317		2
	4ei5	3.1	2012	Kd	4.7544873321858505	uM	302	Kd=17.6+/-0.7uM, incomplete ligand structure	12
	3v4y	2.1	2012	Kd	7.749579997691106	nM	62	structure is NIPP1(158-216):PP1a(7-307); binding data is for NIPP1(1-225) and PP1a(7-330)	8
	4g6u	2.35	2012	Kd	7.749579997691106	nM	177		2
	3rvv	1.9	2012	Kd	7.769551078621726	nM	255		3
	3tje	1.93	2012	Kd	7.769551078621726	nM	245		3
	4g6f	2.1	2012	Kd	7.769551078621726	nM	236		6
	4g8a	2.4	2012	Kd	9.730487055782083	pM	144	X-ray(human TLR4(Asp299Gly/Thr399Ile)/MD-2/LPS), Kd(TLR4(D229G/T399I)/MD-2/endotoxin-CD14 comlpex)	8
	3vfn	1.5	2012	Kd	3.72584215073632	uM	99	Kd=188+/-11.0uM	3
	4ffy	2.5	2012	Kd	7.7447274948966935	nM	111		3
	4h6j	1.52	2012	Kd	6.721246399047171	nM	116	Kd=190nM(temperature is 20 degree);Kd=125nM(10 degrees centigrade)	2
	3t0y	2.1	2012	Kd	6.714442690992226	nM	68		4
	3rvw	1.95	2012	Kd	7.721246399047171	nM	255	4C1 Fab fragment short, code 3rvx is 4C1 Fab fragment long	3
	3u43	1.72	2012	Kd	15.0	fM	134		2
	4f6r	2.64	2012	Kd	9.0	nM	87	Mg-containing	4
	3tjz	2.9	2012	Kd	6.0	uM	355	Kd(H. sapiens Arf1), X-ray(Saccharomyces cerevisiae S288c)	6
	4eoz	2.4	2012	Kd	6.0	uM	364		4
	4giq	2.7	2012	Kd	5.679853713888946	uM	171	Scatchard analysis	2
	4fqy	5.25	2012	Kd	8.657577319177793	nM	224		4
	3ul0	2.0	2012	Kd	8.638272163982407	nM	25		2
	4b93	2.0	2012	Kd	5.638272163982407	uM	269		2
	4eo5	2.35	2012	Kd	8.616184634019568	nM	83	fluorescence quenching	3
	4eqa	1.6	2012	Kd	8.616184634019568	nM	153		4
	4b0m	1.8	2012	Kd	5.616184634019569	uM	235		3
	3ukz	2.3	2012	Kd	8.619788758288394	nM	25		2
	4afq	1.51	2012	Kd	8.619788758288394	nM	85		4
	4aqe	2.27	2012	Kd	5.619788758288394	uM	242		2
	3uez	3.41	2012	Kd	11.602059991327963	pM	208	Using displacement ITC, titrate BARF1 into an established hCSF-1 RD1-D5 and hCSF-1 complex	12
	4en3	2.57	2012	Kd	5.6020599913279625	uM	259		4
	3vpj	2.5	2012	Kd	8.557520230935552	nM	192		8
	4g4s	2.49	2012	Kd	5.555955204081924	uM	276	Kd = 2.78 +/- 0.02 uM (150 nM NaCl);	16
	3ul1	1.9	2012	Kd	8.568636235841012	nM	22		2
	3ula	3.6	2012	Kd	8.546681659952963	nM	142	complex of MD2 and F63W; Kd=2.84+/-1.66nM	6
	4f38	2.8	2012	Kd	8.537602002101044	nM	204	Kd = 2.9 +/- 0.65 nM	2
	4apx	1.65	2012	Kd	5.537602002101044	uM	242		2
	3zwz	2.1	2012	Kd	7.692503962086787	nM	39		2
	4fxg	3.75	2012	Kd	7.684029654543083	nM	242		16
	3vfv	1.55	2012	Kd	4.679853713888946	uM	100	Kd=20.9+/-0.4uM	3
	4ap2	2.8	2012	Kd	7.698970004336019	nM	410		2
	4gms	2.95	2012	Kd	7.698970004336019	nM	225	Kd values measured by bio-layer interferometry using an Octet RED instrument (ForteBio)	24
	4g6v	2.64	2012	Kd	7.675717544702307	nM	111		8
	4fao	3.36	2012	Kd	10.664742743565467	pM	124	ALK1-ECD/BMP9/ActRIIB-ECD ternary structure, BMP9 binds to both ALK1-ECD and ActRIIB-ECD, Kd=45.22pM for ALK1	36
	4dn4	2.8	2012	Kd	10.657577319177793	pM	76		3
	3swp	4.11	2012	Kd	7.616184634019569	nM	26		6
	3uts	2.71	2012	Kd	3.555955204081924	uM	276	complex 1E6-ALW; monoclinic crystal; Kd=278+/-7.6uM(25 degree); Kd=274.5+/-14uM(5 degree); Kd=335+/-44uM(37 degree)	10
	3qwr	3.25	2012	Kd	8.698970004336019	nM	109		4
	3qwq	2.75	2012	Kd	8.698970004336019	nM	114		6
	4ayi	2.31	2012	Kd	8.698970004336019	nM	270		3
	2ypl	2.4	2012	Kd	5.522878745280337	uM	238		5
	4dkf	2.61	2012	Kd	8.508638306165727	nM	226	method:biolayer interferometry.	8
	4etw	2.05	2012	Kd	5.508638306165727	uM	77		4
	4f48	3.0	2012	Kd	5.494850021680094	uM	117	the micromolecule is between the two proteins	2
	3u8x	2.0	2012	Kd	5.468521082957745	uM	54	Mg2+ and ATP containing	4
	3sjh	1.75	2012	Kd	5.468521082957745	uM	54	Mg2+, ATP and Lat.A containing	2
	3tl8	2.5	2012	Kd	5.455931955649724	uM	117		8
	4e05	2.3	2012	Kd	8.437707135543524	nM	61	code 4e05 is high-resolution dataset, 4e06 is low-resolution dataset	3
	4d9q	2.28	2012	Kd	10.522878745280337	pM	217	Kd(cynomolgus)=30pM;Kd(human)=4.0pM	6
	3sjv	3.1	2012	Kd	4.508638306165727	uM	286		20
	4dh2	1.75	2012	Kd	7.486782399932061	nM	82	Ka=3.07E7+/-3.57E6	4
	4aye	2.8	2012	Kd	5.47755576649368	nM	257		6
	4h1l	3.3	2012	Kd	4.416801226031377	uM	113	Kd=38.3uM+/-2.9uM; ANI2.3 TCR with DR52c-pHIR	10
	4dge	2.2	2012	Kd	4.414539270491499	uM	146	Kd=38.5 uM in the presence of DTT, Kd=47.8 uM in the absence of DTT	4
	4d9r	2.42	2012	Kd	11.397940008672037	pM	218	Kd(cynomolgus)=30pM;Kd(human)=4.0pM	6
	4g6j	2.03	2012	Kd	8.387216143280265	nM	218		3
	3uyp	2.0	2012	Kd	5.3872161432802645	uM	253		2
	2y5b	2.7	2012	Kd	5.376750709602099	uM	152		4
	3vg9	2.7	2012	Kd	8.356547323513812	nM	226	complex A2AAR and Fab 2838(resolution=2.7)	3
	4day	3.3	2012	Kd	8.346787486224656	nM	37		3
	4ffz	3.8	2012	Kd	6.380906669373258	nM	217		6
	4a49	2.21	2012	Kd	4.376750709602099	uM	147	Kd=42+/-2uM	2
	3vfw	2.3	2012	Kd	4.351639989019068	uM	99	Kd=44.5+/-1.5uM	3
	3qi2	2.8	2012	Kd	7.346787486224656	nM	36	ligand is Regulator of G-protein signaling 14; GDP containing; Kd=45+/-7nM	4
	3qbv	2.65	2012	Kd	6.320572103387881	nM	351	Kd=478+/-22nM	4
	4hkj	3.0	2012	Kd	6.318758762624412	nM	206		16
	4gh7	2.6	2012	Kd	8.238824186844269	nM	285		4
	4elm	3.48	2012	Kd	5.223298816011589	uM	244	Kd=5.98+/-4.73 uM	10
	4exp	2.8	2012	Kd	6.301029995663981	nM	283	Kd for (D1-D5) domains is 1.3nM	2
	3tvm	2.8	2012	Kd	7.284832642151542	nM	209	Kd=51.9+/-6.6 nM	12
	3tu3	1.92	2012	Kd	7.2441251443275085	nM	711	ExoU was titrated with SpcU	2
	3oun	2.71	2012	Kd	7.236572006437063	nM	288	Kd=58+/-2nM	2
	4a1s	2.1	2012	Kd	8.301029995663981	nM	40		4
	3sqo	2.7	2012	Kd	11.301029995663981	pM	219		4
	4ag2	1.8	2012	Kd	8.207608310501746	nM	84		4
	4gxu	3.29	2012	Kd	8.207608310501746	nM	231	Kd measured using anti-Penta-HIS tips on the Octet QK platform	30
	3zu7	1.97	2012	Kd	8.18045606445813	nM	169		2
	4f9l	3.14	2012	Kd	7.180456064458132	nM	259		4
	4doh	2.8	2012	Kd	6.16304326294045	nM	153		6
	4did	2.35	2012	Kd	5.221848749616356	uM	152	Protein 2 Source: Salmonella enterica subsp. enterica serovar Typhimurium; Kd = 6 +/- 2 uM; Mg-containing	2
	4ds8	2.21	2012	Kd	5.113509274827519	uM	343	in the presence of (+)-ABA	2
	4dtg	1.8	2012	Kd	10.136677139879545	pM	66	Kd=73+/-13pM	3
	3v62	2.9	2012	Kd	7.102372908709558	nM	69	Kd=79+/-18nM for SUMO-K164-PCNA-mono, Kd=26.3+/-3.1nM for SUMO-K164-PCNA-tri, Kd=25.1+/-4.9nM for SUMO-K127-PCNA-tri	6
	3vfp	1.85	2012	Kd	4.087777943467585	uM	99	Kd=81.7+/-3.0uM	3
	4ayd	2.4	2012	Kd	6.086186147616283	nM	257		6
	3vfm	1.9	2012	Kd	4.0467236633326955	uM	100	Kd=89.8+/-5.3uM	3
	3uze	2.04	2012	Kd	8.096910013008056	nM	253		4
	4hcp	2.52	2012	Kd	5.026872146400302	uM	78		2
	4dkd	3.0	2012	Kd	7.026872146400302	nM	292	Kd=120nM(BLI method)	5
	4dj9	2.25	2012	Kd	7.00436480540245	nM	29	Kd=97nM for a second independent experiment.	2
	3vft	1.95	2012	Kd	3.6989700043360187	uM	100		3
	3vfu	1.65	2012	Kd	3.6989700043360187	uM	100		3
	3vfo	1.7	2012	Kd	3.6989700043360187	uM	99		3
	3vfs	1.85	2012	Kd	3.6989700043360187	uM	99		3
	4e41	2.6	2012	Kd	3.5228787452803374	uM	239		10
	4e42	2.7	2012	Kd	3.5228787452803374	uM	190	Kd>300uM, not exact value	4
	3ukw	2.1	2012	Kd	9.958607314841775	nM	28	estimated Kd value	2
	4f0a	3.25	2012	Kd	5.619788758288394	uM	316		5
	4dcn	3.01	2012	Kd	5.481486060122113	uM	198	Mg-containing	4
	4dvg	2.6	2012	Kd	5.522878745280337	uM	353	Mg-containing	2
	4dzu	2.1	2012	Ki	9.698970004336019	nM	38	FP assay, Ki<0.2nM	2
	3uir	2.78	2012	Ki	9.360513510731414	nM	59		4
	4gi3	1.75	2012	Ki	9.167491087293763	nM	83	affinity is Ki=0.68nM, not Kd=0.68nM	2
	3tg1	2.71	2012	Ki	5.995678626217358	uM	158	Ki=1.01+/-0.01uM	2
	3v96	1.9	2012	Ki	8.958607314841775	nM	165		2
	4dzv	2.1	2012	Ki	7.958607314841775	nM	39	FP assay	2
	4dg4	1.4	2012	Ki	5.568636235841013	uM	58	equilibrium inhibition constants (Ki) using classic competitive inhibition experiments	8
	4an7	2.23	2012	Ki	8.494850021680094	nM	185		2
	2yq7	1.9	2012	Ki	7.455931955649724	nM	20	ligand is BimLOCK; Ki=35+/-3.7nM	2
	3so3	2.1	2012	Ki	9.406713932979542	pM	228	KI is calculated from the IC50 value	4
	4g35	2.0	2012	Ki	7.267606240177032	nM	21	Ki=54+/-14nM	2
	3tvj	1.28	2012	Ki	8.221848749616356	nM	38		3
	4hx3	2.7	2012	Ki	8.221848749616356	nM	114		12
	4djz	3.2	2012	Ki	8.154901959985743	nM	38	RCSB says Protease inhibitor SGPI-2, paper says Protease inhibitor SGPI-1	6
	4i77	1.9	2013	Kd	11.0	nM	112	Biacore-derived Kd for IL-13 binding to wt lebrikizumab is lower than the detection limit, 10 pM	3
	4k2u	2.45	2013	Kd	10.8153085691824	nM	234		6
	2ypv	1.8	2013	Kd	10.522878745280337	nM	218		3
	3wd5	3.1	2013	Kd	9.939302159646388	nM	219	Kd=1.152+/-0.172x10-10M	3
	3v6z	3.34	2013	Kd	6.920818753952375	uM	159	The pdb code of HBeAg-e6 Fab complex in paper should be 3V6Z.	6
	3tz1	1.8	2013	Kd	6.85078088734462	uM	24	ITC Ka=7.1x10 E6 M-1, Kd=0.141uM, TnI L was titrated by asTnC C	2
	3w8h	2.43	2013	Kd	6.785156151952302	uM	78		2
	4k0a	2.13	2013	Kd	9.744727494896694	nM	28	Kd = 0.18 +/- 0.03 nm	2
	4kbb	2.3	2013	Kd	6.7447274948966935	uM	68	Kd = 0.14 +/- 0.05 um(without GD1a),Kd = 0.18 +/- 0.06 um(with GD1a)	6
	4hgk	3.04	2013	Kd	9.721246399047171	nM	128		4
	4gn4	1.86	2013	Kd	6.5968794788241825	uM	108		2
	4bpx	3.4	2013	Kd	6.6020599913279625	uM	269		4
	4c4p	2.0	2013	Kd	6.6020599913279625	uM	107	Kd = 0.25 +/- 0.05 uM	2
	4hff	2.4	2013	Kd	9.570247719997592	nM	104	The crystal structure is Tae4-Tai4 complexes from Salmonella Typhimurium	2
	4hfk	2.1	2013	Kd	9.570247719997592	nM	105	The crystal structure is Tae4-Tai4 complexes from Enterobacter cloacae	4
	4kt3	1.44	2013	Kd	9.585026652029182	nM	137		2
	4b1y	1.29	2013	Kd	6.568636235841013	uM	32	this is a prot-prot complex, ligand is not ATP	2
	3zet	2.31	2013	Kd	6.537602002101044	uM	337	Kd=0.29+/-0.1uM	2
	3zeu	1.65	2013	Kd	6.537602002101044	uM	337	bound to ATPgammaS;Kd=0.29+/-0.1uM	4
	4l67	2.8	2013	Kd	6.494850021680094	uM	25		2
	4hdo	1.67	2013	Kd	6.443697499232713	uM	167	Kd = 0.36 +/- 0.11 uM	2
	4iyp	2.8	2013	Kd	6.522878745280337	uM	151		2
	4kp3	2.4	2013	Kd	6.522878745280337	uM	103	MLPH-GTBD and RILP2-RH1 bind to MyoVa-GTD with different interaction modes	6
	4ic7	2.6	2013	Kd	6.366531544420414	uM	126	Kd=0.43+/-0.06uM	4
	3w2d	3.1	2013	Kd	9.237546517636453	nM	223		3
	4bqd	2.45	2013	Kd	9.301029995663981	nM	21		4
	4leo	2.64	2013	Kd	9.301029995663981	nM	621		4
	4awx	2.3	2013	Kd	6.301029995663981	uM	84		2
	4k94	2.4	2013	Kd	9.200659450546418	nM	214		3
	4iop	3.2	2013	Kd	9.173925197299173	nM	158		4
	4gur	2.51	2013	Kd	6.167491087293763	uM	21	Kd=0.68+/-0.07uM(H3K4M bind to LSD2 and WT NPAC);Kd=0.92+/-0.08uM(WT NPAC bind to LSD2,Supplementary Table S3.)	3
	4bfi	3.22	2013	Kd	6.221848749616356	uM	211		2
	4gu0	3.1	2013	Kd	6.130181792020672	uM	26		6
	4fq0	2.82	2013	Kd	6.060480747381382	uM	111		4
	4lmq	2.77	2013	Kd	9.034798298974088	nM	221	chains for antibody FAB on RCSB website should be wrong, assay by Biolayer Interferometry	6
	4hdq	1.95	2013	Kd	6.017728766960432	uM	26	Kd = 0.96 +/- 0.14 uM	3
	4mhh	3.56	2013	Kd	9.045757490560675	nM	222	determined by biolayer interferometry	29
	4c5g	2.1	2013	Kd	5.987162775294828	uM	32	P6122 space group	2
	4g9f	1.9	2013	Kd	5.958607314841775	uM	250	Kd = 1.10 +/- 0.05 uM	5
	4kt5	2.7	2013	Kd	5.958607314841775	uM	137		3
	4dx8	2.54	2013	Kd	5.906578314837765	uM	203	Kd = 1.24 +/- 0.03 uM	8
	4j32	1.8	2013	Kd	8.892790030352131	nM	101	Kd=1.28+/-3.29nM	2
	3zkq	1.51	2013	Kd	8.920818753952375	nM	122		2
	4k3j	2.8	2013	Kd	8.920818753952375	nM	224		4
	4i2x	2.48	2013	Kd	5.920818753952375	uM	328	equilibrium ultracentrifugation, Kd=1.2 +/- 0.3uM	6
	4hh3	1.75	2013	Kd	5.886056647693163	uM	240	microscale thermophoresis, MST assay	3
	4jeu	3.2	2013	Kd	8.853871964321762	nM	242		2
	4jo6	1.75	2013	Kd	8.8153085691824	nM	38		6
	4gko	3.3	2013	Kd	2.8239087409443187	mM	143		18
	3vxu	2.7	2013	Kd	5.795880017344075	uM	275	Kd=1.6+/-0.3uM	10
	4h2w	1.95	2013	Kd	5.761953896871205	uM	103		4
	4idj	3.36	2013	Kd	11.769551078621726	pM	239	determined via the kinetic exclusion assay (KinExA)	3
	4gaf	2.15	2013	Kd	11.744727494896694	pM	319	indirect SPR combined with competition assay	2
	4hsa	3.15	2013	Kd	8.721246399047171	nM	301		10
	3vep	2.5	2013	Kd	4.987162775294828	uM	86		8
	4hem	1.65	2013	Kd	8.0	nM	123		6
	4imy	2.94	2013	Kd	8.0	nM	75	Kd=10+/-1nM	9
	4geh	1.95	2013	Kd	7.931814138253839	nM	91		4
	4i3r	3.0	2013	Kd	7.924453038607469	nM	228	Kd=11.9+/-0.1nM(SPR);Kd=36.8nM(biolayer interferometry) space group P3221	3
	4c99	2.8	2013	Kd	6.943095148663527	nM	121	crystal form I	4
	4h5s	1.7	2013	Kd	4.903089986991944	uM	101		2
	4may	2.2	2013	Kd	3.906578314837765	uM	266		4
	4jeg	2.3	2013	Kd	7.920818753952375	nM	94		2
	4llo	2.0	2013	Kd	4.87942606879415	uM	134	cannot download correct support info PDF	8
	4jw3	2.6	2013	Kd	5.838631997765025	nM	139		4
	4je4	2.31	2013	Kd	7.853871964321762	nM	94		2
	4jzw	1.78	2013	Kd	10.812479279163536	pM	28	Kd = 15.4 +/- 0.8 pM; in P212121 space group	4
	4hix	2.2	2013	Kd	6.82102305270683	nM	28	Microscale Thermophoresis (MST) to measure the affinity	3
	4kgg	2.78	2013	Kd	6.815308569182402	nM	174	SPR Kd=153+/-54 nM	6
	4grl	2.86	2013	Kd	3.812479279163537	uM	268		4
	4j6g	2.4	2013	Kd	7.787812395596042	nM	174	SPR Kd=16.3+/-0.3 nM	5
	4kr0	2.7	2013	Kd	7.777283528852417	nM	251	complex RBD-CD26	7
	4hjj	2.1	2013	Kd	9.795880017344075	pM	348		3
	4krp	2.82	2013	Kd	6.779891911959945	nM	220	ternary complex of 9G8:FabC225:sEGFR, affinity is for 9G8:sEGFR complex	6
	4hgm	2.34	2013	Kd	7.795880017344075	nM	585		2
	3znz	1.9	2013	Kd	6.707743928643524	nM	152		2
	4ios	2.4	2013	Kd	7.721246399047171	nM	123		8
	4eig	2.5	2013	Kd	9.0	nM	123		2
	4hrl	2.55	2013	Kd	9.0	nM	171		2
	4mhj	6.98	2013	Kd	9.0	nM	222	determined by biolayer interferometry	32
	3w8i	2.4	2013	Kd	8.667561540084394	nM	76		2
	4nm8	4.0	2013	Kd	8.602059991327963	nM	230	determined by biolayer interferometry	18
	4glv	2.57	2013	Kd	8.534617148551582	nM	107		8
	4h88	1.9	2013	Kd	8.537602002101044	nM	218		3
	4iu3	1.97	2013	Kd	7.681310730052254	nM	243	SeMet derivative of the type IIIe RfCohE-XDoc complex	2
	4bru	3.24	2013	Kd	6.698970004336019	nM	43		2
	4aoq	2.0	2013	Kd	6.695078838099108	nM	37	Kd=60.9+/-8.4nM(for SOTI-III);Kd=201.8+/-27.7nM(for F14A variant)	6
	4i6l	2.49	2013	Kd	7.698970004336019	nM	76	Kd=20nM, not 20pM	2
	4jan	3.15	2013	Kd	7.698970004336019	nM	226		6
	4hmy	7.0	2013	Kd	4.698970004336019	uM	172	Kd = 20 +/- 0.6 uM	5
	4h2s	2.15	2013	Kd	4.667561540084395	uM	110		4
	4ekc	7.4	2013	Kd	7.657577319177793	nM	137	Kd = 22 +/- 9 nM, IC50 = 0.27 +/- 0.06 uM	4
	4ekd	2.71	2013	Kd	7.657577319177793	nM	137	Kd = 22 +/- 9 nM, IC50 = 0.27 +/- 0.06 uM	2
	4hj0	3.0	2013	Kd	7.638272163982407	nM	227		6
	4jry	2.8	2013	Kd	4.6020599913279625	uM	242	SB47 TCR with the HLA-B*35:08LPEP	5
	4kro	3.05	2013	Kd	6.559090917934782	nM	220	ternary complex of EgA1:FabC225:sEGFR, affinity is for EgA1:sEGFR complex	6
	4bq6	2.3	2013	Kd	7.568636235841013	nM	251	Kd = 27 +/- 2 nM, crystal form I	6
	3wa5	1.9	2013	Kd	7.55129368009492	nM	153		2
	4jgh	3.0	2013	Kd	7.55129368009492	nM	378		4
	4c9b	2.0	2013	Kd	7.546681659952962	nM	291		2
	4jra	2.3	2013	Kd	7.552841968657781	nM	136		4
	4bsr	3.2	2013	Kd	8.698970004336019	nM	126	in P22121 crystal form, Kd=2-3uM from reference	8
	4hlz	2.9	2013	Kd	8.698970004336019	nM	229	biolayer interferometry (BLI) assay	17
	4h3p	2.3	2013	Kd	5.698970004336019	uM	24		4
	3zjy	3.6	2013	Kd	5.522878745280337	uM	112	Kd=3.0+/-0.4uM;differential scanning ﬂuorimetry (DSF)	7
	4ng2	2.41	2013	Kd	5.494850021680094	uM	113		12
	4g01	2.2	2013	Kd	5.468521082957745	uM	181	Ca-containing	2
	4geq	2.01	2013	Kd	5.455931955649724	uM	25		6
	4k81	2.4	2013	Kd	5.443697499232713	uM	171	Kd = 3.6 +/- 0.6 um	8
	4jrx	2.3	2013	Kd	5.425968732272281	uM	238	CA5 TCR with the HLA-B*35:08LPEP	5
	4jw2	1.9	2013	Kd	8.431798275933005	nM	201		2
	4bxz	4.8	2013	Kd	5.42021640338319	uM	594		13
	4hep	1.75	2013	Kd	6.522878745280337	nM	131		2
	4ftg	2.51	2013	Kd	7.522878745280337	nM	22		5
	4bj5	3.29	2013	Kd	4.522878745280337	uM	202	Kd = 30 +/- 10 uM	6
	4gn5	1.86	2013	Kd	7.507239610973162	nM	113		4
	4iiq	2.86	2013	Kd	4.508638306165727	uM	392	human MAIT TCR (type F7)	3
	4ihl	2.2	2013	Kd	6.460923901207224	nM	36		3
	4gla	2.75	2013	Kd	4.452225294612178	uM	109		4
	4kgq	2.27	2013	Kd	7.443697499232712	nM	174	SPR Kd=36+/-1.8 nM	6
	3v3k	3.49	2013	Kd	7.412289034981089	nM	165	method: surface acoustic wave, mean Kd value of five assays is showed in Table S1	16
	4lad	2.3	2013	Kd	7.42021640338319	nM	150	crystal structure, same protein-ligand as 2lxp	2
	4hnj	2.9	2013	Kd	8.522878745280337	nM	25	BCL-xL domain-swapped dimer in complex with PUMA BH3 peptide	3
	4eiz	2.2	2013	Kd	8.522878745280337	nM	134		4
	4euk	1.95	2013	Kd	5.3872161432802645	uM	159		2
	4b1x	1.8	2013	Kd	5.36251027048749	uM	32	this is a prot-prot complex, ligand is not ATP	2
	4g8g	2.4	2013	Kd	5.33913452199613	uM	248	Kd = 4.58 +/- 0.11 uM	5
	4gn3	1.95	2013	Kd	5.337242168318426	uM	113		18
	4ilg	2.1	2013	Kd	8.309803919971486	nM	270		3
	4kjy	1.93	2013	Kd	10.384049948343598	pM	133		4
	4naw	2.19	2013	Kd	7.3872161432802645	nM	34	no direct Kd data for ATG3-RIA12, use Kd=41nM for longer ATG3-FR	16
	3zo0	1.99	2013	Kd	6.359518563029578	nM	207	MURINE TRIM21 IN COMPLEX WITH MURINE IGG FC, Kd=4.3 X 10-7M	3
	4jb8	1.7	2013	Kd	7.356547323513812	nM	171		3
	4jpk	2.4	2013	Kd	7.356547323513812	nM	172		3
	4i0c	1.95	2013	Kd	6.337242168318426	nM	132		4
	4krl	2.85	2013	Kd	7.327902142064283	nM	214	pH 6.0	3
	3vza	1.9	2013	Kd	6.317854923626168	nM	39		6
	4f0z	1.7	2013	Kd	8.397940008672037	nM	43		3
	4iof	3.35	2013	Kd	8.397940008672037	nM	263		6
	4cc4	2.6	2013	Kd	5.267606240177032	uM	68	Kd = 5.4 +/- 0.2 uM	6
	4f37	2.57	2013	Kd	8.259637310505756	nM	219		6
	4i18	3.24	2013	Kd	8.2518119729938	nM	211		6
	4i9x	2.1	2013	Kd	8.224753740259764	nM	127	TRAIL-R2 as Immobilized ligand	6
	4brw	2.8	2013	Kd	7.301029995663981	nM	75		2
	4jkp	2.82	2013	Kd	7.292429823902063	nM	229		6
	3vv2	1.83	2013	Kd	10.2839966563652	pM	69	KD=5.2x10-11M, 52pM, not KD=52nM	2
	4kt1	2.5	2013	Kd	7.247951552180561	nM	90	STF reporter assays	3
	4ika	2.7	2013	Kd	4.2403321553103694	uM	22		2
	4ihh	2.13	2013	Kd	7.229147988357855	nM	80		12
	4m5z	2.25	2013	Kd	8.301029995663981	nM	233	assay by biolayer interferometry, Kd range is 5-50nM in table 2	3
	4bkx	3.0	2013	Kd	5.301029995663981	uM	482	HDAC1 activity was measured with the HDAC Assay Kit (Millipore)	2
	4k9e	2.7	2013	Kd	11.193820026016112	pM	214		3
	4aor	1.7	2013	Kd	7.215382707367125	nM	37	Kd=60.9+/-8.4nM(for SOTI-III);Kd=201.8+/-27.7nM(for F14A variant)	6
	4iw4	3.2	2013	Kd	6.214670164989233	nM	279		4
	3vxs	1.8	2013	Kd	4.188424994129407	uM	275	Kd=64.8+/-3.4uM	5
	3wn7	1.57	2013	Kd	8.136082623042139	nM	35	SPR Kd=7.31 +/- 2.59 nM	4
	4jeh	2.5	2013	Kd	8.09151498112135	nM	243		2
	4ka2	1.79	2013	Kd	11.075720713938118	pM	28		2
	4g3y	2.6	2013	Kd	8.060480747381382	nM	157		3
	4j2l	3.15	2013	Kd	7.053056729302175	nM	28	ITC Kd is for Ataxin-1 and CIC-21 in PDB code 4j2j, CIC-28 has no data	4
	4k71	2.4	2013	Kd	8.096910013008056	nM	274	at PH 6.0	6
	3vxr	2.4	2013	Kd	5.013228265733755	uM	275	Kd=9.7+/-0.7uM	5
	4dpg	2.84	2013	Kd	7.045757490560675	nM	54		12
	4lqw	1.95	2013	Kd	4.026872146400302	uM	177		4
	4fza	3.15	2013	Kd	7.003926345514724	nM	283	Kd1 = 99.1 nM, Kd2 = 69.5 nM, not full-length MST4, Kd1 = 9.12 nM, Kd2 = 80.0 nM	2
	3vux	1.7	2013	Kd	5.045757490560675	uM	35		6
	3w6j	2.6	2013	Kd	7.251811972993799	nM	184		6
	4j2y	2.0	2013	Ki	9.05551732784983	nM	223		2
	4ij3	2.7	2013	Ki	9.045757490560675	nM	484		3
	4doq	2.0	2013	Ki	6.853871964321762	nM	47		5
	4gnk	4.0	2013	Ki	6.657577319177793	nM	235	Ki = 220 +/- 30 nM	5
	4bd9	2.2	2013	Ki	7.508638306165727	nM	165		2
	3zia	2.5	2013	Ki	1.3187587626244128	mM	63	Ki=48+/-7mM	20
	4ilw	2.1	2013	Ki	8.236572006437063	nM	194	competitive inhibition model	4
	4boh	2.6	2013	Ki	7.255237762934422	nM	60		5
	4oqt	3.23	2014	Kd	10.301029995663981	pM	235	SPR Kd<=50 pM for the binding of the Li81 Fab to the LINGO-1 ectodomain	8
	4plo	2.9	2014	Kd	7.42021640338319	uM	205	biolayer interferometry binding studies	2
	4pbz	2.15	2014	Kd	7.301029995663981	uM	26		2
	4u6h	3.1	2014	Kd	10.040958607678906	nM	184	biolayer interferometry (BLI)- based assay	6
	4lgr	1.65	2014	Kd	9.958607314841775	nM	122		2
	4mit	2.35	2014	Kd	6.749579997691106	uM	70	kd=170+/-30 nM	8
	4m1l	2.1	2014	Kd	6.7447274948966935	uM	65	SPR Kd=5.07nM for Ca2+-free CaM, PDB code 4lzx	2
	3wkt	4.3	2014	Kd	7.0	uM	267	SPR analysis showed that the dissociation constant (Kd) of the heme-rHO-1 complex for Delta TGEE was 0.1~0.2 uM	4
	4pz6	2.41	2014	Kd	6.6777807052660805	uM	21	Pol2-CDT; Kd=0.21+/-0.03uM	4
	4lgp	2.4	2014	Kd	9.638272163982407	nM	116		4
	4bkl	3.25	2014	Kd	6.562249437179612	uM	37	SPR Kd=2.74 x 10-7M	5
	4ml7	1.8	2014	Kd	9.568636235841012	nM	99		4
	4qt8	3.0	2014	Kd	6.552841968657781	uM	253		6
	4jmf	2.1	2014	Kd	6.525783735923745	uM	116	SPR Kd=0.298+/-0.06 uM	3
	4mqw	2.9	2014	Kd	9.537602002101044	nM	361	FSH binding to FSHR in the absence of Compound 5	9
	4peq	2.21	2014	Kd	15.698970004336019	fM	456	Kd=2x10-16M	4
	4cmh	1.53	2014	Kd	9.698970004336019	nM	234		3
	4liq	2.6	2014	Kd	9.698970004336019	nM	223		5
	4pc0	2.5	2014	Kd	6.698970004336019	uM	42		4
	3wry	2.3	2014	Kd	6.508638306165727	uM	451	complex type should be protein-protein	4
	4pl8	2.0	2014	Kd	6.494850021680094	uM	73	T-belta4N full length; Kd=0.32+/-0.02uM	3
	4qxa	2.3	2014	Kd	6.494850021680094	uM	180	Kd= 0.32+/- 0.08uM(Rab-9A Q66L mutant(WT));Kd=2.60+/-0.60uM(Rab-9A Q66L mutant(R68A)); Kd=45.0+/-13.0uM((Rab-9A Q66L mutant(L256AWT));Kd=1.41+/-0.30uM((Rab-9A Q66L mutant(Q361AWT))	2
	4p1n	2.2	2014	Kd	6.443697499232713	uM	61	Kd=0.36+/-0.03uM; Atg13 MIM(N+C) wild-type	4
	4nqw	2.4	2014	Kd	6.376750709602099	uM	80	Oxidized sigma condition, Kd on reduced sigma condition is 1.15uM	2
	4r8g	3.5	2014	Kd	6.309803919971486	uM	148	Kd=0.49uM for IQ2 binding motifs, Kd=3.14uM for IQ3 motif, not the whole tail	4
	4n8c	1.6	2014	Kd	9.397940008672037	nM	23	unpublished data	6
	4k24	4.5	2014	Kd	6.267606240177032	uM	228	measured by direct binding assays	7
	4pwx	5.4	2014	Kd	6.267606240177032	uM	288	Get4-5 prefers ATP bound state of Get3; Kd= 0.54+/-0.08uM	6
	4lrz	2.32	2014	Kd	6.301029995663981	uM	318		8
	4ofy	3.3	2014	Kd	6.220403508742176	uM	420	ITC assay is Protein SYG-1 D1, protein in crystal structure is Protein SYG-1 D1-D2	12
	4kdi	1.86	2014	Kd	6.1487416512809245	uM	90		4
	4kvg	1.65	2014	Kd	6.154901959985743	uM	260		4
	4cmm	1.92	2014	Kd	6.096910013008056	uM	127		2
	4od2	3.2	2014	Kd	9.036212172654444	nM	111	Kd=0.92+/-0.01 nM	3
	4mrt	2.0	2014	Kd	6.036212172654444	uM	232	in presence of coenzyme A	2
	4nso	2.4	2014	Kd	9.008773924307505	nM	108		2
	4byf	2.74	2014	Kd	6.045757490560675	uM	149	calmodulin in the pre-power stroke state	4
	4pj8	3.3	2014	Kd	6.0	uM	247	Kd=1.0+/-0.3uM; C-F7 (TRBV20) TCR	4
	4ne9	2.6	2014	Kd	5.931814138253839	uM	26		6
	3wdg	2.2	2014	Kd	8.921543181946708	nM	112	SPR Kd=1.198+/-0.029nM	2
	4pqt	2.05	2014	Kd	5.958607314841775	uM	81		2
	4u0q	3.1	2014	Kd	5.958607314841775	uM	269	in paper, the protein is PfRH5 Delta NL, Kd=1.3 uM, length does not match that in RCSB PDB	4
	4cu4	2.3	2014	Kd	5.920818753952375	uM	21	FhuA-MccJ25	3
	4re1	2.2	2014	Kd	5.920818753952375	uM	149		4
	4mi8	2.1	2014	Kd	5.860120913598763	uM	26		4
	4w4l	2.45	2014	Kd	8.886056647693163	nM	314	assayed by biolayer interferometry	3
	4wfd	2.4	2014	Kd	5.886056647693163	uM	20		9
	4ov6	2.69	2014	Kd	8.801342913045577	nM	99	SPR kd=1.58 +/- 0.18 nM, for Form of Adnectin: 1459D05 (progenitor)	6
	4w6y	1.57	2014	Kd	8.801342913045577	nM	131	Microscale thermophoresis (MST), Kd=1.58 +/- 0.65 nM	2
	4nn6	2.54	2014	Kd	8.823908740944319	nM	223	TSLP N123Q and TSLPR N122Q in ternary complex with IL-7R alpha, complex at neutral pH, crystal form 1B	3
	3wkn	2.9	2014	Kd	8.795880017344075	nM	54		24
	3wn5	2.78	2014	Kd	5.795880017344075	uM	197		13
	4qlb	2.6	2014	Kd	5.795880017344075	uM	36	Kd=1.6 +/- 0.3 uM	8
	4kv5	3.0	2014	Kd	8.769551078621726	nM	136	SPR Kd=1.7 +/- 0.6 nM for GC1008 scFv:TGF beta1	8
	4nee	2.88	2014	Kd	5.7447274948966935	uM	155	ITC Kd=1.8 +/- 0.4uM	12
	4cdk	2.8	2014	Kd	5.721246399047171	uM	126	SPR Kd=1.9 +/- 0.1uM	8
	4k1r	1.63	2014	Kd	4.991399828238083	uM	81		4
	4k5a	1.5	2014	Kd	7.987162775294828	nM	169		2
	4cni	2.2	2014	Kd	11.0	pM	171		6
	4u6v	2.56	2014	Kd	11.0	pM	293	Binding using the ProteOn platform	6
	4q96	1.85	2014	Kd	3.9430951486635273	uM	21	Kd=114 +/- 2uM	6
	4cj2	1.5	2014	Kd	7.958607314841775	nM	78	ITC Kd=11 +/- 2.8 nM	4
	4pas	1.62	2014	Kd	6.897566294318664	nM	41		2
	4m38	2.2	2014	Kd	4.920818753952375	uM	21		4
	4m5f	2.5	2014	Kd	10.869666231504993	pM	127	Kd was approximately 13.5 pM in the presence of 0.1 mM CaCl2	2
	4m1g	1.6	2014	Kd	7.841637507904751	nM	220	assay by BLI	4
	4p3y	2.15	2014	Kd	6.835647144215563	nM	182	Kd=146+/-37nM; oxidized EF-Tu	2
	4ons	2.8	2014	Kd	7.801342913045577	nM	88	Kd is not for exact the same protein sequence	4
	4ozg	3.0	2014	Kd	4.801342913045577	uM	213	this is a protein-protein complex	12
	4pou	1.75	2014	Kd	6.804100347590766	nM	122	ITC Kd=157 +/- 3 nM	2
	3wo4	3.1	2014	Kd	7.823908740944319	nM	344	IL-18 signaling ternary complex, SPR Kd=1.5+/-0.1 x10-8M	10
	4rdq	2.85	2014	Kd	7.823908740944319	nM	217	Ca2+ containing	15
	4lrx	3.25	2014	Kd	4.823908740944319	uM	318		4
	4u3j	2.81	2014	Kd	6.795880017344075	nM	249		3
	4n7z	2.85	2014	Kd	6.752026733638194	nM	58	CPB-binding affinity of Cep192-58mer is Kd= 177 +/- 23 nM	2
	4c1n	2.53	2014	Kd	7.7423214251308154	nM	510		12
	4d0n	2.1	2014	Kd	4.7423214251308154	uM	373	RhoA with GDP, Kd=18.1uM	2
	4v2c	4.0	2014	Kd	4.7447274948966935	uM	161		4
	4myw	3.19	2014	Kd	7.718966632752273	nM	331		6
	4bwq	2.1	2014	Kd	4.7055337738384075	uM	43		8
	4np4	2.89	2014	Kd	10.721246399047171	pM	222	High affinity binding site Kd=19 +/- 5pM, low affinity binding site Kd=370 +/- 310 pM	5
	4per	1.92	2014	Kd	15.0	fM	460	Kd=1x10 -15M	2
	4py8	2.91	2014	Kd	9.0	nM	219	biolayer interferometry (BLI) assay, KD=1nM	5
	4u2x	3.15	2014	Kd	9.0	nM	175	ITC Kd=1.0+/-0.3 nM	6
	4odx	3.1	2014	Kd	8.686132779630846	nM	161		6
	3wrx	2.5	2014	Kd	5.6777807052660805	uM	451	complex type should be protein-protein	4
	4pjd	2.78	2014	Kd	5.657577319177793	uM	271	Kd=2.2+/-0.3uM; C-C10 TCR	8
	4qrp	2.9	2014	Kd	5.605548319173784	uM	245	HSKKKCDEL; Kd=2.48+/-0.11uM	12
	4pbv	2.5	2014	Kd	5.619788758288394	uM	299		5
	4pj9	2.0	2014	Kd	5.619788758288394	uM	271	Kd=2.4+/-0.4uM; number 4 (TRAJ20) TCR	4
	4m62	1.8	2014	Kd	8.590066876668706	nM	155		6
	4u97	2.65	2014	Kd	5.6020599913279625	uM	312	IRAK4 FL-D311N; Asymmetric Dimerization with Kd=2.5+/-0.4uM	2
	4u5w	1.86	2014	Kd	5.580044251510242	uM	180		4
	3wa0	2.31	2014	Kd	5.578396073130169	uM	96	affinity is for C29 DCAF1(1478-1506), crystal is for DCAF1 (1417-1506)	11
	4ra0	3.07	2014	Kd	11.568636235841012	pM	195	measured using the kinetic exclusion assay (KinExA)	6
	4c4k	1.95	2014	Kd	5.568636235841013	uM	102	M10:O1 (orthorhombic)	2
	4pj7	2.5	2014	Kd	5.568636235841013	uM	271	Kd=2.7+/-0.7uM; number 6 TRBV6-4 TCR	8
	4qd2	2.4	2014	Kd	5.568636235841013	uM	213		10
	4mqv	1.95	2014	Kd	5.537602002101044	uM	26	Kd=2.9+/-0.1 uM	4
	4mjs	2.5	2014	Kd	7.665546248849069	nM	104	ITC Kd=21.6+/-2.09 nM	24
	4n8v	2.5	2014	Kd	4.653647025549361	uM	274		8
	4oyd	1.8	2014	Kd	9.657577319177793	pM	117	bio-layer interferometry (BLI) assay	4
	4ojk	2.66	2014	Kd	4.657577319177793	uM	46	Kd=22+/-0.3uM; PKG II LZ (residues 40-83) binds to Rab11b-GDP	4
	4ozh	2.8	2014	Kd	4.605548319173784	uM	213	this is a protein-protein complex	10
	4nl9	1.5	2014	Kd	6.603800652904264	nM	71	SPR Kd= 249 +/- 8 nM	4
	4nzl	1.85	2014	Kd	7.6020599913279625	nM	114		4
	4o27	3.19	2014	Kd	7.6020599913279625	nM	281	between WT MO25-alpha and WT MST3	3
	4ct0	2.45	2014	Kd	7.552841968657781	nM	143		2
	4x7f	1.7	2014	Kd	7.552841968657781	nM	119		4
	4jlr	2.71	2014	Kd	10.52432881167557	pM	123		6
	4p6i	2.3	2014	Kd	6.5376020021010435	nM	305		6
	4w6w	2.51	2014	Kd	8.447331783887806	nM	131	Microscale thermophoresis (MST), Kd=3.57 +/- 2.59 nM	2
	4x7d	2.15	2014	Kd	8.455931955649724	nM	126		4
	4p2c	2.82	2014	Kd	8.40340290437354	nM	128		11
	4m8q	2.89	2014	Kd	8.402304814074487	nM	161		6
	4u4c	2.4	2014	Kd	6.508638306165727	nM	116		2
	4lyl	1.93	2014	Kd	7.508638306165727	nM	84		16
	4n9g	2.5	2014	Kd	9.48678239993206	pM	123		12
	4n7v	2.76	2014	Kd	7.494850021680094	nM	60	CPB-binding affinity of Cep152-60mer is Kd= 32 +/- 4 nM	3
	4p59	3.4	2014	Kd	10.494850021680094	pM	238	solution equilibrium titration	5
	4p46	2.85	2014	Kd	4.494850021680094	uM	218		4
	4p9h	3.0	2014	Kd	7.480172006224281	nM	244	93TH057 gp120 mutant	10
	4v0m	3.45	2014	Kd	6.458420756053419	nM	425	CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM	8
	4v0o	3.35	2014	Kd	6.458420756053419	nM	425	CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; lead soak; same as 4v0m	8
	4v0n	3.13	2014	Kd	6.458420756053419	nM	425	CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; mercury soak; same as 4v0m	8
	4r2g	3.28	2014	Kd	7.468521082957745	nM	236	PGT124 Fab bind to precomplexed HIV-1 JRCSF gp120 core and CD4	22
	4pjf	2.45	2014	Kd	4.450996737974212	uM	271	Kd=35.4+/-3.0uM	8
	4qzv	2.59	2014	Kd	4.447331783887806	uM	246		12
	4kxz	2.83	2014	Kd	8.522878745280337	nM	224	SPR Kd=3.0 +/- 1.2 nM for GC1008 FAB:TGF beta2	12
	3wwk	2.98	2014	Kd	5.522878745280337	uM	146	estimated SPR Kd data	12
	4msm	1.74	2014	Kd	5.522878745280337	uM	81		4
	4khx	2.92	2014	Kd	8.3767507096021	nM	245	A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results	3
	4pjc	2.5	2014	Kd	5.376750709602099	uM	271	Kd=4.2+/-0.5uM; C-A11 TCR	8
	4pja	2.68	2014	Kd	5.376750709602099	uM	271	Kd=4.2+/-0.6uM; B-B10 TCR	8
	4kht	2.82	2014	Kd	8.366531544420413	nM	245	A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results	3
	4ol0	2.9	2014	Kd	8.327902142064282	nM	921	Kd=4.7+/-1.2nM; GTP containing	2
	4noo	2.3	2014	Kd	8.30803489723264	nM	98	putative catalytic domain (VgrG3CCD) as ligand and TsiV3 as analyte	4
	4j4p	2.91	2014	Kd	7.3979400086720375	nM	249		8
	4ovn	2.8	2014	Kd	7.337242168318426	nM	157	Temperature is 28C, Kds ranging from 46 +/- 33 nM to 105 +/- 15 nM depending on the buffer conditions	10
	4pp8	1.95	2014	Kd	6.313363730737707	nM	174	RAE-1 BETA IN COMPLEX WITH murine NKG2D, Kd=486nM	4
	4cj1	1.63	2014	Kd	7.318758762624412	nM	81	ITC Kd=48 +/- 10 nM	2
	4jzj	2.8	2014	Kd	8.397940008672037	nM	221		9
	4lzx	1.5	2014	Kd	8.294992040666664	nM	40	SPR Kd=0.18uM for Ca2+-bound CaM, PDB code 4m1l	2
	4w6x	1.88	2014	Kd	8.279840696594043	nM	131	Microscale thermophoresis (MST), Kd=5.25 +/- 3.08 nM	2
	4ps4	2.8	2014	Kd	11.244125144327509	pM	113	SPR Kd=5.7+/-1.3pM	3
	4lxr	2.2	2014	Kd	8.229147988357855	nM	114		7
	4nzw	3.58	2014	Kd	6.297569463554475	nM	295	between WT MO25-alpha and WT STK25	2
	4pbw	3.05	2014	Kd	6.258848401148215	nM	299		6
	4q5e	1.87	2014	Kd	6.236572006437063	nM	156	OspG with UbcH7~Ub; Kd=580+/-20nM	3
	4js0	1.9	2014	Kd	5.301029995663981	uM	32	Kd measured by ITC	2
	4p5t	3.26	2014	Kd	5.301029995663981	uM	217		8
	4o1q	2.59	2014	Kd	5.2076083105017466	uM	385	affinity is for quinone MADH, not preMADH	6
	3wwn	1.85	2014	Kd	5.1791420105603	uM	54	ITC Kd=6.62+/-0.56 uM	2
	4m0w	1.4	2014	Kd	5.173925197299174	uM	76		2
	4ln0	2.9	2014	Kd	8.167491087293763	nM	58	BLI assay	3
	4lqf	2.3	2014	Kd	10.190440285364732	pM	219	assay by BLI	3
	4k5b	1.85	2014	Kd	9.191789027075778	pM	184	The PDB website may label the two protein chains wrong	4
	4lu5	2.9	2014	Kd	10.18111458540599	pM	219	assay by BLI	6
	4wo4	2.5	2014	Kd	7.180456064458132	nM	245		7
	3wo3	3.1	2014	Kd	7.161150909262744	nM	312	SPR Kd=6.9+/-0.2 x10-8M	38
	4p23	2.25	2014	Kd	5.221848749616356	uM	218		4
	4m6b	1.78	2014	Kd	8.148741651280925	nM	55	ITC Kd is for yeast Swr1 (504-650), length in RCSB PDB is only 55 aa	4
	4ozi	3.2	2014	Kd	4.154901959985743	uM	213	this is a protein-protein complex	10
	4ozf	2.7	2014	Kd	4.100179497572904	uM	213	this is a protein-protein complex	5
	4x7e	2.11	2014	Kd	8.154901959985743	nM	126		4
	4mp0	2.1	2014	Kd	8.060480747381382	nM	44	Kd=8.7 +/-0.8 nM	4
	4pjb	2.85	2014	Kd	5.040958607678906	uM	271	Kd=9.1+/-1.0uM; B-F3-C1 TCR	8
	4c2a	2.08	2014	Kd	8.013228265733755	nM	291	KD values were determined by radiometric titration	2
	4kfz	2.8	2014	Kd	7.026872146400302	nM	129	Mammalian two-hybrid data, Kd=9.4 x 10-8 M	4
	4cj0	1.1	2014	Kd	7.008773924307505	nM	81	ITC Kd=98 +/- 36 nM	2
	4c2b	2.8	2014	Kd	8.045757490560675	nM	291	KD values were determined by radiometric titration	8
	4l0p	2.26	2014	Kd	8.045757490560675	nM	143		3
	4pje	1.95	2014	Kd	3.6989700043360187	uM	271		8
	4pjg	2.4	2014	Kd	3.6989700043360187	uM	271		8
	4pjh	2.0	2014	Kd	3.6989700043360187	uM	271		8
	4pjx	2.25	2014	Kd	3.6989700043360187	uM	271		8
	4pj5	2.0	2014	Kd	3.6989700043360187	uM	271	wild-type TCR	8
	4edw	2.48	2014	Kd	8.0	nM	231		3
	4c7n	2.1	2014	Kd	9.0	nM	51		2
	4q5u	1.95	2014	Kd	12.0	pM	24		2
	4p2o	2.6	2014	Kd	6.0	uM	255		6
	4p2q	3.3	2014	Kd	6.0	uM	266		20
	4p2r	3.3	2014	Kd	6.0	uM	266		20
	4mne	2.85	2014	Kd	7.366531544420414	nM	308	exact value in support information is not available	8
	4niq	2.3	2014	Kd	5.301029995663981	uM	23	ITC Kd is for full-length Vfa1 in this paper, Kd~5-10 uM in ref 32	4
	4u30	2.5	2014	Ki	6.860120913598763	nM	59		8
	4u32	1.65	2014	Ki	6.421360790031928	nM	55		2
	4nm3	2.1	2014	Ki	4.221848749616356	uM	24	phosphoylated Ser9 peptide(pS9); Ki= 60+/-11uM	2
	4nu1	2.5	2014	Ki	4.221848749616356	uM	24	phosphoylated Ser9 peptide; AlF3 is a transition state mimicry ;pS9; Ki= 60+/-11uM	2
	4z5r	3.0	2015	Kd	10.744727494896694	nM	225		24
	5e4e	3.0	2015	Kd	10.075720713938118	nM	318		3
	5c6t	3.6	2015	Kd	9.886056647693163	nM	233		4
	5bnq	2.8	2015	Kd	9.806875401645538	nM	216		2
	4yh7	4.4	2015	Kd	6.823908740944319	uM	348		4
	4r8w	2.79	2015	Kd	9.73754891026957	nM	231		4
	4xhj	3.16	2015	Kd	9.712198270069774	nM	282		13
	4wen	1.89	2015	Kd	7.0	uM	127		2
	4zkc	3.15	2015	Kd	9.657577319177793	nM	82		4
	4qlp	1.1	2015	Kd	9.638272163982407	nM	199	ITC Kd=2.3 x 10E-10M	2
	4rwt	2.98	2015	Kd	6.638272163982407	uM	506	Kd for whole Lmod2 (1-495) (B-GS); also provide Kd for three individual binding sites	4
	4zk9	2.6	2015	Kd	9.619788758288394	nM	83		4
	4uuz	2.9	2015	Kd	6.619788758288394	uM	70		3
	4x33	1.45	2015	Kd	6.6020599913279625	uM	333	[Nonstandard assay: Temp 10]	2
	4zs6	3.17	2015	Kd	6.505845405981558	uM	229		6
	4yk4	2.8	2015	Kd	6.438898616350944	uM	230	assay by biolayer interferometry	6
	4zi2	2.2	2015	Kd	6.376750709602099	uM	135		4
	4xi5	3.9	2015	Kd	9.309803919971486	nM	283		5
	5c7x	2.95	2015	Kd	12.397940008672037	pM	238	MOR04357 in complex with human GM-CSF	6
	5abv	2.13	2015	Kd	9.2839966563652	nM	70		8
	5bw8	2.8	2015	Kd	6.267606240177032	uM	305		5
	5cjq	3.6	2015	Kd	9.301029995663981	nM	230	KD values were determined using biolayer interferometry	4
	5dfv	2.8	2015	Kd	9.301029995663981	nM	222		6
	5dfw	2.33	2015	Kd	9.301029995663981	nM	243		2
	5d3i	3.2	2015	Kd	9.221848749616356	nM	195	Kd=0.6+/-0.4nM, AlphaScreen assay	3
	4yoc	2.92	2015	Kd	6.221848749616356	uM	548		2
	5bo1	2.56	2015	Kd	9.102372908709558	nM	219		6
	4zgy	2.63	2015	Kd	6.154901959985743	uM	135		2
	4wnn	1.8	2015	Kd	6.096910013008056	uM	20		9
	4v3k	2.04	2015	Kd	6.036212172654444	uM	79		6
	5cff	2.5	2015	Kd	5.97061622231479	uM	72	[Different protein in assay: the protein used in binding assay is Trx-Mira (514-595)] [Different ligand in assay: the protein used in binding assay is Trx-Stau (951-1018)]	8
	5bqe	2.3	2015	Kd	5.958607314841775	uM	149	Norrin in complex with the cysteine-rich domain of Frizzled 4 -Methylated form	3
	4xxb	2.4	2015	Kd	5.8297382846050425	uM	148	Microscale thermophoresis (MST) measurements	2
	4r8i	2.05	2015	Kd	8.853871964321762	nM	40	[Nonstandard assay: temp=37C]	2
	4xl5	2.0	2015	Kd	8.853871964321762	nM	263		2
	4zlt	3.0	2015	Kd	8.853871964321762	nM	70		4
	4y5o	2.35	2015	Kd	5.853871964321762	uM	126		2
	4yc7	2.5	2015	Kd	5.723538195826756	uM	381		2
	3wqb	1.41	2015	Kd	8.744727494896694	nM	148		2
	5e8e	1.9	2015	Kd	8.744727494896694	nM	259		6
	4d0g	2.5	2015	Kd	5.7447274948966935	uM	69		2
	5anm	2.85	2015	Kd	11.709965388637482	pM	229	KinExA-determined affinity	12
	4rey	1.96	2015	Kd	6.966576244513051	nM	32		2
	4x7s	1.9	2015	Kd	8.0	nM	218	P212121 symmetry and resolution of 1.9 A, Kd=1x10-8M, data not shown	2
	4s0s	2.8	2015	Kd	7.943095148663527	nM	120		4
	5brm	2.65	2015	Kd	6.924453038607469	nM	31		15
	5bn5	3.0	2015	Kd	4.958607314841775	uM	416	Kd=11+/-2uM	2
	4ui1	2.35	2015	Kd	6.906578314837765	nM	122	RGMC-ND-BMP2	4
	4z80	1.53	2015	Kd	7.920818753952375	nM	37		4
	4wuu	3.05	2015	Kd	7.87942606879415	nM	216		5
	4pw9	2.49	2015	Kd	4.869666231504994	uM	106	SorT/SorU complex	2
	5d1l	1.62	2015	Kd	6.85078088734462	nM	133	Binding was assessed by MST	2
	4uu9	2.12	2015	Kd	10.853871964321762	pM	75		6
	4uyq	1.81	2015	Kd	10.853871964321762	pM	75		2
	4wwi	2.31	2015	Kd	7.818156412055227	nM	220	Ka=6.6 (5.6, 9.5) x 107 M-1	6
	5do2	2.41	2015	Kd	6.790484985457369	nM	219		6
	4zqu	2.09	2015	Kd	7.795880017344075	nM	185	CdiA-CT/CdiIYPIII;	2
	4qti	3.0	2015	Kd	7.764471553092451	nM	283		3
	4z8l	2.6	2015	Kd	6.769551078621726	nM	118		6
	4yeb	3.19	2015	Kd	7.769551078621726	nM	370		2
	5d1k	1.78	2015	Kd	6.7447274948966935	nM	133	Binding was assessed by MST	2
	4ypi	3.71	2015	Kd	7.712198270069774	nM	28		8
	3wih	1.7	2015	Kd	7.721246399047171	nM	219		6
	4zrk	2.32	2015	Kd	6.0	uM	32		8
	5dob	2.47	2015	Kd	6.0	uM	165		2
	4yvq	2.4	2015	Kd	5.692503962086787	uM	159		2
	4ydh	3.8	2015	Kd	5.5934598195660445	uM	181		4
	4zgq	3.0	2015	Kd	5.6020599913279625	uM	118		2
	4wv1	2.36	2015	Kd	8.585026652029182	nM	230	phage ELISA-binding assay	6
	4zrj	2.3	2015	Kd	5.537602002101044	uM	90	S518D, A585W mutant Merlin CTD	2
	4wb2	1.8	2015	Kd	10.69680394257951	pM	40		5
	5d70	2.06	2015	Kd	8.698970004336019	pM	236	MOR03929 in complex with human GM-CSF	3
	4uyp	1.49	2015	Kd	10.698970004336019	pM	75		4
	4zfo	1.9	2015	Kd	10.67778070526608	pM	221	SPR data under 1.1nM BCMA concentration	6
	4rgm	2.69	2015	Kd	7.640164517660112	nM	223	BLI assay, data not shown	6
	5cmn	3.61	2015	Kd	6.657577319177793	nM	261	determined by bio-layer interferometry	8
	4rs1	2.68	2015	Kd	7.621602099051862	nM	112	saturation binding assays using radioiodinated GM-CSF and COS cells transiently expressing GMRa alone	2
	4zv4	3.5	2015	Kd	7.638272163982407	nM	180	Tse6265-CT with EF-TuPA/GDP	4
	5di9	2.28	2015	Kd	5.619788758288394	nM	21		4
	5cyk	3.0	2015	Kd	6.603800652904264	nM	389	Biolayer Interferometry assay	2
	4rjf	2.01	2015	Kd	6.6020599913279625	nM	22		6
	4xlw	3.39	2015	Kd	6.581698708680254	nM	261		8
	5ajk	2.55	2015	Kd	5.578396073130169	nM	26		12
	4pgj	2.6	2015	Kd	7.585026652029182	nM	129	crystal with well solution (100mM sodium citrate, pH 5.4, supplemented with 28% (w/v) PEG 1500	4
	4xhu	2.09	2015	Kd	7.585026652029182	nM	359		4
	4pvz	2.5	2015	Kd	7.5638373529592435	nM	43		4
	5eiv	2.41	2015	Kd	4.549750891680639	uM	21	consensus THP	11
	4yyp	2.6	2015	Kd	6.552841968657781	nM	32		2
	4qci	2.3	2015	Kd	10.55284196865778	pM	110		6
	4yiq	1.85	2015	Kd	5.698970004336019	uM	108	heterodimer	4
	5e6p	3.22	2015	Kd	5.698970004336019	uM	88		2
	5aam	2.49	2015	Kd	8.42021640338319	nM	115	Entry 5AAM supersedes 4UD3	4
	5bvp	2.2	2015	Kd	10.515700160653214	pM	153		3
	4xl1	2.3	2015	Kd	6.517126416391246	nM	230		6
	4cvw	2.67	2015	Kd	10.522878745280337	pM	120	PH=6.5, temp=25C	4
	5a6w	1.6	2015	Kd	7.508638306165727	nM	93		3
	4wnd	1.5	2015	Kd	7.482804102050026	nM	53	[Different ligand in assay: MBP-Frmpd4 (978-1011)]	2
	5ajj	1.75	2015	Kd	5.492144128304169	nM	34		2
	3wwq	1.9	2015	Kd	4.444905551421681	uM	44		12
	4tq1	1.8	2015	Kd	3.4559319556497243	uM	39	[Different ligand in assay: minimal peptide, 36 residue from Thr575 to Val610 of TECPR1]	2
	4y61	3.36	2015	Kd	6.449160394934215	nM	272	PTPdelta Ig1-Fn1 meA9B+	2
	5a3i	2.89	2015	Kd	7.443697499232712	nM	230		10
	5dh9	2.55	2015	Kd	7.431798275933005	nM	20		4
	4xkl	2.1	2015	Kd	4.407823242604133	uM	80		4
	4uwq	3.28	2015	Kd	5.522878745280337	uM	136	disulfide-linked complex	12
	5c0n	3.0	2015	Kd	5.384049948343599	uM	222	biomolecular interaction analysis	6
	5aoq	2.7	2015	Kd	8.387216143280265	nM	109	two sequential binding events	6
	4w4o	1.8	2015	Kd	8.3767507096021	nM	280		7
	4xvp	3.4	2015	Kd	8.3767507096021	nM	170		6
	5aaw	3.27	2015	Kd	8.364516253185087	nM	115		12
	4xwj	2.1	2015	Kd	8.351639989019068	nM	85	[Different protein in assay: The Rsd protein is A133S mutant]	2
	5d2n	2.1	2015	Kd	5.327902142064283	uM	276		10
	5e3e	1.7	2015	Kd	7.388276691992658	nM	114	biolayer interferometry assay	6
	4ypg	3.0	2015	Kd	10.356547323513812	pM	161	KD was determined using a KinExa instrument	6
	4pj2	1.24	2015	Kd	10.327902142064282	pM	122	[Different ligand in assay: SPR assay is for i-type lysozyme from V. philippinarium]	4
	5dwu	3.97	2015	Kd	7.309803919971486	nM	222		4
	5d2l	3.51	2015	Kd	5.292429823902063	uM	276		20
	4yl8	1.5	2015	Kd	5.267606240177032	uM	43	[Nonstandard assay: assay in the presence of 400 mM NaCl]	2
	4d2g	2.65	2015	Kd	5.2549252084179425	uM	21	[Different ligand in assay: The protein in crystal structure is P15(51-71),the protein uesd in binding assay is P15(50-77)]	5
	4weu	2.61	2015	Kd	5.2441251443275085	uM	127	PDF is not editable	4
	5bw7	3.0	2015	Kd	7.281498311132726	nM	179		7
	4zak	2.82	2015	Kd	7.251811972993799	nM	241	mCD1d/DB06-1/iNKTCR ternary complex;	5
	4zfg	2.27	2015	Kd	8.301029995663981	nM	228		3
	4zff	2.75	2015	Kd	8.301029995663981	nM	99		6
	4s3o	2.0	2015	Kd	5.214670164989233	uM	118	assay using bio-layer interferometry (BLI)	6
	5ee4	2.3	2015	Kd	5.214670164989233	uM	146		6
	4uem	2.82	2015	Kd	8.193820026016112	nM	127		2
	5e8d	2.5	2015	Kd	8.187086643357144	nM	220		3
	4wem	1.55	2015	Kd	5.167491087293763	uM	127		2
	4uf1	2.3	2015	Kd	5.156144577376839	uM	26		2
	4tq0	2.7	2015	Kd	5.161150909262744	uM	69	[Different ligand in assay: mininal peptide, 36 residues from Phe10 to Lys45 of ATG16L1]	6
	4uwx	1.65	2015	Kd	5.161150909262744	uM	21		4
	5d1m	1.58	2015	Kd	7.2076083105017466	nM	133	Binding was assessed by MST	2
	5d71	2.25	2015	Kd	10.187086643357144	pM	236	MOR04302 in complex with human GM-CSF	3
	5d72	2.6	2015	Kd	11.221848749616356	pM	447	MOR04252 in complex with human GM-CSF	6
	4xoi	2.09	2015	Kd	5.136677139879544	uM	270		4
	5c0s	4.3	2015	Kd	8.113509274827518	nM	226		3
	4rgo	1.8	2015	Kd	8.102372908709558	nM	222	BLI assay, data not shown	3
	5dha	2.95	2015	Kd	6.107905397309519	nM	21	competition test	4
	4x4m	3.49	2015	Kd	8.05551732784983	nM	275	[Nonstandard assay: NaCl=0.15M]	11
	4yn0	2.2	2015	Kd	7.070581074285707	nM	223	assay by biolayer interferometry	2
	4ui0	2.8	2015	Kd	7.055517327849832	nM	96	crystal form 2	3
	4xnm	2.51	2015	Kd	8.096910013008056	nM	212	Measured on an Octet interferometry instrument	7
	4yiz	2.2	2015	Kd	8.096910013008056	nM	40		6
	5cxb	2.1	2015	Kd	8.036684488613888	nM	369		2
	5e7f	2.7	2015	Kd	8.040958607678906	nM	131	Biolayer interferometry (BLI)	6
	5cjs	4.3	2015	Kd	8.022276394711152	nM	230	KD values were determined using biolayer interferometry	8
	4zpt	2.59	2015	Kd	8.003050751504619	nM	208	Crystal Form 1, measured in triplicate by biolayer interferometry	6
	4yj4	2.1	2015	Kd	8.00436480540245	nM	21		2
	4qnp	2.8	2015	Kd	7.022276394711152	nM	212	BioLayer Interferometry	8
	5d1z	3.17	2016	Kd	12.0	pM	157		10
	5j57	1.7	2016	Kd	10.698970004336019	nM	127		2
	5hvf	2.85	2016	Kd	10.522878745280337	nM	119	0.3 x 10 -10M is not 3nM	3
	5hgg	1.97	2016	Kd	10.267606240177031	nM	128	+/-0.02	4
	5eg3	2.61	2016	Kd	6.8696662315049934	uM	114	cSH2	2
	5f6k	2.41	2016	Kd	6.886056647693163	uM	184		7
	5hpy	2.4	2016	Kd	6.886056647693163	uM	185		4
	5jsb	2.74	2016	Kd	6.823908740944319	uM	116	BLI assay	12
	4ybl	3.1	2016	Kd	9.769551078621726	nM	224		6
	5dcq	1.83	2016	Kd	6.7447274948966935	uM	271		6
	5lxm	2.08	2016	Kd	6.7447274948966935	uM	38	ligand is stapled TPX2 protein 10	2
	5t5f	2.98	2016	Kd	9.721246399047171	nM	216		3
	5eoa	2.5	2016	Kd	7.0	uM	57	[Different protein in assay: Optineurin, OPTN(26-119) E50K mutant] ITC assay use OPTN(26-119) E50K mutant	4
	5j7c	2.54	2016	Kd	9.679853713888946	nM	102	bio-layer interferometry (BLI) assay	4
	5ibw	1.9	2016	Kd	9.602059991327963	nM	43	[Multiple sites: Kd1=0.25nM, Kd2=55nM] 2:1 MlcC / M1C-IQ1.2 Complex	3
	5cw7	2.83	2016	Kd	12.55284196865778	pM	100	T=300.15K	16
	5ifs	2.46	2016	Kd	9.698970004336019	nM	481		4
	5sx4	2.8	2016	Kd	9.468521082957745	nM	201		6
	5fo8	2.4	2016	Kd	6.455931955649724	uM	252		5
	5ies	2.16	2016	Kd	6.434152181326483	uM	183		3
	5eo9	2.3	2016	Kd	6.431798275933005	uM	206	Dpr6 D1 / DIP-alpha (CG32791) D1-D2	2
	5czv	3.19	2016	Kd	9.522878745280337	nM	223	flow cytometric studies	3
	5mi0	2.35	2016	Kd	6.3872161432802645	uM	258	SPR Kd after lyophilizing of PfRH5 Delta NL-HS1 is 0.30uM	3
	4zi3	2.0	2016	Kd	6.376750709602099	uM	135	[Nonstandard assay: Temp 20C]	4
	5li1	2.0	2016	Kd	6.327902142064283	uM	20		2
	5ays	2.09	2016	Kd	9.29413628771608	nM	112		4
	5cx3	2.3	2016	Kd	6.267606240177032	uM	31		8
	5c0b	2.03	2016	Kd	6.301029995663981	uM	277	complex of 1E6-A2-RQF[I]	10
	5sv3	2.73	2016	Kd	9.202732459169283	nM	190		4
	5hvg	3.05	2016	Kd	9.200659450546418	nM	128	6.3 x 10 -10M is not 63nM	6
	5lxq	3.34	2016	Kd	6.1938200260161125	uM	156		4
	5czx	2.1	2016	Kd	9.221848749616356	nM	226	flow cytometric studies	6
	5ep6	1.45	2016	Kd	6.142667503568732	uM	57		4
	5boz	3.1	2016	Kd	9.154901959985743	nM	127		12
	5d5m	2.2	2016	Kd	6.154901959985743	uM	245		8
	5eyp	1.9	2016	Kd	9.086186147616283	nM	169	+/-0.18	3
	5bt1	2.62	2016	Kd	6.080921907623926	uM	143	ITC Kd1=0.83uM, Kd2=0.22uM; SPR Kd1=0.52uM, Kd2=0.21uM	4
	5ctr	3.01	2016	Kd	6.055517327849832	uM	233		4
	5jsn	2.1	2016	Kd	6.096910013008056	uM	118	BLI assay	4
	5dmi	3.69	2016	Kd	9.040958607678906	nM	223		3
	4xkh	3.0	2016	Kd	6.026872146400302	uM	76		9
	5k8q	1.74	2016	Kd	9.045757490560675	nM	29	[Nonstandard assay: assay at temp 37C]	2
	5kho	2.78	2016	Kd	6.045757490560675	uM	156	Kd=0.9+/-0.2uM, Rasip1 in complex with Rap1B	4
	5sx5	2.5	2016	Kd	8.939302159646388	nM	201		6
	5l2k	3.2	2016	Kd	5.939302159646388	uM	300		4
	5c4v	2.6	2016	Kd	5.958607314841775	uM	127		6
	5szk	2.8	2016	Kd	5.958607314841775	uM	203		2
	5hdq	1.83	2016	Kd	8.920818753952375	nM	220		3
	5j3d	4.08	2016	Kd	8.863279432843592	nM	73	protein 2 in crystal is RSV A2 F, protein name for assay is FFL_001	12
	5fob	2.6	2016	Kd	5.886056647693163	uM	245		5
	5chv	3.01	2016	Kd	5.826813731587726	uM	155		4
	5edv	3.48	2016	Kd	5.795880017344075	uM	149		9
	5jg6	2.0	2016	Kd	5.795880017344075	uM	84	measured by BLI	4
	5d8j	3.0	2016	Kd	8.749579997691106	nM	221	biomolecular interaction analysis	3
	5kov	3.25	2016	Kd	8.7281583934635	nM	251		16
	5b78	1.4	2016	Kd	5.72584215073632	uM	25		2
	4zrp	2.1	2016	Kd	8.744727494896694	nM	119	Solid-phase binding assay	4
	5fvk	1.66	2016	Kd	5.7447274948966935	uM	22		4
	5ayr	2.4	2016	Kd	8.707965564005264	nM	112		4
	5fo9	3.3	2016	Kd	5.721246399047171	uM	196		6
	5d7l	3.4	2016	Kd	4.982966660701219	uM	243		8
	5b77	1.55	2016	Kd	4.966576244513051	uM	25		2
	5czf	2.67	2016	Kd	10.0	pM	111	T=300.15K	4
	5kn5	2.8	2016	Kd	9.991399828238082	pM	40		6
	5et1	1.65	2016	Kd	6.97061622231479	nM	36		4
	5b75	1.7	2016	Kd	5.0	uM	25		2
	5dju	2.1	2016	Kd	7.943095148663527	nM	61	A radiometric binding assay	4
	5ft8	2.5	2016	Kd	6.931814138253839	nM	154	(CsdAper-CsdEper)2, interaction between the CsdA homodimer and each CsdE monomer	16
	5g1x	1.72	2016	Kd	4.91721462968355	uM	63	[Nonstandard assay: 150mM NaCl] +/-0.6; phosphorylated Aurora-A	2
	5inb	1.3	2016	Kd	6.910094888560602	nM	46		2
	5ius	2.89	2016	Kd	9.896196279044043	pM	225	SPR PH=7.4	4
	5e9d	2.51	2016	Kd	6.889410289700751	nM	156		10
	5fhx	2.55	2016	Kd	10.920818753952375	pM	345	SPR Kd for antigen 1, IL4	3
	4z9v	2.1	2016	Kd	4.920818753952375	uM	21	[Different protein in assay: Bcl-xL]	8
	4rt6	2.8	2016	Kd	7.87942606879415	nM	214	SI page of nature is not accessible with internal error 500, please check ITC Kd data later	3
	5ij9	3.7	2016	Kd	4.872895201635193	uM	426	Kd=13.4+/-3.7uM	2
	5d1q	3.22	2016	Kd	10.886056647693163	pM	118	SPR Kd is 13-16pM	5
	5eb1	1.8	2016	Kd	6.853871964321762	nM	135		4
	5fr2	3.35	2016	Kd	6.85078088734462	nM	213	+/-45	2
	5hk5	2.9	2016	Kd	6.835647144215563	nM	120		8
	5e95	1.4	2016	Kd	7.804100347590766	nM	97	+/-2.7	2
	5f1b	2.3	2016	Kd	3.8013429130455774	uM	256		4
	5jlv	2.0	2016	Kd	7.823908740944319	nM	117	ITC curve has two binding components	6
	5i5k	4.2	2016	Kd	10.75448733218585	pM	230		8
	5djt	1.4	2016	Kd	7.769551078621726	nM	61	A radiometric binding assay	2
	5j28	2.0	2016	Kd	6.714442690992226	nM	46		4
	5ejc	3.1	2016	Kd	6.705533773838407	nM	55		6
	5lz3	3.0	2016	Kd	4.721246399047171	uM	58		2
	4z2m	2.98	2016	Kd	5.696803942579511	uM	103	1:1 stoichiometry	5
	5jhf	3.21	2016	Kd	5.698970004336019	uM	413	Kd=2.0+/-0.2uM	10
	5ksb	2.9	2016	Kd	5.698970004336019	uM	225	Kd=2.0+/-0.1uM	12
	4z9k	1.5	2016	Kd	8.657577319177793	nM	116	another PDB code 5E1H for antibody F8 is not in PDBbind	2
	5tar	1.9	2016	Kd	5.638272163982407	uM	148		2
	5te6	2.4	2016	Kd	8.586700235918748	nM	225		3
	5j3h	3.27	2016	Kd	8.602059991327963	nM	123	Kd=2.5+/-0.6uM	7
	5k59	2.84	2016	Kd	11.602059991327963	pM	227	measured by MSD	8
	5d50	2.49	2016	Kd	5.585026652029182	uM	86	assay using bio-layer interferometry (BLI)	16
	5jhl	3.0	2016	Kd	8.568636235841012	nM	231		3
	5te7	2.15	2016	Kd	8.55129368009492	nM	225		3
	5jh5	2.55	2016	Kd	5.552841968657781	uM	281	heterotetramer structure of two dimers	4
	5ks9	2.55	2016	Kd	5.552841968657781	uM	230		10
	5kw9	2.3	2016	Kd	7.688246138944246	nM	227	biolayer interferometry (BLI)	3
	5glh	2.8	2016	Kd	10.684029654543082	pM	21		2
	4zs7	2.93	2016	Kd	10.67778070526608	pM	222	Kd=13-21pM, Dissociation kinetics outside the detection limit of the Biacore T200	3
	5d1x	3.21	2016	Kd	10.67778070526608	pM	118	SPR Kd is 21-31pM	5
	4xr8	2.25	2016	Kd	4.655607726314889	uM	199		8
	5fqd	2.45	2016	Kd	6.657577319177793	nM	341	+/-4; lenalidomide induced, competes with CRL4CRBN	6
	5f5s	2.4	2016	Kd	7.657577319177793	nM	80	[Nonstandard assay: ITC test at 10 centigrade] ITC test at 10 centigrade	2
	5szi	2.85	2016	Kd	6.5968794788241825	nM	153		2
	5k22	3.0	2016	Kd	7.6020599913279625	nM	155		2
	5kvd	1.65	2016	Kd	6.575118363368933	nM	222	KD (equilibrium) determined by BLI	3
	5ee5	2.28	2016	Kd	4.585026652029182	uM	171	[Nonstandard assay: pH 8.0] [Different protein in assay: Protein in binding assay is DCB domain of BIG1] ARL1 with ATP; +/-5	2
	5d28	2.85	2016	Kd	7.568636235841013	nM	127	bio-layer interferometry (BLI) assay	8
	5ikc	2.06	2016	Kd	7.568636235841013	nM	215	[Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)	6
	5cd5	3.4	2016	Kd	6.539102157243452	nM	220	Glycosylated Kd1	7
	5mhs	3.7	2016	Kd	8.698970004336019	nM	221		9
	5l8j	1.68	2016	Kd	5.698970004336019	uM	117	[Different ligand in assay: ligand protein in assay is wildtype vNAR-D01] SPR Kd=2uM for wt vNAR-D01	2
	5f3x	2.65	2016	Kd	8.507239610973162	nM	81		4
	5j56	1.8	2016	Kd	8.494850021680094	nM	129		2
	5fr1	2.75	2016	Kd	5.481486060122113	uM	213		2
	5ibl	3.39	2016	Kd	5.443697499232713	uM	230	biolayer interferometry (BLI) assay	8
	5eof	2.05	2016	Kd	5.42021640338319	uM	57		4
	4ww2	2.48	2016	Kd	5.4089353929735005	uM	284		4
	5sws	2.86	2016	Kd	4.522878745280337	uM	242	ligand is NP2-B17 TCR	5
	5hps	2.05	2016	Kd	6.490931954982838	nM	83	BLI assay	2
	5kvf	1.4	2016	Kd	7.494850021680094	nM	221	KD (equilibrium) determined by BLI	3
	5m72	1.6	2016	Kd	7.481486060122112	nM	71		2
	5hxb	3.6	2016	Kd	6.459670525209126	nM	1140	[Nonstandard assay: 150 mM NaCl] CC-885	6
	5men	2.81	2016	Kd	4.468521082957745	uM	240		5
	5dc4	1.48	2016	Kd	7.455931955649724	nM	95	crystal form A, mean fluorescence intensity (MFI)	2
	5kve	1.7	2016	Kd	7.455931955649724	nM	129	KD (equilibrium) determined by BLI	2
	5imt	2.7	2016	Kd	6.43533393574791	nM	77	[Different protein in assay: assay use wildtype ILY (ILY-wt)] assay by microscale thermophoresis	2
	5hys	2.5	2016	Kd	10.410050398674292	pM	222		16
	5jdo	3.2	2016	Kd	8.522878745280337	nM	145		6
	5f3b	1.76	2016	Kd	11.522878745280337	pM	109		6
	5d7j	1.97	2016	Kd	5.522878745280337	uM	245		8
	4wwk	3.1	2016	Kd	5.3979400086720375	uM	278		4
	5drz	2.54	2016	Kd	8.356547323513812	nM	36	SPR Kd=4.4nM, ITC Kd=34nM	6
	5fug	2.7	2016	Kd	8.356547323513812	nM	68		12
	5ksa	2.0	2016	Kd	5.327902142064283	uM	225		5
	5eib	2.1	2016	Kd	5.318758762624412	uM	23	[Nonstandard assay: Temp 15C, pH 6.8] [Different protein in assay: protein in binding assay is tubulin-PN2-3c without DARPin] DARPin molecule didnot affect binding of PN2-3C to tubulin	4
	4zw2	1.86	2016	Kd	8.309803919971486	nM	20		2
	5elu	2.35	2016	Kd	6.382999658879101	nM	77		2
	5grj	3.21	2016	Kd	10.37571790416433	pM	221		3
	5kwy	2.41	2016	Kd	6.367542707815276	nM	133	[Different protein in assay: Kd for murine NPC1 middle lumenal domain] Microscale thermophoresis; Kd for murine NPC1 middle lumenal domain bound to NPC2; SPR Kd is about 2uM	4
	5c0c	1.97	2016	Kd	4.35261702988538	uM	277	complex of 1E6-A2-RQF[A]	10
	5ip4	1.81	2016	Kd	6.345823458122039	nM	121	[Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)	4
	5f4e	2.4	2016	Kd	7.318758762624412	nM	215		2
	5fzt	2.1	2016	Kd	4.318758762624412	uM	23		2
	4udm	2.96	2016	Kd	8.397940008672037	nM	96	under 20mM NaCl concentration	2
	4xxw	2.26	2016	Kd	5.29073003902417	uM	214		4
	5szh	2.3	2016	Kd	5.2839966563652006	uM	203		2
	5gzn	3.0	2016	Kd	5.268411234813262	uM	228	apparent KD was calculated by steady-state affinity mode	8
	5dmj	2.79	2016	Kd	8.275724130399212	nM	121	CD40/3h-56-5 dAb C2 crystal form	6
	5b76	1.65	2016	Kd	5.236572006437063	uM	26		2
	5l6y	1.99	2016	Kd	10.236572006437063	pM	238	SPR Kd=58pM for Tralokinumab IgG4; Kd=63pM for Tralokinumab IgG1	3
	5hlz	2.85	2016	Kd	8.301029995663981	nM	116	biolayer interferometry (BLI) assay	8
	5jem	2.5	2016	Kd	5.220403508742176	uM	47	IRF-3/CBP complex	8
	5foa	4.19	2016	Kd	5.214670164989233	uM	194	[Different ligand in assay: The binding data is for C3b and DAF (CCP1-4)] Maybe author made a typo as DAF (CCP1-4)	6
	5eu6	2.02	2016	Kd	5.200659450546418	uM	276	Kd for PMEL17 TCR and A2-YLE-9V	5
	5eql	2.49	2016	Kd	7.167491087293763	nM	77		2
	5fcu	1.85	2016	Kd	8.221848749616356	nM	233		3
	5fv2	3.45	2016	Kd	11.1444808443322	pM	116	[Different ligand in assay: ligand in assay is VEGF-A165]	6
	5jze	2.47	2016	Kd	5.126098402135539	uM	76	Kd=7.48+/-0.26uM	4
	5c07	2.11	2016	Kd	5.130768280269024	uM	277	complex of 1E6-A2-YQF	10
	5c08	2.33	2016	Kd	5.107905397309519	uM	277	complex of 1E6-A2-RQW	10
	5ij0	3.8	2016	Kd	5.102372908709558	uM	426	Kd=7.9+/-3.2uM	2
	5ixd	2.85	2016	Kd	7.151810883008602	nM	55	Biolayer Interferometry assay	2
	5b64	2.7	2016	Kd	7.154901959985743	nM	126		2
	5igx	3.39	2016	Kd	6.148130399270234	nM	236		4
	5j4a	2.0	2016	Kd	7.142667503568732	nM	120	Biolayer interferometry (BLI) assay	4
	5itz	2.2	2016	Kd	7.1249387366083	nM	127	Kd=75+/-12nM	4
	5ioh	2.57	2016	Kd	6.1090204030103115	nM	64		4
	5imy	2.4	2016	Kd	6.108462542327436	nM	78	[Different protein in assay: assay use wildtype VLY (VLY-wt)] assay by microscale thermophoresis	4
	5szj	2.66	2016	Kd	3.1023729087095586	uM	153		2
	5d3f	2.74	2016	Kd	5.094204119632131	uM	28	ligand is CFTR_R6 peptide, in presence of stabilizer FC-A; Kd=24uM when without FC-A	3
	5jyl	2.55	2016	Kd	8.060480747381382	nM	253		4
	5kvg	1.4	2016	Kd	8.05551732784983	nM	219	KD (equilibrium) determined by BLI	3
	5fw5	1.92	2016	Kd	7.096910013008056	nM	25	MST assay in a two-phase binding mode	3
	5d7i	2.0	2016	Kd	4.089375595110798	uM	245		8
	5lcv	2.64	2016	Kd	6.075720713938118	nM	283	Biolayer interferometry experiments	5
	5t1d	3.1	2016	Kd	7.066512712151295	nM	217		7
	5jmc	2.64	2016	Kd	7.0655015487564325	nM	124		8
	5lz6	2.6	2016	Kd	5.096910013008056	uM	38		2
	5lrw	2.0	2016	Kd	5.031517051446065	uM	76		4
	5ghw	2.4	2016	Kd	8.017728766960431	nM	36		3
	5hpk	2.43	2016	Kd	8.013228265733755	nM	86	BLI assay	2
	5te4	2.75	2016	Kd	8.00436480540245	nM	225		3
	5jke	2.86	2016	Kd	7.040958607678906	nM	221		4
	5hhm	2.5	2016	Kd	3.6989700043360187	uM	241		10
	5hho	2.95	2016	Kd	3.6989700043360187	uM	241		5
	5lqb	1.95	2016	Kd	9.0	nM	224	near 1nM SPR data in figure S3A, but SI file is not freely available	3
	5c09	2.48	2016	Kd	3.3979400086720375	uM	277	complex of 1E6-A2-YLG	10
	5swz	2.65	2016	Kd	4.3979400086720375	uM	242	ligand is NP1-B17 TCR	20
	5c0a	2.46	2016	Kd	3.2218487496163566	uM	276	complex of 1E6-A2-MVW	10
	5e6j	2.85	2016	Ki	4.91829272990265	uM	76		6
	5d93	2.2	2016	Ki	7.795880017344075	nM	218		6
	5d96	2.3	2016	Ki	8.657577319177793	nM	220		6
	5c67	1.83	2016	Ki	10.050609993355087	pM	81		4
	5th9	3.0	2017	Kd	11.096910013008056	nM	231	assay using a ProteOn XPR36 biosensor	9
	5wql	2.3	2017	Kd	8.0	nM	682	[Different protein in assay: protein in crystal is K477A] Prc-sNlpI	8
	5nhu	1.45	2017	Kd	9.0	nM	82	another Kd=0.3nM from displacement titration experiments	9
	5tdy	2.11	2017	Kd	7.3979400086720375	nM	98		4
	5usl	2.9	2017	Kd	10.795880017344075	nM	224	biolayer interferometry (BLI) assay	6
	5jw9	2.0	2017	Kd	7.0655015487564325	uM	122	Fluorescence anisotropy	2
	5mj3	1.74	2017	Kd	9.958607314841775	nM	118	Crystal form 1	4
	5t5b	2.07	2017	Kd	9.910094888560602	nM	163	mutant 5	6
	5gjk	2.05	2017	Kd	6.920818753952375	uM	68		2
	5m2j	1.9	2017	Kd	9.886056647693163	nM	115		2
	5w06	2.6	2017	Kd	9.853871964321762	nM	229		3
	5b71	2.11	2017	Kd	9.818156412055227	nM	110	SKY59 bind human C5 at pH 7.4 with KD of 0.152nM, in a pH-dependent manner	6
	5vob	3.02	2017	Kd	9.823908740944319	nM	289	SI file is not available	8
	5gzo	2.76	2017	Kd	6.786216700664696	uM	220	real-time biophysical binding assays (BIAcore)	6
	5thp	3.01	2017	Kd	9.67778070526608	nM	217	binds to close conformation of integrin alpha2-A domain	18
	5o76	2.47	2017	Kd	6.6020599913279625	uM	82	+/-0.04	6
	5h3j	1.33	2017	Kd	6.568636235841013	uM	28		2
	5xot	2.79	2017	Kd	6.568636235841013	uM	276	TU55/B35-pol448-9	5
	6b9j	2.9	2017	Kd	9.455931955649724	nM	217	biolayer interferometry (BLI) assay	6
	5t29	2.03	2017	Kd	9.421360790031928	nM	163	mutant 3	3
	5u4m	2.5	2017	Kd	9.4089353929735	nM	129	crystal under no salt conditions	2
	5nvl	2.3	2017	Kd	9.522878745280337	nM	75		4
	5vmm	3.6	2017	Kd	9.3767507096021	nM	146	previous ITC assay for carboxyhemoglobin	8
	5omb	1.94	2017	Kd	6.366531544420414	uM	111	[Different ligand in assay: ligand protein in bioassay is ScDdc2N] MST assay	4
	6atk	3.51	2017	Kd	6.366531544420414	uM	146		11
	5kxh	1.33	2017	Kd	6.309803919971486	uM	40	[Nonstandard assay: 500 uM GDP]	2
	5nvk	2.9	2017	Kd	9.397940008672037	nM	75		8
	5vx3	1.95	2017	Kd	9.397940008672037	nM	26	Bcl-xL: Bim-h3Pc-RT	8
	5xeq	3.14	2017	Kd	9.397940008672037	nM	319	[Multiple sites: site 1: Kd=0.4 nM; site 2: Kd=11 nM] assay by biolayer light interferometry, dimeric NL2 contains two binding sites for MDGA1	3
	5lp5	2.74	2017	Kd	6.3979400086720375	uM	248		6
	5m2i	2.15	2017	Kd	9.267606240177031	nM	121		12
	5wy2	1.9	2017	Kd	6.267606240177032	uM	21		4
	5o2u	2.76	2017	Kd	9.161150909262744	nM	132	assay by biolayer Interferometry	4
	5wrv	1.7	2017	Kd	6.136677139879544	uM	163	microscale thermophoresis (MST) assay; length of SRP68 is not 103 as described on RCSB	2
	5wb7	2.94	2017	Kd	6.119186407719209	uM	62		15
	5jq6	2.4	2017	Kd	9.102372908709558	nM	222	[Different protein in assay: Clumping factor A, ClfA (229-545)]	3
	5ky5	1.5	2017	Kd	6.102372908709558	uM	40	[Nonstandard assay: 500 uM GDP]	2
	5wgg	2.04	2017	Kd	6.154901959985743	uM	21	[Different ligand in assay: Ligand in binding assay is 5,6-TAMRA label on the N-terminus] CteB+SAM +CteA-M1-C21	2
	5o05	2.0	2017	Kd	9.09151498112135	nM	120		4
	5uk5	2.51	2017	Kd	6.0915149811213505	uM	318		3
	5tvq	2.35	2017	Kd	6.055517327849832	uM	86		2
	5tuv	2.9	2017	Kd	6.096910013008056	uM	41		6
	5npo	1.95	2017	Kd	6.022276394711152	uM	265		2
	5tgh	2.8	2017	Kd	6.022276394711152	uM	23		8
	5n88	1.7	2017	Kd	5.99439055463972	uM	79		4
	5xov	2.68	2017	Kd	5.97469413473523	uM	274	S19-2/A24-nef138-10	10
	5oo6	2.8	2017	Kd	6.0	uM	48	+/-0.2, ARS2	24
	5tz2	2.3	2017	Kd	8.950781977329818	nM	129		5
	5mad	1.53	2017	Kd	8.958607314841775	nM	160		8
	5lgk	3.5	2017	Kd	5.920818753952375	uM	120	[Multiple sites: site 1: Kd=1.2 uM; site 2: Kd=14.4 uM] The two CD23 binding sites on IgE	8
	5vwy	1.56	2017	Kd	5.886056647693163	uM	26	Bak Core/Latch Dimer: Bim-h3Pc-RT	2
	5wt9	2.4	2017	Kd	8.838631997765026	nM	173		4
	5mv8	1.88	2017	Kd	5.853871964321762	uM	130	Myo7b MF2	2
	5sxp	1.65	2017	Kd	5.798602875679548	uM	27		6
	5m2m	2.3	2017	Kd	8.823908740944319	nM	129		12
	5ush	2.3	2017	Kd	8.823908740944319	nM	224	biolayer interferometry (BLI) assay	6
	5xbf	1.8	2017	Kd	5.769551078621726	uM	125	Myo7b CMF/USH1C PDZ3; +/- 0.1	2
	5iia	1.7	2017	Kd	8.742321425130816	nM	136	MST assay	8
	5whk	2.5	2017	Kd	8.742321425130816	nM	297	SPR assay at pH 7.5	4
	5omm	1.7	2017	Kd	7.982966660701219	nM	119		3
	5tru	3.0	2017	Kd	7.97469413473523	nM	118		6
	5nt7	1.4	2017	Kd	4.97469413473523	uM	107		4
	5upk	2.4	2017	Kd	3.9829666607012197	uM	185	Kd=104+/-38uM, complex is PAK4cat-PAK4N45-CDC42	3
	5n4w	3.9	2017	Kd	8.0	nM	160	ITC Kd=10nM at 298K, 42nM at 303K	5
	5uzu	2.4	2017	Kd	8.0	nM	578	SPR Kd=10nM, AlphaScreen Kd=2nM	4
	5vt9	1.85	2017	Kd	8.0	nM	37		4
	5ky4	1.47	2017	Kd	5.0	uM	40	[Nonstandard assay: 500 uM GDP]	2
	5lhn	2.55	2017	Kd	7.950781977329818	nM	152	[Nonstandard assay: Temp 37] muPA:Nb7	2
	5sy8	1.62	2017	Kd	10.950781977329818	pM	163	mutant 1	3
	5mjy	2.25	2017	Kd	4.94692155651658	uM	22	+/-0.3, SARA	6
	5w1t	4.5	2017	Kd	6.950781977329818	nM	151		14
	5vkl	2.2	2017	Kd	6.94692155651658	nM	23	[Different ligand in assay: ligand in assay is RPB1 (1468-1500) pS1493 peptide]	2
	5nus	2.2	2017	Kd	7.958607314841775	nM	113		2
	5un7	2.1	2017	Kd	6.920818753952375	nM	86		2
	5b3h	2.7	2017	Kd	6.907279355315901	nM	72		6
	5h7y	2.2	2017	Kd	6.903089986991944	nM	27		2
	6b3s	2.8	2017	Kd	7.920818753952375	nM	222		20
	5xfs	2.9	2017	Kd	6.8786700020639095	nM	308	MST assay	3
	5vwx	2.49	2017	Kd	7.826813731587726	nM	23	Bak core/latch dimer: Bim-h0-h3Glt	4
	5nvm	2.0	2017	Kd	7.853871964321762	nM	42		4
	5hyc	2.4	2017	Kd	4.818156412055227	uM	35	[Different ligand in assay: ITC Kd for MoDyn1I2(122-143) peptide] ITC Kd for MoDyn1I2(122-143) peptide	3
	5uws	2.4	2017	Kd	5.823908740944319	nM	22	protein2 is X11L2 NES Peptide.	4
	5osh	4.3	2017	Kd	6.82102305270683	nM	299		12
	5v5h	1.5	2017	Kd	6.801342913045577	nM	105	assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.2	2
	5tfw	2.17	2017	Kd	10.785156151952302	pM	163	mutant 2	3
	5f5o	2.2	2017	Kd	6.790484985457369	nM	29		6
	5o2t	2.19	2017	Kd	6.777283528852417	nM	187	GTPgammaS forms	2
	5nqf	1.9	2017	Kd	6.772113295386326	nM	39		2
	5tzq	1.65	2017	Kd	7.795880017344075	nM	26		4
	6b08	2.2	2017	Kd	7.795880017344075	nM	183	biolayer interferometry	3
	5ngv	2.0	2017	Kd	10.795880017344075	pM	121		3
	5t5w	2.85	2017	Kd	4.795880017344075	uM	218		3
	5nan	3.3	2017	Kd	7.756961951313706	nM	311		7
	5wvo	2.0	2017	Kd	7.749579997691106	nM	250		4
	6amb	2.5	2017	Kd	4.749579997691106	uM	99	AF6-RAS	2
	6b0s	1.95	2017	Kd	6.749579997691106	nM	82	biolayer interferometry assay	3
	5vpl	1.9	2017	Kd	7.769551078621726	nM	255	Entry 5VPL supersedes 3RVV	3
	5uq3	3.6	2017	Kd	6.7447274948966935	nM	201		3
	5ona	2.7	2017	Kd	6.73754891026957	nM	24		6
	5tl7	2.44	2017	Kd	2.728158393463501	uM	79	ligand is C-terminal domain of mouse ISG15	4
	5mfc	2.4	2017	Kd	7.7447274948966935	nM	257		4
	5un5	2.99	2017	Kd	7.7447274948966935	nM	123		4
	5vpg	1.95	2017	Kd	7.721246399047171	nM	255	5VPG supersedes 3RVW	3
	5wko	3.49	2017	Kd	9.0	nM	331	biolayer interferometry (BLI), Kd is 1-10nM, marked as +++ level	24
	5hu3	1.89	2017	Kd	6.0	uM	54	[Nonstandard assay: MG2+, ADP] Kd=1+/-0.1uM	2
	5mv9	2.6	2017	Kd	6.0	uM	130	Myo7a MF2	2
	5w6g	2.79	2017	Kd	5.673664139071248	uM	230	measured by BLI assay	5
	5me5	1.9	2017	Kd	5.667561540084395	uM	90	MBP pull-down assay	2
	5gwp	2.58	2017	Kd	8.67778070526608	nM	175		4
	5gvi	1.87	2017	Kd	5.657577319177793	uM	76	[Different protein in assay: bioassay use catalytically inactive zUSP30 mutant (C73A)] bioassay use catalytically inactive zUSP30 mutant (C73A)	3
	5x4l	2.4	2017	Kd	5.6307841425898575	uM	83		4
	5swk	1.92	2017	Kd	5.590066876668706	uM	153	measured by biolayer interferometry	4
	5vx2	1.85	2017	Kd	8.602059991327963	nM	26	Mcl-1/Bim-h3Pc-RT	4
	6bit	2.19	2017	Kd	8.585026652029182	nM	117	SPR Kd for prevalent Allele 1 and 2	6
	5mn2	2.35	2017	Kd	5.585026652029182	uM	101		4
	5m36	2.45	2017	Kd	5.560667306169737	uM	38	[Nonstandard assay: 250 uM CLR01] +/-0.57, Cdc25CpS216	4
	5h07	2.59	2017	Kd	5.549750891680639	uM	91		3
	5tzt	2.89	2017	Kd	8.542118103266008	nM	129		6
	5wb8	3.0	2017	Kd	5.552841968657781	uM	61		10
	6b6u	1.35	2017	Kd	4.696803942579511	uM	525	monomer/dimer equilibrium;+/- 1.3	2
	5uwq	2.28	2017	Kd	4.698970004336019	nM	22	protein2 is CDC7 NES Peptide.	4
	5ml9	2.35	2017	Kd	6.663540266151471	nM	115		2
	5v5v	4.11	2017	Kd	7.6777807052660805	nM	230		12
	5vx0	1.6	2017	Kd	4.6777807052660805	uM	26	Bim-h3Glg;+/-3	4
	5mtn	2.85	2017	Kd	7.628932137728263	nM	95	+/-7.6, Mb(Lck_1)/Lck SH2	2
	5toj	3.3	2017	Kd	7.638272163982407	nM	131	KD of F-VHH-4 for monomeric prefusion F was 23nM, while for tri-meric prefusion F is < 18pM	6
	5odw	2.8	2017	Kd	9.619788758288394	pM	217		4
	5y11	2.1	2017	Kd	7.586700235918748	nM	321		5
	5u4y	2.5	2017	Kd	7.6020599913279625	nM	55	Kd=25+/-2nM, complex is Fc/Z-domain	6
	5ua4	2.6	2017	Kd	7.585026652029182	nM	34		2
	5w8t	2.76	2017	Kd	4.567672207738396	uM	322		4
	5wux	2.9	2017	Kd	10.562249437179613	pM	157		9
	5tte	3.5	2017	Kd	6.565431095965801	nM	167		3
	5u52	1.94	2017	Kd	7.568636235841013	nM	34	Kd=27+/-1.4nM, complex is Fc/Z34C	6
	5t6l	2.1	2017	Kd	10.54515513999149	pM	163	mature wild-type	6
	5y4r	2.3	2017	Kd	7.543633966870957	nM	294	CheR1/MapZ/c-di-GMP	4
	5j11	2.56	2017	Kd	7.5376020021010435	nM	240	bio-layer interferometry (BLI) assay	3
	5mak	2.5	2017	Kd	10.537602002101044	pM	298		4
	5ma5	1.85	2017	Kd	10.537602002101044	pM	302		4
	5knm	3.3	2017	Kd	5.698970004336019	uM	267	biolayer interferometry (BLI) assay	4
	5mk0	1.77	2017	Kd	5.508638306165727	uM	22	+/-0.1, Endofin	4
	5w3x	2.0	2017	Kd	5.4723700991286615	uM	80	[Different protein in assay: protein in binding assay is PopP2 C321A] assay in presence of IP6, AcCoA	4
	5oob	2.79	2017	Kd	5.481486060122113	uM	21	+/-1.1, NELF-E	11
	5imm	1.2	2017	Kd	8.455931955649724	nM	127	crystal form 1 with lower resolution	2
	5ohp	2.8	2017	Kd	5.455931955649724	uM	76		3
	5l21	1.68	2017	Kd	8.431798275933005	nM	119	HCA1-ciA-C2 (PDB: 5L21)	2
	6b0a	2.5	2017	Kd	8.431798275933005	nM	183	biolayer interferometry	3
	5v52	3.1	2017	Kd	5.431798275933005	uM	140		4
	5x0w	3.0	2017	Kd	5.431798275933005	uM	108		8
	5my6	2.25	2017	Kd	8.399027104313252	nM	115		3
	5o2s	3.22	2017	Kd	8.4089353929735	nM	178	GDP forms	8
	5o4e	2.15	2017	Kd	8.4089353929735	nM	96		10
	5uwo	2.35	2017	Kd	5.522878745280337	nM	20	protein2 is FMRP-1b NES Peptide.	4
	5ma6	2.3	2017	Kd	9.518557371497694	pM	161		2
	5gwo	2.82	2017	Kd	7.522878745280337	nM	175	[Nonstandard assay: PH=8]	4
	5tzp	1.35	2017	Kd	7.522878745280337	nM	25		2
	6b0g	1.9	2017	Kd	7.508638306165727	nM	183	biolayer interferometry	3
	5mtj	1.95	2017	Kd	6.471083299722345	nM	98	Mb(Yes_1)/Yes SH2;determined by the yeast binding assay;	2
	5oc7	1.65	2017	Kd	7.481486060122112	nM	92	+/-8 PH/Mb(Bcr-PH_4)	4
	6azp	2.29	2017	Kd	7.454692883534176	nM	60		3
	5v69	2.55	2017	Kd	7.444905551421681	nM	104	assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.4	2
	5wos	2.45	2017	Kd	6.452225294612178	nM	26		2
	5ma3	1.7	2017	Kd	10.42021640338319	pM	302		2
	5jds	1.7	2017	Kd	8.522878745280337	nM	124	assay by differential scanning calorimetry (DSC)	2
	5y1z	2.68	2017	Kd	5.366531544420414	uM	137		4
	5xjg	2.4	2017	Kd	5.3448615651886175	uM	93	Vac8p-Nvj1p	4
	6b0e	3.3	2017	Kd	7.3872161432802645	nM	183	biolayer interferometry	3
	5wuj	2.3	2017	Kd	6.374687549038326	nM	105		2
	5mu3	2.1	2017	Kd	7.366531544420414	nM	67		6
	5nnp	2.6	2017	Kd	7.328827157284917	nM	195	ligand protein is HypK-THB	8
	5uwu	2.24	2017	Kd	5.337242168318426	nM	20	protein2 is SMAD4 NES Peptide.	4
	5v5i	2.2	2017	Kd	6.334419008982047	nM	105	assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.1	4
	5gtb	2.87	2017	Kd	4.337242168318426	uM	24	[Different protein in assay: protein in assay is ARC6 (674-801)] [Different ligand in assay: ligand protein in assay is PDV2 (282-307)] ITC Kd data is for ARC6 (674-801) and PDV2 (282-307)	2
	5ohm	3.8	2017	Kd	10.327902142064282	pM	116	(MST) binding assay, in paper code 5ohm is K6 Affimer: K6 diUb, but in RCSB is K33 Affimer: K33 diUb	12
	5vko	1.8	2017	Kd	8.397940008672037	nM	34	[Different ligand in assay: ]	2
	5tzn	2.6	2017	Kd	5.236572006437063	uM	190		10
	5ky9	1.83	2017	Kd	5.229147988357856	uM	40	[Nonstandard assay: 500 uM GDP]	2
	5ufe	2.3	2017	Kd	7.298432014944073	nM	61	Wild-type K-Ras(GNP)/R11.1.6 complex	2
	5nqg	2.15	2017	Kd	7.301029995663981	nM	39		2
	5ma4	1.4	2017	Kd	10.2839966563652	pM	298		2
	5v6a	2.7	2017	Kd	7.274088367704952	nM	104	assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.2	2
	5nvn	1.9	2017	Kd	7.259637310505756	nM	38		4
	5tl6	2.62	2017	Kd	4.239577516576788	uM	79	ligand is C-terminal domain of human ISG15	4
	5oaq	1.95	2017	Kd	7.236572006437063	nM	41	[Different protein in assay: Non-Acyl-TEAD4] [Different ligand in assay: hYAP51-99] +/-3	2
	5ufq	2.2	2017	Kd	8.193820026016112	nM	61	K-RasG12D(GNP)/R11.1.6 complex	4
	5ky0	1.53	2017	Kd	5.187086643357144	uM	40	[Nonstandard assay: 500 uM GDP]	2
	6azz	2.4	2017	Kd	8.173925197299173	nM	183	biolayer interferometry	6
	5o03	2.19	2017	Kd	7.221848749616356	nM	135		4
	5j13	2.3	2017	Kd	10.221848749616356	pM	263	bio-layer interferometry (BLI) assay	3
	5vcb	4.1	2017	Kd	7.2076083105017466	nM	79	[Multiple sites: Kd1: 62+/-13nM; Kd2: 1.2+/=0.2uM] Kd=62+/-13nM, complex is Holo-ACPP:ACPS	30
	5twa	1.85	2017	Kd	7.180456064458132	nM	25	Kd=66+/-30nM, protein2 is LB-Bak.	4
	5uwh	2.26	2017	Kd	6.173925197299173	nM	22	protein2 is Paxillin NES Peptide.	4
	5h9b	2.25	2017	Kd	6.171275672861209	nM	54	[Nonstandard assay: MG2+, AMPPNP] Kd(dEAG-long)=674.1+/-82.4nM	2
	5w0k	3.1	2017	Kd	7.162411561764489	nM	217		10
	5mtm	2.41	2017	Kd	8.154901959985743	nM	95	+/-3.9, Mb(Lck_3)/Lck SH2	2
	5xsq	2.6	2017	Kd	8.133712660915805	nM	28		6
	5lpu	2.1	2017	Kd	5.107905397309519	uM	104		4
	5m5e	2.3	2017	Kd	10.154901959985743	pM	259	KDkin,	7
	5vxz	2.3	2017	Kd	12.142667503568731	fM	102	On-rates were directly measured using the KinExA	6
	5o0w	2.57	2017	Kd	10.131767131577535	pM	143		8
	5tez	1.7	2017	Kd	4.119186407719209	uM	243	Kd=76+/-4uM, complex is M1-HLA-A2/TCR F50	5
	6b12	1.71	2017	Kd	8.09151498112135	nM	153		4
	5ffo	3.49	2017	Kd	8.086186147616283	nM	363		22
	5xco	1.25	2017	Kd	8.050609993355087	nM	21	KRas(G12D) mutant WITH GDP and KRpep-2d	2
	5imk	1.23	2017	Kd	6.070581074285707	nM	220	crystal form 1 with lower resolution	2
	5vz4	2.2	2017	Kd	8.096910013008056	nM	245		2
	5jw7	2.85	2017	Kd	5.041436116778033	uM	93	[Different protein in assay: protein in bioassay is SopA (163-782)] protein in bioassay is SopA (163-782)	2
	5jjd	2.4	2017	Kd	5.036212172654444	uM	106		2
	5vag	1.9	2017	Kd	8.0268721464003	nM	247	BLI assay, pH-sensitive binding to HA; at PH 7.4, Kd=9.4nM; at PH=5.0, Kd=0.8nM	3
	5omn	2.68	2017	Kd	8.022276394711152	nM	119		2
	5xxy	2.9	2017	Kd	8.001740661576301	nM	124	Assay by forteBio Octet K2 2-channel system, described in ref. 19	3
	5nh3	2.35	2017	Kd	9.011887159731648	pM	121		7
	5v5g	2.1	2017	Kd	8.045757490560675	nM	105	assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.4	4
	5xku	1.78	2017	Kd	10.7594507517174	pM	233		3
	5ivx	2.1	2017	Kd	6.267606240177032	uM	277	ligand is P18-I10/H2-Dd, not P18-I10 peptide	5
	5o74	2.5	2017	Kd	5.0	uM	180	10~30 uM, in present of GDP	12
	5ezo	3.63	2017	Kd	9.0	nM	222	RCSB made a mistake, mark AL chain as antibody	4
	5x60	2.69	2017	Ki	7.522878745280337	uM	20	ligand is peptide 9	3
	5h6q	2.53	2017	Ki	7.221848749616356	uM	21	ligand is peptide 11	3
	5ovw	2.65	2017	Ki	9.0268721464003	nM	159	competitive binding equilibria	12
	5l6n	1.63	2017	Ki	8.515700160653214	nM	35		3
	5uul	1.33	2017	Ki	8.318758762624412	nM	25		2
	5gim	2.09	2017	Ki	9.263603497723357	pM	20		4
	5h6r	2.6	2017	Ki	5.200659450546418	uM	21	ligand is peptide 13	3
	6dnq	2.35	2018	Kd	7.376750709602099	uM	88	KIX:c-Myb:HBZ(3-77) complex	5
	5w08	2.6	2018	Kd	7.3979400086720375	uM	244	ligand is K03.12 Fab, measured by biolayer interferometry	28
	6c48	2.32	2018	Kd	7.3979400086720375	uM	32	Kd for ITC assay is 0.04uM, Kd for FP assay is 0.53nM	6
	6dmx	2.8	2018	Kd	6.958607314841775	uM	88	KIX:c-Myb:HBZ(3-56) complex	10
	6h6y	1.58	2018	Kd	9.787812395596042	nM	132		8
	5otj	2.35	2018	Kd	9.769551078621726	nM	110		6
	5g15	2.06	2018	Kd	6.769551078621726	uM	96	[Nonstandard assay: with AMPPCP] Kd(Mb1)=0.17+/-0.02uM	2
	5vyf	2.9	2018	Kd	9.7281583934635	nM	199	SPR data	6
	6ehg	2.65	2018	Kd	9.619788758288394	nM	130		4
	5yir	2.75	2018	Kd	9.568636235841012	nM	27		6
	6mkz	2.65	2018	Kd	9.698970004336019	nM	139		6
	6ath	1.82	2018	Kd	9.481486060122112	nM	68		3
	6hul	2.55	2018	Kd	6.522878745280337	uM	425		2
	6ddm	1.3	2018	Kd	9.3767507096021	nM	94		3
	6aqr	2.1	2018	Kd	6.366531544420414	uM	76		5
	6bli	2.12	2018	Kd	9.2839966563652	nM	45	ligand is 45-mer G peptide	12
	5wpa	2.29	2018	Kd	6.259637310505756	uM	261	sedimentation equilibrium experiments, KD for heterodimer	2
	5xj4	2.3	2018	Kd	9.175874166083451	nM	121		3
	6b3m	3.92	2018	Kd	9.162411561764488	nM	221	biolayer interferometry assay	42
	6a7v	1.67	2018	Kd	9.221848749616356	nM	62		8
	6ejg	2.82	2018	Kd	9.09151498112135	nM	251		4
	6hpr	1.7	2018	Kd	6.080921907623926	uM	147		4
	6bck	2.7	2018	Kd	9.065501548756432	nM	228		3
	6ejm	2.15	2018	Kd	9.065501548756432	nM	249		4
	6bkc	2.6	2018	Kd	9.096910013008056	nM	189	KD values were determined by biolayer interferometry	3
	6h9n	2.6	2018	Kd	6.096910013008056	uM	103		2
	6ddr	1.9	2018	Kd	9.0268721464003	nM	94		3
	6fg8	1.25	2018	Kd	6.008773924307505	uM	241		8
	5y9j	2.05	2018	Kd	9.002176919254275	nM	152		3
	5z78	1.76	2018	Kd	6.045757490560675	uM	123		3
	6a67	2.33	2018	Kd	8.998266287190999	nM	230		6
	6cql	2.4	2018	Kd	5.935542010773082	uM	190	Kdeq values previously published (10)	5
	5bk1	2.15	2018	Kd	8.958607314841775	nM	236	in the absence of maltose	6
	5o90	2.49	2018	Kd	5.958607314841775	uM	29		2
	6co2	2.49	2018	Kd	5.920818753952375	uM	123		4
	5nqw	3.4	2018	Kd	8.853871964321762	nM	134		6
	6dcn	2.44	2018	Kd	5.853871964321762	uM	26	MST Kd=1.4uM; SPR IC50=1.2uM	4
	6bkb	2.8	2018	Kd	8.823908740944319	nM	189	KD values were determined by biolayer interferometry	4
	6f9s	3.03	2018	Kd	5.790484985457369	uM	90		2
	5xda	3.29	2018	Kd	5.795880017344075	uM	84		12
	6fv0	2.29	2018	Kd	5.764471553092451	uM	121		2
	5nzz	2.6	2018	Kd	5.769551078621726	uM	360	[Different protein in assay: TAB1 in binding assay is pSer423]	8
	6brs	2.3	2018	Kd	5.769551078621726	uM	104	crystal of Ethylmercury phosphate soaked dataset	4
	5yi8	2.0	2018	Kd	5.7447274948966935	uM	33		2
	6b05	1.9	2018	Kd	5.721246399047171	uM	104		3
	6arq	2.88	2018	Kd	4.991399828238083	uM	317		5
	6cqr	3.04	2018	Kd	4.976336081802207	uM	190	Kdeq values previously published (10)	10
	5w9a	2.74	2018	Kd	3.987162775294828	uM	114	binding by SV-AUC	4
	5oen	2.92	2018	Kd	8.0	nM	175	[Different protein in assay: ITC Kd is for STAT2 133-679] ITC Kd is for STAT2 133-679	2
	6bkd	3.25	2018	Kd	6.94692155651658	nM	189	KD values were determined by biolayer interferometry	4
	5xqz	2.1	2018	Kd	4.910094888560602	uM	68		4
	6ff3	2.57	2018	Kd	7.866461091629782	nM	70		2
	6e3j	1.48	2018	Kd	7.854492828590337	nM	23	assay by yeast cell surface display	2
	6bxc	2.5	2018	Kd	7.886056647693163	nM	178		5
	6mlk	2.45	2018	Kd	7.886056647693163	nM	251	ELISA Kd=13nM, BLI Kd = 16 nM	3
	6cqn	2.5	2018	Kd	4.843753809602656	uM	190	Kdeq values previously published (10)	5
	5xwt	4.18	2018	Kd	4.841637507904751	uM	367		10
	6asr	2.36	2018	Kd	4.826813731587726	uM	51		3
	5uv8	2.7	2018	Kd	6.852014679316195	nM	122	measured in saturation binding assays using radioiodinated cytokine	7
	6bx5	3.0	2018	Kd	7.853871964321762	nM	97		4
	6bb4	2.1	2018	Kd	7.8124792791635365	nM	23		9
	5nt1	2.82	2018	Kd	4.79317412396815	uM	154	biolayer interferometry (BLI) assay	6
	5w1m	3.91	2018	Kd	7.787812395596042	nM	152		15
	6ii4	3.3	2018	Kd	7.779891911959945	nM	225		8
	6fq0	2.5	2018	Kd	6.795880017344075	nM	152		4
	5xmh	2.8	2018	Kd	3.7958800173440754	uM	208		8
	6aaf	2.2	2018	Kd	6.79317412396815	nM	31		2
	6aod	1.8	2018	Kd	9.790484985457368	pM	245		3
	5uwc	2.4	2018	Kd	7.749579997691106	nM	122	measured in saturation binding assays using radioiodinated cytokine	3
	5nl1	2.5	2018	Kd	6.7594507517174005	nM	46		12
	6flc	2.0	2018	Kd	6.752763450493236	nM	231		6
	6bf4	2.38	2018	Kd	6.749579997691106	nM	229	Kd for fully glycosylated HXB2 gp120, while no binding for deglycosylated HXB2 gp120	14
	5xj3	3.2	2018	Kd	7.739928612014925	nM	127		12
	6e2p	2.83	2018	Kd	4.728158393463501	uM	75	Biolayer Interferometry assay	4
	5yc5	2.71	2018	Kd	6.7447274948966935	nM	182	SPR Kd for peak 1	5
	5utz	2.75	2018	Kd	8.726073219899474	pM	133	further, Ab can inhibit IL-2 binding to IL-2R alpha or beta	12
	5yoy	2.73	2018	Kd	10.744727494896694	pM	119	measured using soluble form of TNFa and golimumab IgG	18
	6ii9	3.5	2018	Kd	7.712198270069774	nM	221		12
	5nmv	1.65	2018	Kd	9.0	nM	86		3
	6flb	2.2	2018	Kd	9.0	nM	227		3
	6a3w	2.0	2018	Kd	8.638272163982407	nM	163		12
	5ock	1.6	2018	Kd	5.638272163982407	uM	21	Human ACPA E4 Fab L/H, 217, 221	3
	6mft	2.32	2018	Kd	5.638272163982407	uM	347	BLI binding data	10
	5xln	1.9	2018	Kd	5.605548319173784	uM	190		2
	5u8q	3.27	2018	Kd	5.619788758288394	uM	70	Kd = 2.4 +/- 0.5 uM, IGF-I for IGF-1Rdeltabeta pre-complexed with Fv 24-60	7
	6isc	2.2	2018	Kd	5.619788758288394	uM	118		2
	5vu0	2.26	2018	Kd	8.602059991327963	nM	172		5
	5ywp	4.6	2018	Kd	8.536107011014092	nM	218		10
	6i3f	2.55	2018	Kd	7.692503962086787	nM	340	Bio-layer interferometry assay	4
	6fc3	1.75	2018	Kd	7.698970004336019	nM	52		2
	6eyo	3.7	2018	Kd	10.698970004336019	pM	227		8
	6b8n	2.2	2018	Kd	6.6777807052660805	nM	149	1 uM CaCl2 soak	8
	6bx4	2.55	2018	Kd	6.6777807052660805	nM	96		4
	6c74	1.36	2018	Kd	3.6595558851598815	uM	113		1
	5mr4	2.4	2018	Kd	6.657577319177793	nM	458	ligand is GFRa2 D1-D3	4
	6mhr	2.8	2018	Kd	7.657577319177793	nM	235		8
	6h0e	1.95	2018	Kd	6.619788758288394	nM	24	assay by octet biolayer interferometry	12
	6gbu	3.44	2018	Kd	6.605548319173784	nM	65		8
	6imf	2.3	2018	Kd	7.619788758288394	nM	109	use assay method as ref. 14	2
	6byh	2.61	2018	Kd	7.6020599913279625	nM	87		9
	5xiu	1.8	2018	Kd	4.6020599913279625	uM	76	[Different ligand in assay: ]	2
	5ydr	2.0	2018	Kd	4.578396073130169	uM	250		3
	6cmg	2.7	2018	Kd	7.562249437179612	nM	235	assay by BioLayer Interferometry	7
	5xod	1.85	2018	Kd	7.55129368009492	nM	31		2
	5xnp	3.73	2018	Kd	6.550059011226662	nM	291		4
	5xis	1.78	2018	Kd	3.54821356447571	uM	77	[Different ligand in assay: assay use RNF168 UDM1-UM1, not full UDM1] crystal form I	6
	6d01	3.2	2018	Kd	6.543633966870957	nM	20		10
	6fub	1.3	2018	Kd	7.5376020021010435	nM	93	Pikm-HMA and AVR-PikE	2
	6cwt	3.15	2018	Kd	11.698970004336019	pM	149		6
	6fuz	2.7	2018	Kd	5.496209316942819	uM	121	ITC Kd for His6-KLC1 TPR and JIP1 C-term	2
	6e3i	1.48	2018	Kd	8.493494967595128	nM	23	assay by yeast cell surface display	2
	6e62	2.7	2018	Kd	8.494850021680094	nM	222	BLI assay	6
	6ce9	4.3	2018	Kd	8.455931955649724	nM	30	Insulin Receptor ectodomain in complex with two insulin molecules	18
	5oy9	3.6	2018	Kd	5.425968732272281	uM	37		3
	5yip	1.85	2018	Kd	8.431798275933005	nM	26		2
	6e63	2.6	2018	Kd	8.431798275933005	nM	222	BLI assay	6
	6bmt	2.4	2018	Kd	6.508638306165727	nM	105		2
	6fc2	1.92	2018	Kd	5.468521082957745	nM	64		4
	5mzv	2.8	2018	Kd	7.443697499232712	nM	328		9
	5nx3	2.3	2018	Kd	10.443697499232712	pM	25		4
	5kof	2.4	2018	Kd	4.424812155072339	uM	78	Kd=37.6+/-6.6uM	4
	6ii8	3.32	2018	Kd	6.413412695328245	nM	223		12
	5ywr	1.47	2018	Kd	7.4089353929735005	nM	89		2
	6fp7	1.58	2018	Kd	8.522878745280337	nM	164	mTFP1/DARPin 1238_E11 complex in space group P6522	2
	6blh	2.0	2018	Kd	8.387216143280265	nM	45	ligand is 45-mer G peptide	3
	5yis	2.2	2018	Kd	8.3767507096021	nM	27		4
	6bw9	1.6	2018	Kd	8.357535479757878	nM	459	MST assay; code 6bvv and 6bwa in other crystal form	2
	6h6z	2.09	2018	Kd	8.339134521996131	nM	141		4
	6fu9	1.2	2018	Kd	8.327902142064282	nM	93	Pikm-HMA and AVR-PikD	4
	6avg	2.6	2018	Kd	4.391473966422806	uM	362		10
	6f3z	2.0	2018	Kd	6.392544976785332	nM	206		4
	6bxa	2.3	2018	Kd	7.3979400086720375	nM	209		7
	6gbg	2.8	2018	Kd	6.379863945026242	nM	115		2
	6c16	3.27	2018	Kd	6.375717904164332	nM	86		6
	6h71	2.31	2018	Kd	7.36251027048749	nM	136		4
	5w42	3.57	2018	Kd	7.3535962737769305	nM	236	Kd values were determined by bio-layer interferometry	10
	6fgo	2.5	2018	Kd	6.356547323513812	nM	69	(KD) of ZCa to Fc of human IgG1 in the presence of calcium is 440 nM as estimated by the SPR analysis, which is in the	12
	6fhp	1.7	2018	Kd	7.318758762624412	nM	62		4
	6h06	2.63	2018	Kd	5.251811972993799	uM	26	assay by octet biolayer interferometry	12
	6ddv	2.05	2018	Kd	8.23807216157947	nM	94		3
	5xwd	2.89	2018	Kd	8.229147988357855	nM	132		4
	6g10	1.35	2018	Kd	8.229147988357855	nM	93	Pikp1-HMA and AVR-PikD	3
	5nx1	1.85	2018	Kd	8.276544327964814	pM	25		4
	6a0z	2.33	2018	Kd	7.275724130399211	nM	224		3
	5zxv	4.48	2018	Kd	7.239577516576788	nM	215		6
	6aw2	2.68	2018	Kd	7.2441251443275085	nM	439	[Nonstandard assay: PH=4.5]	2
	6ewb	2.78	2018	Kd	7.229147988357855	nM	216		12
	6fgb	2.9	2018	Kd	10.229147988357855	pM	228		4
	5n48	1.6	2018	Kd	8.301029995663981	nM	106	data from previous biochemical analysis	4
	5ywo	4.7	2018	Kd	8.185086818724926	nM	215		10
	6cqq	2.8	2018	Kd	5.161150909262744	uM	190	Kdeq values previously published (10)	10
	6mgp	2.13	2018	Kd	6.167491087293763	nM	144		9
	6gbh	2.59	2018	Kd	7.161150909262744	nM	115		4
	6mi2	2.72	2018	Kd	7.161150909262744	nM	230		7
	5oyl	2.25	2018	Kd	5.1249387366083	uM	46		2
	5yr0	1.9	2018	Kd	5.119186407719209	uM	48		2
	6and	1.75	2018	Kd	8.10790539730952	nM	223	Biolayer interferometry (BLI) experiments	3
	6ani	2.4	2018	Kd	8.10790539730952	nM	223	Biolayer interferometry (BLI) experiments	6
	6fud	1.3	2018	Kd	7.136677139879544	nM	93	Pikm-HMA and AVR-PikA	2
	6eg1	2.95	2018	Kd	4.115771230367396	uM	314		15
	6eg0	2.9	2018	Kd	4.1095789811990855	uM	314		6
	5n47	3.0	2018	Kd	8.154901959985743	nM	284	data from previous biochemical analysis	6
	6cbp	2.17	2018	Kd	5.154901959985743	uM	30	BLI measurements	6
	5mr5	2.0	2018	Kd	7.096910013008056	nM	216	ligand is GFRa2 D2-D3	4
	5n7w	1.96	2018	Kd	7.096910013008056	nM	155	assay by Octet RED system (ForteBio)	6
	6a3v	3.39	2018	Kd	7.0675262353228465	nM	163		24
	5wi9	2.7	2018	Kd	10.065501548756432	pM	225		6
	5vmo	1.7	2018	Kd	6.052076380168273	nM	26		2
	5xoc	2.4	2018	Kd	5.096910013008056	uM	141		2
	6d13	3.06	2018	Kd	8.031517051446064	nM	177	determined by bio-layer interferometry (BLI), RppH in surface and DapF in solution	2
	6fe4	3.0	2018	Kd	8.017728766960431	nM	119		10
	6bva	2.66	2018	Kd	7.040958607678906	nM	86		6
	6ana	1.7	2018	Kd	8.045757490560675	nM	219	Biolayer interferometry (BLI) experiments	4
	6avf	2.03	2018	Kd	3.6989700043360187	uM	99		5
	6ch3	2.68	2018	Kd	5.0	uM	198		2
	6ch2	2.7	2018	Kd	4.5376020021010435	uM	179		6
	6eyd	4.2	2018	Kd	7.045757490560675	nM	466	ITC data not shown	6
	5mrv	1.85	2018	Ki	5.42021640338319	uM	53	Michaelis-Menten kinetic analysis, NvCI displays a typical competitive inhibition behavior	3
	6gfi	2.3	2018	Ki	9.306273051076353	pM	81	competitive inhibition assay	4
	6mlm	3.5	2019	Kd	10.0	nM	219		12
	6mam	4.1	2019	Kd	12.0	pM	234		15
	6sak	2.0	2019	Kd	7.508638306165727	uM	96	C129A mutation do not change too much affinity	4
	6f0g	2.3	2019	Kd	7.259637310505756	uM	26	Kd(ip3)=0.055+/-0.02uM	4
	6cwg	2.6	2019	Kd	9.991399828238082	nM	137		4
	6nmv	2.61	2019	Kd	9.910094888560602	nM	127		3
	6jb8	1.65	2019	Kd	9.88941028970075	nM	129		2
	6nmt	1.83	2019	Kd	9.790484985457368	nM	127		3
	6j4s	2.8	2019	Kd	6.795880017344075	uM	66	V2-SVBP complex	2
	6nr8	7.8	2019	Kd	6.795880017344075	uM	517	hTRiC-hPFD Class6	22
	6q69	2.75	2019	Kd	6.769551078621726	uM	59		4
	6nmr	2.42	2019	Kd	9.73754891026957	nM	127		12
	6f0f	2.0	2019	Kd	6.7447274948966935	uM	29	Kd(ip2_s)=0.18+/-0.04uM	2
	6mvl	1.61	2019	Kd	6.7447274948966935	uM	229	pH-selective antibody, Kd at PH=6.7	3
	6ird	2.81	2019	Kd	6.6777807052660805	uM	216	PLCb4 CC8KA-PBM and INADL PDZ89 complex	2
	6dld	3.3	2019	Kd	9.619788758288394	nM	304	affinity for IgLON5-fc/NEGR1-AP heterodimer	5
	6p7s	3.49	2019	Kd	9.619788758288394	nM	429		8
	6n85	2.5	2019	Kd	6.619788758288394	uM	415	[Different ligand in assay: Kd is for MBP-tagged transducin-alpha residues 333-350] Kd is for MBP-tagged transducin-alpha residues 333-350	3
	6o1f	2.15	2019	Kd	9.602059991327963	nM	227		4
	5zqv	2.95	2019	Kd	6.585026652029182	uM	99	Kd(ITC)=0.26+/-0.03uM, PP1Calpha(6-299)	8
	6jcs	3.18	2019	Kd	6.542118103266008	uM	97		2
	6ndz	2.26	2019	Kd	9.698970004336019	nM	200		6
	6jbt	2.47	2019	Kd	9.489454989793387	nM	223		5
	6u2h	2.5	2019	Kd	9.481486060122112	nM	232	average affinity of two-state model	4
	6qmq	2.5	2019	Kd	6.431798275933005	uM	21		3
	6j6y	2.15	2019	Kd	9.522878745280337	nM	249		6
	6j7w	2.6	2019	Kd	9.522878745280337	nM	118		4
	6nmu	2.55	2019	Kd	9.370590400897282	nM	127	value 4,26 E-10 in the table should be 4.26 E-10	6
	6n5w	2.15	2019	Kd	6.356547323513813	uM	149	Kd=0.44uM for A domain of KCNQ2-4; Kd=0.24uM for B domain	3
	6nms	2.11	2019	Kd	9.339134521996131	nM	127		6
	6q0o	3.0	2019	Kd	6.3979400086720375	uM	241		4
	6p7y	2.84	2019	Kd	9.2518119729938	nM	430		15
	6kbm	2.9	2019	Kd	6.221848749616356	uM	506		2
	6qj4	5.8	2019	Kd	6.200659450546418	uM	197		5
	5z2w	3.0	2019	Kd	6.173925197299173	uM	35	bio-layer interferometry (BLI) experiment	2
	6j56	1.8	2019	Kd	6.173925197299173	uM	27		4
	6q18	2.55	2019	Kd	6.221848749616356	uM	243		3
	6r2g	1.9	2019	Kd	12.120330794367947	pM	36		2
	6qmp	2.0	2019	Kd	6.154901959985743	uM	31		3
	6k0y	1.7	2019	Kd	9.049635145623878	nM	143	glycosylated hPD-1 protein Kd=0.892nM, deglycosylated hPD-1 protein Kd=40.3nM	3
	6gho	1.79	2019	Kd	6.096910013008056	uM	298		2
	6fg1	2.03	2019	Kd	9.045757490560675	nM	234		4
	6gku	1.91	2019	Kd	9.045757490560675	nM	228		3
	6iu7	1.9	2019	Kd	9.045757490560675	nM	22	microtiter-plate binding assay	2
	6mud	2.69	2019	Kd	5.991399828238082	uM	140	[Different ligand in assay: bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)] bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)	2
	6jep	2.32	2019	Kd	8.97469413473523	nM	101	PH=7.5	6
	6qms	1.8	2019	Kd	5.966576244513051	uM	21		3
	6c83	2.55	2019	Kd	6.0	uM	93	[Nonstandard assay: with AMPPCP] Kd(Mb2)=1.0+/-0.06uM	4
	6qb6	2.24	2019	Kd	5.943095148663527	uM	230		3
	6plk	2.3	2019	Kd	8.939302159646388	nM	110		6
	6nha	2.38	2019	Kd	8.924453038607469	nM	434	Kd=1.19nM at pH = 7.4	4
	5xkj	3.48	2019	Kd	5.958607314841775	uM	52		6
	5zo2	3.29	2019	Kd	5.958607314841775	uM	147		4
	6og4	1.7	2019	Kd	8.88941028970075	nM	77		3
	6mnr	2.2	2019	Kd	8.920818753952375	nM	227		3
	5z7l	2.02	2019	Kd	5.920818753952375	uM	43	NDP52(10-126)/NAP1(33-75) complex	4
	6gum	1.79	2019	Kd	5.920818753952375	uM	180		2
	6in9	1.8	2019	Kd	5.920818753952375	uM	89		4
	6e4z	2.2	2019	Kd	8.886056647693163	nM	22		3
	6ne2	1.3	2019	Kd	8.886056647693163	nM	200		2
	5xjo	2.63	2019	Kd	5.886056647693163	uM	52		6
	6kbn	3.2	2019	Kd	5.835647144215563	uM	563		4
	6msl	3.1	2019	Kd	8.853871964321762	nM	32		12
	6ne1	3.01	2019	Kd	8.853871964321762	nM	192		2
	6j14	1.4	2019	Kd	8.812479279163536	nM	115	humanized GY-14 for PD-1 Kd=2.21nM, chimeric GY-14 for PD-1 Kd=1.54nM	3
	6ne4	1.65	2019	Kd	8.795880017344075	nM	200		2
	6uys	1.59	2019	Kd	5.795880017344075	uM	29	Kd = 1.6 +/- 0.1 uM	4
	6o39	1.8	2019	Kd	8.769551078621726	nM	123		3
	6moe	2.09	2019	Kd	8.723538195826755	nM	229		4
	6o3o	2.8	2019	Kd	5.7447274948966935	uM	317		8
	6q0h	2.75	2019	Kd	5.7447274948966935	uM	241		3
	6cxg	2.3	2019	Kd	8.721246399047171	nM	40	previously reported affinity data	8
	6m7l	2.65	2019	Kd	4.982966660701219	uM	404		2
	6ire	3.25	2019	Kd	7.97469413473523	nM	194	NORPA CC8KA-PBM and INAD PDZ45 complex; assay PH=7.8	2
	6mnq	1.8	2019	Kd	7.962573502059376	nM	221		3
	6fpg	1.8	2019	Kd	6.991825815993574	nM	175		8
	6h47	1.7	2019	Kd	8.0	nM	178	ForteBio Octet Red384 bioassay	2
	6i07	2.35	2019	Kd	8.0	nM	253		4
	6on9	2.0	2019	Kd	5.0	uM	118	ZIG-8-RIG-5 IG1-IG1 heterodimer, tetragonal form	3
	6cug	2.4	2019	Kd	4.950781977329818	uM	245	Kd(CD1b-PC-BC8B)=11.2+/-2.2uM	4
	6fg2	2.79	2019	Kd	10.958607314841775	pM	234		9
	6o8b	3.4	2019	Kd	4.958607314841775	uM	39		4
	6oor	2.45	2019	Kd	7.903089986991944	nM	234		4
	6h15	2.6	2019	Kd	7.892790030352131	nM	123		9
	6iwa	2.4	2019	Kd	6.899629454882437	nM	433		2
	6m9k	2.3	2019	Kd	4.920818753952375	uM	67		6
	6oro	3.9	2019	Kd	4.920818753952375	uM	254	Germline Kd=12uM, BLI assay	39
	6iw0	3.6	2019	Kd	7.8696662315049934	nM	145		3
	6mss	3.0	2019	Kd	4.835647144215563	uM	302		5
	6dc9	3.0	2019	Kd	7.817300096663957	nM	30		6
	6dg5	2.52	2019	Kd	7.79317412396815	nM	104		5
	6isu	1.87	2019	Kd	6.795880017344075	nM	76		3
	6mba	1.8	2019	Kd	7.769551078621726	nM	149		2
	6o07	2.7	2019	Kd	7.769551078621726	nM	854		3
	6iwd	1.8	2019	Kd	7.739928612014925	nM	55		2
	6ieb	2.41	2019	Kd	7.732828271596986	nM	316		6
	6j4o	2.3	2019	Kd	7.7447274948966935	nM	66		2
	6jhw	2.04	2019	Kd	7.7447274948966935	nM	139		4
	6phb	2.0	2019	Kd	7.716698771296451	nM	220		6
	6tzc	2.41	2019	Kd	5.702239488900866	nM	26		4
	6p50	2.9	2019	Kd	9.0	nM	225		3
	5z7g	2.3	2019	Kd	5.688246138944246	uM	43	TAX1BP1(1-121)/NAP1(33-75) complex	4
	6iua	1.7	2019	Kd	8.698970004336019	nM	22	microtiter-plate binding assay	2
	6gvk	1.55	2019	Kd	5.698970004336019	uM	30		2
	6uyu	1.66	2019	Kd	5.698970004336019	uM	29	Kd = 2.0 +/- 0.2 uM	4
	6qb3	1.9	2019	Kd	5.623423042943488	uM	255	ITC Kd=2.38uM, SPR Kd=17.1uM	2
	6cxl	3.59	2019	Kd	8.619788758288394	nM	40	previously reported affinity data; why glycopeptide 10F5M not listed in PDB	6
	6hhc	2.7	2019	Kd	8.619788758288394	nM	238		3
	6phd	3.1	2019	Kd	8.602059991327963	nM	231		3
	6fto	1.6	2019	Kd	8.585026652029182	nM	81		3
	6umt	1.99	2019	Kd	8.585026652029182	nM	123		2
	6h2y	2.65	2019	Kd	8.568636235841012	nM	224		3
	6k7o	3.0	2019	Kd	8.537602002101044	nM	228		12
	6d7g	2.75	2019	Kd	5.537602002101044	uM	258	biolayer interferometry (BLI) assay	3
	6jdj	2.6	2019	Kd	6.698970004336019	nM	78		3
	6r2s	3.04	2019	Kd	10.698970004336019	pM	300		3
	6dfs	3.1	2019	Kd	4.669586226650809	uM	183		4
	6dc8	1.8	2019	Kd	7.667561540084395	nM	31		3
	6j9l	1.78	2019	Kd	5.674689628288939	nM	47		3
	6nfj	3.19	2019	Kd	6.675717544702307	nM	50	sKLB:Nb30:FGF19CT ternary structure	6
	6nuc	1.9	2019	Kd	7.6777807052660805	nM	48		3
	6nuf	1.9	2019	Kd	7.6777807052660805	nM	48		3
	6k06	1.75	2019	Kd	6.6439741428068775	nM	433		2
	6ous	3.4	2019	Kd	10.657577319177793	pM	231	Pre-fusion F Protein Kd=22pM, Post-fusion F Protein Kd=1.35pM	30
	6a78	2.1	2019	Kd	6.621602099051862	nM	138		6
	6nrw	2.4	2019	Kd	4.638272163982407	uM	112	when DIP-eta IG1 is captured on SPR chip; Kd=4uM when non-dimerizing Dpr1 is captured on SPR chip	8
	6ilm	3.4	2019	Kd	6.616184634019569	nM	263	at PH 7.4	6
	6a6x	2.7	2019	Kd	7.58838029403677	nM	83		4
	6cxf	2.5	2019	Kd	6.598599459218456	nM	285	[Nonstandard assay: linking with alphaGSA[26,P5p]]	5
	6gjq	2.49	2019	Kd	7.6020599913279625	nM	147		8
	6im9	3.3	2019	Kd	7.6020599913279625	nM	122		2
	6j11	3.0	2019	Kd	7.6020599913279625	nM	132		24
	6gwc	2.6	2019	Kd	6.568636235841013	nM	217		3
	6pxh	2.3	2019	Kd	7.552841968657781	nM	447		16
	6oqq	2.1	2019	Kd	7.552841968657781	nM	147	[Different protein in assay: Calmodulin in binding assay is from human;] [Different ligand in assay: Kd for Legionella pneumophila SidJ D542A]	4
	6iea	2.0	2019	Kd	6.530177984021837	nM	316		3
	6jb2	1.5	2019	Kd	6.530177984021837	nM	129		2
	6pnp	1.94	2019	Kd	6.524038410807576	nM	168		2
	6oc3	2.85	2019	Kd	8.698970004336019	nM	227		6
	6nzu	3.2	2019	Kd	5.478861916295964	uM	132		10
	6idx	1.7	2019	Kd	5.473660722610156	uM	25		2
	6jjp	2.9	2019	Kd	8.449771646944907	nM	147		8
	6ov2	3.2	2019	Kd	8.446116973356126	nM	131		2
	6e4y	2.24	2019	Kd	5.42021640338319	uM	22		3
	6n6r	1.95	2019	Kd	5.42021640338319	uM	70		4
	6f2g	2.92	2019	Kd	8.4089353929735	nM	134	Kd=3.9+/-1.4nM	2
	6obn	2.7	2019	Kd	7.517126416391246	nM	305	No Mn2+ metal ion	4
	6mc9	3.3	2019	Kd	6.515700160653214	nM	149		2
	6h46	2.22	2019	Kd	7.522878745280337	nM	156	ForteBio Octet Red384 bioassay	2
	6orq	4.4	2019	Kd	7.522878745280337	nM	218		34
	6h16	2.9	2019	Kd	7.497572880015567	nM	119		6
	6iw8	2.8	2019	Kd	6.478861916295964	nM	433		2
	6fbx	1.64	2019	Kd	6.464705879957229	nM	26		2
	6dc3	3.5	2019	Kd	7.468521082957745	nM	568	RSV F subtype A Kd=34nM; RSV F subtype B Kd<0.016nM	3
	6oy4	2.45	2019	Kd	7.455931955649724	nM	221		3
	6a6i	2.6	2019	Kd	4.442492798094342	uM	76		8
	6gtq	2.49	2019	Kd	6.43533393574791	nM	46		4
	6h3u	3.17	2019	Kd	7.443697499232712	nM	248		10
	6ilk	3.0	2019	Kd	6.425968732272281	nM	192	at PH 7.4	5
	6j5f	1.8	2019	Kd	6.4089353929735005	nM	120		3
	6f0h	1.98	2019	Kd	8.522878745280337	nM	26	Kd(ip4)=3+/-1nM	4
	6o3b	2.5	2019	Kd	8.346787486224656	nM	140		6
	6phc	2.9	2019	Kd	8.337242168318426	nM	228		6
	6r8x	2.04	2019	Kd	11.327902142064282	pM	236	solution equilibrium titration measurements	3
	6otc	1.7	2019	Kd	8.309803919971486	nM	240		3
	6her	1.2	2019	Kd	7.3979400086720375	nM	124	Crystal 1 at pH 8.0	2
	6s8s	2.21	2019	Kd	6.3872161432802645	nM	44		4
	6j9h	2.31	2019	Kd	7.376750709602099	nM	238		4
	6gvl	2.05	2019	Kd	4.356547323513813	uM	30		2
	6j5d	1.8	2019	Kd	7.342944147142896	nM	120		3
	6pnq	1.95	2019	Kd	7.309803919971486	nM	168		2
	6rhw	2.75	2019	Kd	8.397940008672037	nM	195		3
	6thg	4.07	2019	Kd	8.397940008672037	nM	151	binding was assessed by flow cytometry	23
	6o3a	2.1	2019	Kd	8.2839966563652	nM	138		3
	6km7	1.8	2019	Kd	5.2839966563652006	uM	69		4
	6i2m	2.3	2019	Kd	8.27490547891853	nM	388		2
	6h3t	2.84	2019	Kd	8.267606240177031	nM	248		10
	6u8c	2.61	2019	Kd	7.301029995663981	nM	238		6
	6er6	1.56	2019	Kd	7.292429823902063	nM	93		2
	6um5	4.2	2019	Kd	6.274088367704952	nM	238		33
	6uvo	2.9	2019	Kd	9.237321436272564	pM	232		3
	6ihb	2.84	2019	Kd	7.2441251443275085	nM	735		2
	6s53	2.8	2019	Kd	5.301029995663981	uM	152		12
	6jo8	3.5	2019	Kd	5.220403508742176	uM	269		12
	6k4k	2.72	2019	Kd	8.186419011431807	nM	149		4
	6akm	2.3	2019	Kd	5.161150909262744	uM	64		2
	6dkj	1.95	2019	Kd	10.214670164989233	pM	117	Binding of hGIPR-Ab to human GIPR membranes measured using KinExA technology	6
	6rhv	2.29	2019	Kd	7.200659450546418	nM	195		3
	6o60	2.5	2019	Kd	7.161150909262744	nM	424		4
	6s29	1.99	2019	Kd	8.11069829749369	nM	61		4
	6ppg	2.75	2019	Kd	11.10902040301031	pM	226		6
	6mm6	2.39	2019	Kd	4.133712660915805	uM	209		4
	6ere	2.25	2019	Kd	7.136677139879544	nM	95		4
	6iec	3.2	2019	Kd	6.129011186239425	nM	316		12
	6a79	2.31	2019	Kd	8.086186147616283	nM	138		6
	6jjw	2.4	2019	Kd	8.086186147616283	nM	32		2
	6p67	2.9	2019	Kd	8.060480747381382	nM	225		15
	6kbr	2.0	2019	Kd	11.050122295963126	pM	65	KLK4-K41043 complex	2
	6j9m	2.39	2019	Kd	7.0915149811213505	nM	74		6
	6nk7	4.99	2019	Kd	7.0762380391713	nM	261	Cryo-EM Structure	17
	6dca	2.6	2019	Kd	7.073451775364381	nM	31		12
	6jwj	1.58	2019	Kd	7.0670191780768015	nM	23		2
	6oel	3.1	2019	Kd	6.055517327849832	nM	229		6
	6plm	2.59	2019	Kd	7.047691990337875	nM	147		4
	6czo	2.95	2019	Kd	7.050609993355087	nM	62		4
	6msu	3.11	2019	Kd	8.036212172654444	nM	32		12
	6pdx	3.99	2019	Kd	11.011441043121385	pM	237		27
	6ivz	2.4	2019	Kd	8.013228265733755	nM	131		3
	6ib8	1.65	2019	Kd	7.026872146400302	nM	72		3
	6uda	4.2	2019	Kd	8.045757490560675	nM	249	protein was generated in GnT1- cell line	15
	6saz	3.0	2019	Ki	9.853871964321762	nM	202	determined in vitro in a Varioskan Flash 3001 spectral plate reader	7
	6ht9	3.1	2019	Ki	10.0	nM	378		5
	6dwh	2.0	2019	Ki	9.698970004336019	nM	175	wildtype BBKI	12
	6bx8	1.98	2019	Ki	6.698970004336019	uM	80		8
	6dwf	1.94	2019	Ki	8.886056647693163	nM	169		12
	6n9d	2.67	2019	Ki	10.749579997691106	pM	184		2
	6mav	2.37	2019	Ki	10.474955192963154	pM	184		2
	6har	1.5	2019	Ki	10.214670164989233	pM	80		2

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment